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Abstract 
 
All cells require means to obtain nutrients, dispose of waste, and communicate with 
other cells.  One mechanism fulfilling these requirements is active transport, and many 
permeases in proteomes provide this function.  One family of permeases is the 
Oligopeptide Transport (OPT) family, which is characterized by transporting 
tetra/penta-peptides across the plasma membrane. 
In this research, an informatic approach was taken to identify 103 family members, 
all from plant or fungal species with sequence homology to OPTs of known function.  
Eighteen conserved motifs were identified in these homologues.  Using several 
computational algorithms and multiple sequence alignment, 12 transmembrane domains 
have been identified in the family, with the termini predicted to be outside of the cell.  
Most, but not all, of the conserved motifs lie in the non-transmembrane loops of the 
proteins. 
One OPT family member in the yeast Saccharomyces cerevisiae, Opt1p, was further 
characterized and found to transport Leu-enkephalin (Tyr-Gly-Gly-Phe-Leu) and 
reduced glutathione (γ-Glu-Cys-Gly).  The uptake of these substrates was inhibited by 
substrates of other OPTs (i.e. KLGL) and substrates that inhibit Leu-enkephalin uptake 
into mammalian brain (i.e.. naloxone, naltrexone, and morphine).  A screen was 
conducted to identify an OPT functional homologue in rat brain, but none was found. 
The expression of the gene encoding Opt1p, OPT1, was characterized using a 
reporter construct with the promoter of OPT1 cloned up-stream of lacZ, the gene 
encoding β-galactosidase.  When sulfur was absent from the medium, OPT1 was up-
regulated.  Additionally, when naturally occurring amino acids were added to the sulfur-
free medium, OPT1 was further up-regulated, up to 30-fold.  Furthermore, this induction 
was dependent on the presence of PTR3 and SSY1, genes encoding Ptr3p and Ssy1p.  
These proteins form the SPS complex with Ssy5p to sense extracellular amino acids.  
The complex transduces the signal to up-regulate amino acid and the di/tri-peptide 
permease genes. 
iv 
The OPT family is a relatively new family of transporters.  This study of its structure, 
function, and regulation lays the groundwork and defines future areas of investigation. 
v 
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Chapter 1 
Characteristics of the Oligopeptide Transport family. 
 
Background and Significance 
Active transport is a mechanism by which cells may obtain nutrients, dispose of 
waste, and mediate cell-cell communication.  These are needs of every cell, and 
therefore permeases pervade the proteomes of every species and cell type.  The 
Transport Classification Database (TCDB) (tcdb.ucsd.edu/index.php) lists over 360 
transporter families, each identifed by a “TC” number.  One specific cellular transport 
need is the uptake of peptides from the environment.  The TCDB lists three families of 
peptide transporters:  ABC (TC #3.A.1), PTR (TC #2.A.17), and OPT (TC #2.A.67). 
Members of the ABC (ATP binding cassette) transporter superfamily transport a 
large variety of substrates, from carbohydrates, amino acids, and peptides, to ions, lipids, 
and proteins.  The superfamily is currently divided into 212 families.  An ABC 
transporter protein is composed of two domains that bind and hydrolyze ATP 
(nucleotide binding domains) and two domains that usually make up 12 transmembrane 
domains (TMDs) (Dassa and Bouige 2001).  Permeases in the PTR (peptide transport) 
family have 12 TMDs and transport di- and tripeptides using the proton gradient, and 
this family is a member of the Major Facilitator Superfamily (Chang et al. 2004).  All PTR 
family members contain the conserved motif FYXXINXGSL (Hauser et al. 2001).  The 
OPT (oligopeptide transport family) is the newest member of the peptide transport 
families.  Members of this family have the ability to transport tetra- and pentapeptides. 
 
History of the OPT family. 
During studies of peptide transport in Candida albicans, it was noted that this yeast 
was able to transport peptides consisting of two to five amino acid residues.  The 
cloning of a peptide transporter gene, CaPTR2, accounted for the phenotype of di- and 
tripeptide transport, but clearly, a second transporter responsible for tetra- and 
pentapeptide uptake was present in the organism.  It was this observation that led 
Lubkowitz et al. (1997) to clone CaOPT1, the tetra-/pentapeptide transporter from C. 
2 
albicans.  CaOPT1 was cloned by heterologous expression of a C. albicans genomic library 
in an oligopeptide transport deficient strain of Saccharomyces cerevisiae.  The predicted 
protein (CaOpt1p) was characterized as containing 12 to 14 TMDs.  It was not a 
member of either the ABC or the PTR membrane transport families:  CaOpt1p contains 
neither the nucleotide binding domains of the ABC family nor the conserved PTR family 
motif. 
The Schizosaccharomyces pombe OPT homologue ISP4 was subsequently cloned and 
identified by function as an oligopeptide transporter (Lubkowitz et al. 1998), as were the 
two S. cerevisiae ORFs YJL212C and YPR194C, later named OPT1 and OPT2, respectively 
(Hauser et al. 2000).  Since neither OPT1 nor OPT2 were expressed well under standard 
conditions in strains with auxotrophic requirements, they were cloned and expressed 
from the constitutive promoter ADH in the plasmid pDB20 (Becker et al. 1991).  The 
phenotype of strains expressing these OPTs was similar to that of the S. cerevisiae strain 
expressing CaOPT1:  they were able to transport tetra- and pentapeptides. 
The focus of this dissertation is the study of OPT family members, especially those in 
S. cerevisiae, and the search for other proteins that may share the family’s transport 
characteristics.  Also included is a study of TMD locations in the family. 
 
Materials and Methods 
Algorithms used. 
Using Opt1p as the query, a Position Specific Iterative-Basic Local Alignment 
Sequence Tool (PSI-BLAST) search (Altschul et al. 1997; Schaffer et al. 2001) of the non-
redundant, protein database at National Center for Biotechnology Information (NCBI; 
www.ncbi.nlm.nih.gov/) was conducted on 1 February 2005, until no new sequences 
were found.  Sequences were inspected individually for overall conservation before 
being included in each subsequent iteration of the algorithm.  Protein sequences 
reported after the last iteration were retrieved from GenBank.  The algorithms 
ClustalW (ClustalX; www.embl.de/~chenna/clustal/darwin) and DrawTree (Phylip; 
evolution.genetics.washington.edu/phylip.html) were used to align and visualize the 
family. 
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In vivo DNA manipulations. 
Escherichia coli was often used for amplification of plasmid:  all plasmids used in this 
dissertation were designed for yeast expression but also could be shuttled through E. 
coli.  E. coli transformations were carried out using DH5α heat-shock competent cells 
(Gibco/Invitrogen; Carlsbad, CA).  The manufacturer’s protocol was followed with 10 
ng plasmid DNA.  For plasmid preps, Wizard® Plus SV Miniprep DNA Purification spin 
columns (Promega; Madison, WI) were used.  E. coli containing plasmid was maintained 
on LB Amp (Appendix 1). 
Yeast was also employed to aid in DNA manipulation.  Yeast transformations were 
performed following the Gietz lab protocol (Gietz and Woods 2002).  In brief, cells to 
be transformed were harvested in log phase and made competent with lithium acetate.  
From 1 to 4 µg of linear or plasmid DNA was used in the transformation; twice as much 
insert to linearized plasmid (2:1) was used when making use of homologous 
recombination.  When transforming yeast with linear DNA for the purpose of creating a 
knock-out strain, cells were allowed to recover for two hours in YEPD (Appendix 1) at 
30 C shaking at 200 rpm before plating on YEPD containing the appropriate drug 
(Appendix 1).  Knock-out colonies were picked and streaked for isolation after four 
days of incubation; plasmid transformants and cells transformed to make use of 
homologous recombination were picked after two to three days of growth on casamino 
acid medium (Appendix 1).  Plasmids were recovered from yeast with a Zymoprep kit 
(Zymo Research; Orange, CA). 
Yeast genomic DNA was obtained by the following method.  A 5 mL culture of the 
strain whose genomic DNA was to be purified was grown overnight at 30 C at 200 rpm 
in YEPD (Appendix 1).  The cells were harvested in a tabletop centrifuge at top speed 
for five minutes, and they were resuspended in 500 µL of sterile water.  The cells were 
again pelleted at top speed, this time in a microfuge.  The cells were resuspended in 300 
µL breaking buffer (2% w/v Triton X-100, 1% w/v SDS, 100 mM NaCl, 10 mM Tris-HCl 
pH 8.0, 1 mM EDTA pH 8.0), and 450 mg of glass beads and 300 µL phenol/chloroform/ 
isoamyl alcohol (24:24:1) were added to the tube.  The tube was vortexed at top speed 
for three minutes.  Then 100 µL TE buffer was added, and the tube was vortexed 
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briefly.  The sample was again microfuged at top speed for five minutes, and the aqueous 
layer was transferred to a new tube.  One milliliter of ethanol was added and mixed into 
the solution by inversion, and the tube was placed at -20 C for twenty minutes.  The 
tube was again microfuged at top speed for three minutes, the supernatant removed, 
and the pellet resuspended in 400 µL TE.  Three microliters of RNase (10 mg/mL, 
Ambion; Austin, TX) was mixed into the solution, and it was incubated at 37 C for five 
minutes.  Eight microliters of 5 M ammonium acetate and 1 mL ethanol were mixed into 
the tube, and it was again incubated at -20 C for twenty minutes.  The solution was then 
microfuged for three minutes at top speed, and the pellet was dried.  The genomic 
DNA was resuspended in 100 µL sterile water. 
 
Strain construction. 
An opt1∆ opt2∆ double knock-out in the strain BY4730 (Appendix 2) was created to 
study the open reading frame (ORF) YGL114W in the absence of the two confirmed 
oligopeptide transporters in S. cerevisiae.  Cassettes providing resistance to G418 and 
hygromycinB (Appendix 3) were amplified by PCR with primers designed for 
homologous recombination (Appendix 4) flanking the ORFs of OPT1 and OPT2 
respectively.  The reaction consisted of 2 units of RedTaq™ (Sigma-Aldrich; St. Louis, 
MO), 1 pmol of each primer (Appendix 4), 200 µM dNTPs, 1x Sigma RedTaq buffer with 
MgCl2, and 2 ng plasmid DNA (Appendix 3).  The components were combined on ice 
and immediately placed at 95 C for five minutes to begin the reaction.  Forty cycles 
were carried out:  1 minute at 95 C, 1 minute at 52 C for KanMX4 or 55 C for 
HphMX3, and 3 minutes at 72 C.  An additional seven minutes were added at 72 C for 
extension, followed by a hold at 4 C.  The reactions were visualized by separation of 
DNA on a 1% agarose/TAE gel with subsequent staining with ethidium bromide.  PCR 
products were purified by SOPE column (Open Biosystems; Huntsville, AL). 
Gene knock-outs were confirmed by both PCR and Southern blot analysis.  Primers 
were designed to anneal to sequence flanking the knocked-out region (Appendix 4).  
The reaction consisted of 2 units of RedTaq™ (Sigma-Aldrich; St. Louis, MO), 1 pmol of 
each primer, 200 µM dNTPs, 1x Sigma RedTaq buffer with MgCl2, and 8 ng genomic 
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DNA.  The components were combined on ice and immediately placed at 95 C for five 
minutes to begin the reaction.  Forty cycles were carried out:  1 minute at 95 C, 1 
minute at 54 C, and 3 minutes at 72 C.  An additional seven minutes were added at 72 
C for extension, followed by a hold at 4 C.  Products were visualized by agarose gel 
electrophoresis. 
Twenty micrograms of genomic DNA was digested overnight in a volume of 200 µL 
with 10 µL of one of two restriction enzymes chosen for each gene, one which cut only 
flanking the ORF, the other which cut internally:  BamHI flanked both, while KpnI cut 
OPT1 and FspI cut OPT2.  Buffers, BSA concentration, and temperatures were used as 
dictated by the New England BioLabs Catalog (Beverly, MA).  Also included was 
genomic DNA from the parent strain FY2 (Appendix 2).  After digestion, DNA was 
precipitated with 1 mL ethanol and 30 µL ammonium acetate (5 M) by incubating at -20 
C for two hours followed by centrifugation for eight minutes under vacuum. 
Digested DNA was resolved on a 0.7% agarose/TAE gel in a 400 cm2 gel box.  After 
visualization, the gel was depurinated in acid (0.26 N HCl, 500 mL) for 20 minutes, 
denatured in saline base (0.5 M NaOH, 1.5 M NaCl, 500 mL) for 30 minutes, and 
neutralized in saline Tris buffer (0.5 M Tris-HCl pH 7.5, 1.5 M NaCl, 500 mL) for at least 
30 minutes, all while gently shaking.  The solutions were decanted after each step.  The 
DNA was blotted overnight to a positive nitrocellulose membrane (Osmonics/GE 
Water Technologies; Piscataway, NJ) overnight in 20x SSC (175.3 g sodium chloride and 
88.2 g sodium citrate per 1 L, pH 7.0) by capillarity action, then air dried before the 
DNA was cross-linked to the membrane using a UV Stratalinker (Stratagene; La Jolla, 
CA) set to 1200 kJ. 
Probes were constructed by PCR from amplification of the ORF from genomic DNA 
using probe primers specific for each gene (Appendix 4).  The following conditions were 
used:  2 units of RedTaq™ (Sigma-Aldrich; St. Louis, MO), 1 pmol of each primer 
(Appendix 4), 200 µM dNTPs, 1x Sigma RedTaq buffer with MgCl2, and 8 ng genomic 
DNA obtained as described above.  The components were combined on ice and 
immediately placed at 95 C for five minutes to begin the reaction.  Forty cycles were 
carried out:  1 minute at 95 C, 1 minute at 55 C, and 3 minutes at 72 C.  An additional 
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seven minutes were added at 72 C for extension, followed by a hold at 4 C.  PCR 
products were purified by SOPE column (Open Biosystems). 
Purified PCR product was labeled using a random-prime labeling technique as 
follows.  Fifty nanograms of DNA was incubated for 1 hour at 37 C with 3 µg random 
9-mer or 5 µg random 6-mer, 1x label buffer (900 µM HEPES, 100 µM Mg), 50 nM 
dNTP (no ATP), 10 mM DTT, 3 µL 32P dATP, and 1 µL Klenow enzyme (Fisher 
Scientific; Hampton, NH) in 20 µL.  A spin-column purification was performed to purify 
the radioactive probe — either Bio-Spin® chromatography columns (Bio-Rad; Hercules, 
CA) or ProbeQuant micro columns (Amersham/GE Heathcare; Piscataway, NJ) were 
used. 
The membrane was washed in 2x SSC and placed into a hybridization bag (Roche; 
Indianapolis, IN) along with 25-30 mL prehybridization solution [1x HPB (5x HPB is 
146.1 g sodium chloride, 134.0 g disodium hydrogen phosphate, and 9.3g EDTA per 1L, 
pH 7.0), 1% sarkosyl, 200 µg/mL boiled herring sperm DNA (Promega)], sealed, and 
incubated while shaking at 65 C for 4 hours.  The probe was boiled for five minutes 
then added to the bag and the bag resealed.  Hybridization took place overnight, shaking 
at 65 C.  The blot was rinsed three times with 0.1% SDS, 0.1x SSC (1 L total) at 65 C.  
The blot was then wrapped in plastic wrap and placed in a cassette against a Molecular 
Dynamics phosphor screen (Amersham/GE Heathcare) overnight.  The screen was 
analyzed on a STORM 840 densitometer with ImageQuant (Amersham/GE Heathcare). 
 
Plasmid construction. 
The S. cerevisiae ORF YGL114W was cloned into the vector pDB20 for constitutive 
expression (Appendix 3) in a manner similar to the cloning of OPT1 and OPT2 
(Lubkowitz et al. 1998; Hauser et al. 2000).  Primers were designed to amplify YGL114W 
from genomic DNA and to make use of homologous recombination for plasmid 
construction (Appendix 4).  PCR conditions were as follows:  2 units of Pfu DNA 
polymerase (Stratagene; La Jolla, CA), 1 pmol of each primer, 200 µM dNTPs, 1x buffer 
supplied with enzyme, 2.5 mM MgCl2, and 8 ng genomic DNA.  The components were 
combined on ice and immediately placed at 95 C for five minutes to begin the reaction.  
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Forty cycles were carried out:  45 seconds at 95 C, 45 seconds at 55 C, and 3.5 minutes 
at 72 C.  An additional seven minutes were added at 72 C for extension, followed by a 
hold at 4 C.  The reaction was visualized by separation of DNA on a 1% agarose/TAE 
gel with subsequent staining with ethidium bromide.  PCR products were purified by 
SOPE column (Open Biosystems).  The parent plasmid, pDB20, was linearized with 2 µL 
of NotI in a 20 µL reaction, and it and the YGL114W PCR product were co-transformed 
into FY2 (Appendix 2).  Plasmid was isolated from transformants and sequenced 
(Appendix 4; Sanger et al. 1977).  In line with cloned OPT1 and OPT2, the plasmid 
containing the ORF YGL114W was named pADH114w (Appendix 3). 
 
Growth assays. 
Cells were grown overnight in 50 mL of poor nitrogen medium with appropriate 
free amino acids to satisfy auxotrophic requirements (Appendix 1) at 30 C shaking at 
200 rpm.  Cultures were harvested by centrifugation for five minutes at top speed in a 
tabletop centrifuge, washed twice with water, and resuspended at 2x106 cells per mL.  
Cells were then spotted in 5 µL spots onto a variety of agar media, all with poor 
nitrogen medium as a base (Appendix 1).  These media contained methionine to fulfill 
the auxotrophic requirement and one of the following:  no leucine, 230 µM leucine, 300 
µM Leu-enkephalin (YGGFL), or 300 µM KLGL.  Plates were observed for growth for 
up to four days. 
 
Uptake assays. 
Cells were grown overnight in 50 mL of poor nitrogen medium with appropriate 
free amino acids to satisfy auxotrophic requirements (Appendix 1) at 30 C shaking at 
200 rpm.  Cultures were harvested at 4 C by centrifugation at top speed in a tabletop 
centrifuge, washed twice with cold 2% glucose, and resuspended at 2x108 cells per mL.  
These cells were then combined with an equal part of 2x uptake medium (2% glucose, 
400 µM citric acid/potassium phosphate buffer pH5.5, 250 µM [3H]-Leu-enkephalin or 
reduced [3H]-glutathione at 1 µCi per mL) and incubated for the appropriate time at 30 
C, after which the cells were filtered using a vacuum manifold fitted with 0.45 µm 
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nitrocellulose filters (Millipore; Billerica, MA).  These were then washed with 4 mL of 
ice cold water.  Filters were dissolved with CytoScent (MP Biomedicals; Irvine, CA) and 
counted with a scintillation counter. 
If inhibitors were added, they were added to the cells simultaneously with the 
radiolabeled substrates, final concentration as follows:  100 µM carbonyl cyanide 3-
chlorophenylhydrazone (CCCP), 2.5 mM tyrosine, 2.5 mM Gly-Gly-Phe, 2.5 mM Gly-
Gly-Phe-Leu, 2.5 mM Lys-Leu-Gly-Leu, or 2.5 mM Leu-Leu.  In assays using glutathione 
(GSH; γ-Glu-Cys-Gly), all tubes containing it were purged with nitrogen to keep the 
GSH in its reduced form until it was combined with cells. 
 
Results 
The OPT family is found in multiplicity in fungal and plant species. 
To obtain a current list of OPT family members, PSI-BLAST was employed to search 
the non-redundant protein database at NCBI on 1 February 2005, with Opt1p used as 
the query.  All default settings were retained.  The search was repeated until no new 
proteins were obtained — in this instance, the program was executed eight times.  
Before each successive iteration, each alignment was inspected for overall homology, 
and those subjects with weak homology (less than 40% identical/similar to Opt1p) or 
those with strong homology over only a very short region (less than 40% of the length 
of Opt1p; bit score less than 200) were omitted.  The final iteration yielded 81 unique 
fungal and 22 unique plant proteins (Table 1-1) with minimum scores of 452 bits.  (E-
values were not used because as the dataset in a database grows, an e-value for a certain 
query retrieving a certain subject changes.  E-values represent the likelihood that the 
subject would be found in the given dataset by random chance.  Bit scores, however, 
remain constant since they reflect the pairwise alignment score).  Sequences that 
appeared to be truncations of these 103 proteins were removed from the list.  Likely 
truncations were defined as sequences that were identical to a represented protein but 
were less than three-fourths of the length of that protein.  Only one copy of pairs of 
sequences with only one residue different between them was retained, since these 
differences were likely either allelic variation or sequencing error. 
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Table 1-1.  Genomes containing OPT homologues.  Genomes listed are 
those found to contain hypothetical members of the OPT family by PSI-BLAST analysis.  
The number of potential OPTs in each, as of 1 February 2005, is listed.  ORF 
translations that differed by one amino acid and those that appeared to be a truncation 
of a protein already represented (were identical to, but less than three-fourths as long 
as a represented protein) were removed from this dataset. 
 
 
Fungal genomes 
Species a Number of OPTs 
Yarrowia lipolytica b 17 
Gibberella zeae 9 
Magnaporthe grisea 8 
Neurospora crassa 8 
Candida albicans 7 
Cryptococcus neoformans b 6 
Aspergillus nidulans 5 
Ustilago maydis 5 
Ashbya gossypii b 4 
Schizosaccharomyces pombe b 4 
Kluyveromyces lactis b 3 
Debaryomyces hansenii b 2 
Saccharomyces cerevisiae b 2 
Schizophyllum commune 1 
Plant genomes 
Species Number of OPTs 
Oryza sativa b 11 
Arabidopsis thaliana b 9 
Brassica juncea 1 
Zea mays 1 
a Spizellomyces punctatus and Candida glabrata have been completely sequenced but PSI-
BLAST did not return an OPT homologue from either genome. 
b Genomes reported by the European Molecular Biology Laboratory website (EMBL; 
www.ebi.ac.uk/embl/) to be complete as of 1 February 2005.  All other species included 
in this table contain OPTs as indicated but do not have a completely sequenced genome. 
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An unrooted phylogenetic tree was created (Figure 1-1) using the alignment 
program ClustalX and the tree-drawing program DrawTree from Phylip, with all default 
settings retained.  All 22 plant members are segregated from the fungal members and 
grouped relatively tightly in comparison.  All but one of the OPT members found in Y. 
lipolytica also are grouped in their own branch.  All homologues from other species are 
distributed throughout the rest of the tree. 
Multiple OPT homologues were found in each plant or fungal genome that has been 
completely sequenced (Table 1-1), except Spizellomyces punctatus and Candida glabrata.  
PSI-BLAST only queries protein sequences, not nucleotide entries, and if a putative OPT 
member has not yet been annotated as an ORF, it would not be found by PSI-BLAST. 
 
Conserved motifs and single residues in the OPT family. 
Upon retrieval of the results from the PSI-BLAST search and analysis of the proteins 
by multiple-sequence alignment with ClustalW, 18 conserved motifs were found in the 
OPT family (Figure 1-2).  These motifs contained at least three residues found in more 
than half of the 103 family members, spread over no fewer than four residues.  If there 
were more than four non-conserved residues in a row, the motif ended.  Most residues 
were not 100% conserved; frequently, these residues were replaced with an amino acid 
with similar attributes, i.e. if arginine were the conserved residue, it was often 
substituted with a lysine.  Additionally, there were 28 amino acid residues that were 
highly conserved but not part of a motif as defined above (Table 1-2).  Each of these 
single, conserved residues was present in at least 60% of the family — nine were found 
in at least 90% of the family.  All conserved motifs or single residues are found 
consecutively in the primary sequences of OPT family members. 
A large number of proteins that are members of an iron-phytosiderophore transport 
family were found by the PSI-BLAST search, with bit scores below 452.  All of these 
contained the sequence X4PFTRQEX in place of the LNPGP[F/W/Y][N/S/T]XKE[H/Q] 
motif.  Since the iron-phytosiderophore transporter motif overlaps with the OPT motif, 
PSI-BLAST gives the family a higher score for the region.  Unfortunately, many of these 
putative proteins have already been labeled in NCBI databases as oligopeptide 
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Figure 1-1.  Unrooted phylogenetic tree of the OPT family.  In the 
phylogenetic tree, OPT members found in plant species have their own branch and are 
marked accordingly; the rest are fungi.  Similarly, 16 of the 17 members found in Y. 
lipolytica are grouped together and are labeled.  All other species with multiple members 
are distributed throughout the rest of the tree.  ORF translations not from a plant or 
named in a database are represented by the first letter of their genus and first two 
letters of their species name as listed in Table 1-1.  Those fungal members that have 
been named in databases or in the literature have been labeled, such that Opt1p and 
Opt2p are from S. cerevisiae, CaOpt1p through CaOpt7p are from C. albicans, Isp4p is 
from S. pombe, and Mtd1p is from S. commune.  ClustalW with default parameters in 
ClustalX and DrawTree from the phylogeny package Phylip were used to create this 
tree. 
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Figure 1-2.  Conserved motifs of the OPT family.  Eighteen conserved motifs 
of the OPT family are shown.  The percent listed under each conserved residue 
(represented by the single letter code for amino acids) is the frequency at which it is 
conserved in all members.  If there were no conserved residue in a location, an X is set 
in the position; if more than one residue in a row could be any amino acid, the number 
of Xs in a row is represented by subscript.  The corresponding residue number of 
Opt1p is found in bold to the left of the motif. 
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Table 1-2.  Single, conserved residues of the OPT family.  Twenty-eight 
single, conserved residues were found in over 60% of the 103 OPT family members, but 
were not assigned to the motifs listed in Figure 1-2.  These residues were consecutive in 
the linear sequence of family members. 
 
 
 
Residue 
Percent 
conserved 
Residue 
number in 
Opt1p 
T 96 106 
R 99 108 
Q 75 142 
P 84 147 
G 95 149 
P 90 157 
F 62 204 
Y 79 205 
D 98 335 
W 93 336 
P 98 351 
N 76 357 
G 84 361 
Y 73 432 
F 81 436 
P 85 508 
W 85 510 
P 86 525 
T 77 533 
V 62 606 
V 65 610 
C 82 622 
Y 97 658 
G 98 668 
K/R 73 680 
P 75 683 
F 65 755 
F 71 756 
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transporters, even though they are more closely related to the iron-phytosiderophore 
transporters. 
 
YGL114W cannot support growth on known substrates of the OPT 
family. 
Growth assays were conducted to determine if the S. cerevisiae ORF YGL114W is an 
OPT.  The ORF was cloned into the constitutive expression vector pDB20 (Appendix 
3), and cells containing pADH114w were challenged to grow on Leu-enkephalin 
(YGGFL) and KLGL, known substrates of other OPT family members, as the sole 
sources of leucine (Figure 1-3).  Unlike cells expressing CaOPT1 from C. albicans or OPT1 
from S. cerevisiae, cells containing YGL114W under a constitutive promoter could not 
grow on these media. 
 
Opt1p transport characteristics. 
When over-expressed from a constitutive promoter (pADH212c, Appendix 3) in 
the strain BY4730 (Appendix 2), OPT1 from S. cerevisiae supports the transport of both 
Leu-enkephalin, a pentapeptide, and reduced glutathione (Figure 1-4).  Cells were 
incubated for one to 12 minutes with 250 µM of either [3H]-Leu-enkephalin or [3H]-
glutathione.  Only cells that expressed Opt1p were able to accumulate substrate. 
The Km of GSH for Opt1p was determined to be 110 µM (Figure 1-5).  Five 
concentrations of GSH, from 5 to 750 µM, were tested in quadruplicate over four time-
points, ranging from one to nine minutes.  The velocity was determined for each 
concentration by ascertaining the slope of substrate transported per minute.  Velocity 
was plotted verses substrate concentration, and the Km determined by plotting one-site 
binding with Prism (GraphPad Software; San Diego, CA). 
Leu-enkephalin and GSH compete for uptake by Opt1p, inhibiting each other (Figure 
1-6).  When Leu-enkephalin uptake was measured, 25 to 500 µM of cold GSH was 
added to the uptake medium — corresponding to 0.1 to 2x the concentration of 
Leu-enkephalin (250 µM).  The Ki of GSH for Leu-enkephalin was measured as 83 µM.  
When GSH transport was measured, 0.25 to 5 mM cold Leu-enkephalin was added — 
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Figure 1-3.  Ygl114wp cannot use OPT family substrates to support 
growth in the absence of leucine.  In rows, 104 cells of the strain BY4730 (ura3Δ 
leu2Δ met15Δ, Appendix 2), either expressing CaOPT1, OPT1, or YGL114W from a 
constitutive promoter or containing the empty vector pDB20 (Appendix 3), were 
grown on poor nitrogen medium supplemented with methionine (Appendix 1).  In 
columns, the medium was supplemented with 230 µM leucine, no leucine, 300 µM 
YGGFL, or 300 µM KLGL.  Growth was observed on medium containing free leucine, 
while none was seen on medium without any leucine present.  Cells overexpressing 
CaOPT1 grew well on medium containing KLGL and very poorly on medium with 
YGGFL.  Cells overexpressing OPT1 grew well on medium containing YGGFL and 
poorly on medium with KLGL.  Cells harboring YGL114W under a constitutive 
promoter do not grow on medium with either YGGFL or KLGL as the sole source of 
leucine. 
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Figure 1-4.  Opt1p transports Leu-enkephalin and glutathione.  Cells of 
the strain BY4730 (Appendix 2)either constitutively expressing OPT1 or containing 
empty vector (Appendix 3)were incubated in the presence of either 250 µM [3H]-Leu-
enkephalin (A) or 250 µM [3H]-glutathione (B).  Only cells over-expressing OPT1 
accumulated substrate over time. 
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Figure 1-5.  Determination of Km of reduced glutathione for Opt1p.  
The Km of GSH for Opt1p was determined by uptake assays conducted in the linear 
range of transport.  In quadruplicate, five concentrations of GSH (5-750 µM) were 
evaluated over four time-points (one to nine minutes).  The slope of the line for each 
concentration (nmol substrate transported per mg dry weight of cells per minute), 
representing velocity, was determined and plotted below verses substrate 
concentration.  The Km of was determined to be 110 µM. 
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Figure 1-6.  Leu-enkephalin and glutathione compete for uptake by 
Opt1p.  Cells constitutively expressing Opt1p were incubated with either [3H]-Leu-
enkephalin and non-radiolabeled GSH (A [left] and B) or [3H]-glutathione and non-
radiolabeled Leu-enkephalin (A [right] and C) for 12 minutes.  A.  Non-radiolabeled 
substrate was present at concentrations from 0.1 to 2x (in the case of GSH) or 1 to 20x 
(in the case of Leu-enkephalin) as compared to the concentration of radiolabeled 
substrate present (250 µM).  These data were transformed and plotted as velocity 
(nmol/mg dry weight of cells/min) verses log[substrate] to determine the Kis of GSH’s 
inhibition of Leu-enkephalin (83 µM, B) and Leu-enkephalin’s inhibition of GSH (935 
µM, C). 
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1 to 20x the concentration of GSH present (250 µM).  The Ki of Leu-enkephalin for 
GSH was determined to be 935 µM. 
To determine if Opt1p was using the proton-gradient as an energy source for 
peptide transport, the protonophore CCCP was incubated with the cells during an 
assay.  With the proton-gradient abolished, Leu-enkephalin uptake by over-expressed 
Opt1p was inhibited (Figure 1-7), demonstrating that the permease does use the 
proton-gradient. 
Peptides that are transported by Opt1p are either tetra- or pentapeptides.  A 
substrate of Ptr2p, dileucine, does not inhibit Leu-enkephalin uptake (Figure 1-7), nor do 
the truncations of Leu-enkephalin tyrosine and Gly-Gly-Phe.  The tetrapeptide 
truncation Gly-Gly-Phe-Leu, however, does inhibit transport of Leu-enkephalin.  In 
addition, the tetrapeptide Lys-Leu-Gly-Leu (KLGL), a known substrate of other OPT 
members, inhibits Leu-enkephalin transport by Opt1p.  Further characterization of 
inhibitors of Opt1p transport may be found in Chapter 3. 
 
Characteristics of other family members. 
An uptake assay was performed to ascertain whether other OPTs – AtOPT1-7 from 
A. thaliana, CaOpt1p from C. albicans, and Opt2p from S. cerevisiae – transported GSH in 
a manner similar to Opt1p from S. cerevisiae (Figure 1-8).  When expressed from a 
constitutive promoter in S. cerevisiae, they do not support transport, and Opt1p remains 
the only family member that has been observed to transport GSH.  AtOPT4, however, 
does transport the tetrapeptide KLGL, although it does so poorly (Figure 1-9).  To 
observe transport of KLGL by AtOPT4, the incubation time was increased from the 
normal 12 minutes to 30 minutes. 
 
Discussion 
Our laboratory first identified the Oligopeptide Transport (OPT) system in 1997 in 
C. albicans (Lubkowitz et al. 1997) and later established it in S. pombe (Lubkowitz et al. 
1998).  At that time, the ORFs YJL212C and YPR194C, both from S. cerevisiae, were 
identified as potential homologues based on sequence homology.  They were cloned and 
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Figure 1-7.  Inhibitors of Leu-enkephalin transport by Opt1p.  With 
uptake medium, the protonophore CCCP was added to cells over-expressing Opt1p 
and incubated for 12 minutes.  Likewise, truncations of Leu-enkephalin (tyrosine, Gly-
Gly-Phe, and Gly-Gly-Phe-Leu) or known substrates of other peptide transporters (Lys-
Leu-Gly-Leu, CaOpt1p; Leu-Leu, Ptr2p) were added at a 10x concentration to that of 
the 250 µM [3H]-Leu-enkephalin.  Bars represent percent of Leu-enkephalin transported 
as compared to control. 
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Figure 1-8.  Opt1p is the only family member known to transport 
glutathione.  Cells of the strain BY4730 (Appendix 2) constitutively expressing OPT1 
or OPT2 from S. cerevisiae or AtOPT1-7 from A. thaliana, or cells of the same strain 
expressing CaOPT1 from its native promoter, and cells containing the empty vector 
pDB20 were incubated in uptake medium for 12 minutes with 250 µM [3H]-glutathione.  
Only cells over-expressing Opt1p from S. cerevisiae accumulated the substrate over 
time. 
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Figure 1-9.  AtOPT4 transports KLGL.  Cells of the strain BY4730, expressing 
CaOPT1 from its own promoter, AtOPT4 from a constitutive promoter, or the empty 
vector pDB20, were incubated with 500 µM [3H]-KLGL for 30 minutes at 30 C or 0 C.  
CaOPT1 was used here as a positive control.  Cells harboring the plasmid containing 
AtOPT4 were able, albeit poorly, to accumulate KLGL while at 30 C. 
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determined to be OPT members by functional analysis, namely uptake and growth 
assays, and therefore named Opt1p (Hauser et al. 2000) and Opt2p, respectively. 
 
A multiplicity of OPTs. 
By PSI-BLAST analysis, the family has now been extended to 81 fungal and 22 plant 
members, the plant members comprising their own branch.  This seems to imply a single 
ancestor before the fungi and plant kingdoms were formed.  This new PSI-BLAST 
analysis yielded no new OPT members in A. thaliana; in 2002, we identified and named 
AtOPT1 through 9 (Koh et al. 2002).  Zhang et al. (2004) have recently cloned and 
confirmed the first OPT member in O. sativa — OsGT1.  It is likely that as more plant 
genomes near sequence and annotation completion, more OPT members will be added 
to this small OPT sub-section. 
The fungal family members are not grouped by species, with two exceptions:  OPTs 
in Y. lipolytica are more closely related to each other than to OPTs in any other 
organism and some of the OPTs found in C. albicans form a cluster.  The three most 
closely related C. albicans proteins — CaOpt2p, CaOpt3p, and CaOpt4p — are the top 
three unique C. albicans OPT members to be up-regulated when the cell is phagocytosed 
by macrophages (Lorenz et al. 2004).  These three are the same three also up-regulated 
in the opaque as compared to white phase of the yeast (Tsong et al. 2003).  OPTs in C. 
albicans are not up-regulated, however, when the cell is phagocytosed by neutrophils 
(Rubin-Bejerano et al. 2003).  Perhaps these OPTs are involved in virulence or even 
mating — C. albicans cells in opaque phase are the only cells that have been observed to 
mate (Soll et al. 2003) .  Two OPTs in other species, Isp4p in S. pombe and Mtd1p in S. 
commune, were originally identified in screens to search for proteins involved in mating 
(Sato et al. 1994; Lengeler and Kothe 1999).  In fungi, conditions for mating are also 
conditions in which the cell is starving for nutrients.  In the past, the idea that OPTs 
were involved in mating was dismissed the the argument that the genes were simply up-
regulated during starvation conditions.  Now that three C. albicans OPTs have been 
observed to be up-regulated in both opaque phase cells and cells that have been 
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phagocytosed by macrophages, proteins encoded by these genes are implicated in either 
the mating process or virulence. 
Because of the multiplicity of family members in each species, it is surprising that no 
OPTs were found in the two completed genomes S. punctatus and C. glabrata.  If these 
species have the ability to transport oligopeptides, they must do so utilizing permeases 
unrelated to the OPT family. 
 
OPT familial motifs. 
The “SPY,” or SPYXEVR[A/S][A/V]VX3DDP, conserved motif was first reported in 
1998 (Lubkowitz et al. 1997).  We have later referred to the “NPG” motif 
(NPG[P/A]F[N/T/S]XKEH[V/T/A][L/I/V][I/V]I[T/S/V][I/V/M][F/M][A/S][N/S/A]) and the 
“KIPPR” motif (K[L/F][G/A][H/M/T]YMK[I/V/L][P/D/S]PR) (Koh et al. 2002).  Here, 
having over ten-fold the number of homologues from which to draw, we wish to clarify 
the OPT family motifs.  When analyzing 103 OPT homologues, the “SPY” motif is 
altered to SPYXEVRXV[V/T]X3D[D/E]P.  In addition, the “NPG” motif is now shortened 
to LNPGP[F/W/Y][N/S/T]XKE[H/Q]; the last nine residues of the motif as we 
previously reported are mainly hydrophobic but not conserved enough to be included in 
the motif.  The “KIPPR” motif has been lengthened and modified.  It now stands as 
QGX2FX2DXKX2HYXKXPPRX2FX2Q[V/I/L], the section underlined representing the 
residues of the motif as it formerly was reported.  Furthermore, 28 single residues were 
also conserved, present in at least 60% of the family members.  These amino acid 
residues were more than four residues away from a motif, but due to their 
conservation, they are likely important in function of the transporters. 
The PSI-BLAST iterations yield a group of proteins below the bit score of 452.  Most 
of these proteins contained a X4PFTRQEX motif, in place of the “NPG” motif 
(LNPGP[F/W/Y][N/S/T]XKE[H/Q]) identified for the OPT family.  These proteins did 
not, however, contain any of the other OPT conserved motifs, although they did have 
an overall weak homology (less than 40% identity/similarity) to Opt1p, mainly in the 
hydrophobic stretches.  Many of the PFTRQE containing proteins had been labeled as 
members of an iron-phytosiderophore transport family — some had also been labeled 
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as OPT members.  It has even been published that one of these confirmed iron-
phytosiderophore transporters, Yellow Stripe 1 (YS1) from Z. mays, is an OPT member 
on the basis of a BLAST alignment report (Yen et al. 2001).  It is not surprising that a 
transporter with a large number of TMDs hits another transporter with a large number 
of TMDs during a BLAST search.  BLAST searches are the only evidence there is for 
these iron-phytosiderophore transporters being part of the OPT family.  Because YS1 
homologues do not contain any of the OPT family motifs and transport different 
substrates, I propose that they constitute a family separate from the OPTs. 
 
Substrates of OPTs. 
We have identified the S. cerevisiae protein Opt1p as a transporter of the 
pentapeptide Leu-enkephalin (Hauser et al. 2000).  The Km of the pentapeptide was 
calculated to be 310 µM.  The transport was determined to be dependent on both 
temperature, suggestive of active transport, and pH.  Bourbouloux et al. (2000) 
determined that GSH was also a substrate of Opt1p, with a Km of 54 µM.  Our repeat of 
this experiment, shown here, doubles that Km to 110 µM.  As expected, Leu-enkephalin 
and GSH compete with each other for transport by Opt1p. 
Our work suggests that Opt1p is unique in its ability to transport GSH.  A recent 
paper by Cagnac et al. (2004) describes the ability of AtOPT6 to uptake GSH.  Although 
we only witnessed the ability of AtOPT6 to grow on KLLLG as the sole source of 
leucine (Koh et al. 2002), Cagnac et al. have shown that uptake of GSH by the 
permeases was inhibited by Leu-Leu, contrary to our growth assays.  Zhang et al. (2004) 
have also recently shown evidence that OsGT1 from O. sativa can transport glutathione 
derivatives; this uptake can also be inhibited by Leu-Leu.  The fact that the OPTs that 
mediate GSH uptake are not phylogenetically grouped suggests that the family did not 
evolve into proteins that group by function, but rather evolved as general oligopeptide 
transporters with some members converging in their capability of transporting GSH. 
Saier’s lab (Yen et al. 2001) has labeled the S. cerevisiae ORF YGL114W as a putative 
OPT homologue due to a BLAST result.  Indeed, we have also observed this ORF in 
BLAST results, albeit with a low bit score of 189 and only 11% identity.  Despite it being 
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retrieved via BLAST and Yen et al.’s claim that it is an OPT, here we show that the 
over-expression of YGL114W is not sufficient to support growth on a tetra- or 
pentapeptide as the sole source of leucine.  This does not mean that YGL114W does not 
encode a peptide transporter.  There are 16,000 possible tetrapeptides and an 
enormous 320,000 possible pentapeptides; it is impossible to test even a fraction of 
these. 
Another possible role for Ygl114wp is that of receptor.  Snf3p and Rgt2p had initially 
been thought to be hexose transporters, and it was believed that Ssy1p was an amino 
acid transporter.  All of these were later discovered to be receptors (Ozcan et al. 1996; 
Iraqui et al. 1999).  What distinguishes these three receptors from Ygl114wp, however, 
is their lengthy N-termini, used in signaling.  The N-terminus of Ygl114wp is predicted 
to be a mere 27 residues long, and therefore it is unlikely that the protein’s N-terminus 
is involved in signaling. 
 
A niche for the OPT family. 
It is difficult to propose a single biological niche for the OPT family:  some members 
appear to be GSH transporters while other are clearly not; some C. albicans members 
are up-regulated during phagocytosis and opaque phase while the rest are not.  The 
small amount of data available suggests that members of the OPT family are often up-
regulated during times of stress and cell-wall turnover.  For example, AtOPT3 is 
required for embryonic development in A. thaliana (Stacey et al. 2002). This development 
relies heavily on nutrients as the plant begins growth.  Nutrient starvation also induces 
mating in the fungi’s natural environment.  The regulation of MTD1, an OPT in S. 
commune, is dependent on mating-type, and its transcript levels are significantly higher in 
fully compatible mated cells (Lengeler and Kothe 1999).  ISP4 from S. pombe was 
originally designated as a gene involved in sexual differentiation (Sato et al. 1994), but 
later shown to be simply up-regulated while using proline as a nitrogen source 
(Lubkowitz et al. 1998).  Additionally, three OPTs from C. albicans are up-regulated in 
opaque-phase cells, the only phase of Candida in which mating has currently been 
observed.  All of the conditions share one thing:  they all place a nutrient stress on the 
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cell, requiring it to scavenge nutrients from its immediate environment.  Predictably, 
organisms require methods to take in essential nutrients, and therefore oligopeptide 
transporters are up-regulated at these times. 
We have established distinct motifs covering the entire length of the proteins in the 
OPT family and have identified their transport characteristics.  We have discovered a 
wide range of peptides that this family can uptake, from various tetra- and pentapeptides 
and the tripeptide glutathione, to cyclic compounds that mimic the pentapeptide Leu-
enkephalin, discussed in detail in Chapter 3.  This opens other lines of inquiry:  the 
regulation of OPT expression in S. cerevisiae, topology of family members with respect to 
conserved domains, and the true function of Ygl114wp, the first two of which are 
investigated in this dissertation in Chapters 2 and 4, respectively.  This is the first time 
the OPT family has been so extensively studied, by either computational or functional 
analysis. 
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Chapter 2 
Regulation of the Oligopeptide Transport family in 
Saccharomyces cerevisiae. 
 
Background and Significance 
Little is known about the regulation of OPT expression in S. cerevisiae (Hauser et al. 
2001).  While some microarray data have been gathered on various environmental 
conditions that regulate OPT (to be summarized in the discussion section of this 
chapter), the proteins involved have not been clearly defined.  In strain backgrounds 
necessary for functional studies of Opt1p and Opt2p, their transcripts are not 
expressed under a number of growth conditions, requiring activation by an artificial 
constitutive promoter to observe the transport phenotype they mediate (Lubkowitz et 
al. 1998; Hauser et al. 2000; Chapter 1).  The conditions that allow native expression of 
these proteins are not known. 
In other organisms that have a multiplicity of OPTs, however, some information has 
been generated regarding expression of OPT genes.  Stacey et al. (2002) found that 
AtOPT3 is expressed during and required for embryonic growth of A. thaliana, which 
has nine OPTs.  Lorenz et al. (2004) observed up to 30-fold induction of three of the 
nine C. albicans OPTs upon phagocytosis by macrophages and no induction of other 
family members in the same species.  We hypothesize that the multiplicity of OPTs in A. 
thaliana and C. albicans may allow differential expression under various environmental or 
developmental conditions. 
 
Regulation of the di/tri-peptide transporter in S. cerevisiae. 
The regulation of the gene encoding the other peptide transporter in yeast, PTR2, is 
better understood than OPT1 or OPT2.  Transcript levels of PTR2 are increased when 
cells are grown on the poor nitrogen source allantoin (Island et al. 1987).  Levels of 
Ptr2p at the membrane drop dramatically within 30 minutes after the addition of a rich 
nitrogen source, such as ammonium sulfate (Minkin and Becker, unpublished).  In 
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addition, PTR2 expression is increased when cells are exposed to tryptophan or leucine.  
PTR2 RNA levels peak at 40 minutes when induced with leucine (Perry et al. 1994), but 
dipeptide transport peaks at four hours when induced with tryptophan (Island et al. 
1987). 
It is not known which proteins regulate the nitrogen response of PTR2, but the 
amino acid response is regulated through the amino acid receptor Ssy1p (Didion et al. 
1998).  Ssy1p is an integral membrane protein that interacts with Ptr3p and Ssy1p to 
form the SPS complex (Forsberg and Ljungdahl 2001). Ssy1p is also required for the 
induction of genes encoding amino acid transporters, AGP1, BAP1, BAP2, GAP1, GNP1, 
TAT1, and TAT2 in S. cerevisiae (Kodama et al. 2002).  Upon receptor activation by amino 
acids, the signal is transduced, presumably by the SPS complex processing the 
transcription factors Stp1p and Stp2p, which then migrate to the nucleus.  Then, a 
complex interaction with the repressor Cup9p initiates transcription of PTR2. 
 
Regulation of OPT1. 
Preliminary microarray data from our lab indicated that Ptr3p is required for 
expression of OPT1 (Goldstein and Becker, unpublished).  The relative transcript levels 
of OPT2 were not observed since the gene was not included in the data set.  Both 
because of this microarray data and because the SPS complex regulates amino acid and 
peptide transporters in S. cerevisiae, in this chapter we investigated the roles of Ptr3p 
and Ssy1p in OPT expression.  Additionally, we tested the effect of starvation conditions 
on OPT expression.  We were also interested in whether each individual OPT or the 
Ygl114wp had an effect on expression of OPT1 or OPT2.  Ptr3p and Ssy1p are known to 
play a role in gene expression of amino acid and di/tri-peptide transporters, and 
therefore we hypothesized that these proteins were also involved in the regulation of 
the OPTs.  Additionally, it was hypothesized that the presence or absence of an OPT also 
affected OPT1 expression.  If either Opt1p or Opt2p is absent, perhaps the yeast cell is 
able to ascertain that fewer oligopeptide transporters are available and the transcription 
of OPT1 is increased to overcome this deficiency. 
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Materials and Methods 
Strain construction. 
Single gene knock-outs of OPT1, OPT2, YGL114W, PTR3, and SSY1 and the double 
knock-out of PTR3 and  SSY1 and the double knock-out of PTR3 and OPT1 were created 
in the S. cerevisiae FY2 strain background (Appendix 2) using the drug resistance 
cassettes KanMX4, providing resistance to G418; HphMX3, providing resistance to 
hygromycinB; and NatMX3, providing resistance to clonNAT (Appendix 3).  PCR was 
carried out in order to amplify the cassette with ends homologous to the genomic 
region to be knocked-out.  The reaction consisted of 2 units of RedTaq™ (Sigma-
Aldrich; St. Louis, MO), 1 pmol of each primer (Appendix 4), 200 µM dNTPs, 1x Sigma 
RedTaq buffer with MgCl2, and 2 ng plasmid DNA (Appendix 3).  Seven percent DMSO 
was included in any PCR to amplify the NatMX3 cassette due to its high G/C content.  
The components were combined on ice and immediately placed at 95 C for five minutes 
to begin the reaction.  Forty cycles were carried out:  1 minute at 95 C; 1 minute at 52 
C for KanMX4, 55 C for HphMX3, or 52 C for NatMX3; and 3 minutes at 72 C.  An 
additional seven minutes were added at 72 C for extension, followed by a hold at 4 C.  
The reactions were visualized by separation of DNA on a 1% agarose/TAE gel with 
subsequent staining with ethidium bromide.  PCR products were purified by SOPE 
column (Open Biosystems; Huntsville, AL). 
Gene knock-outs were confirmed by PCR and Southern blot analysis (Figure 2-1).  
Primers were designed to anneal to sequence flanking the knocked-out region 
(Appendix 4).  The reaction consisted of 2 units of RedTaq™ (Sigma-Aldrich; St. Louis, 
MO), 1 pmol of each primer, 200 µM dNTPs, 1x Sigma Red Taq buffer with MgCl2, and 
8 ng genomic DNA obtained as described in Chapter 1.  Seven percent DMSO was 
included in any PCR that would amplify the NatMX3 cassette.  The components were 
combined on ice and immediately placed at 95 C for five minutes to begin the reaction.  
Forty cycles were carried out:  1 minute at 95 C, 1 minute at 54 C, and 3 minutes at 72 
C.  An additional seven minutes were added at 72 C for extension, followed by a hold at 
4 C.  Products were visualized by agarose gel electrophoresis.  Southern blot analysis 
was carried out as described in Chapter 1.  PCR conditions to construct the DNA that 
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Figure 2-1.  Confirmation of a gene knock-out.  After PTR3 was knocked-out 
of FY2 with the cassette NatMX4, the knock-out was confirmed.  The FY2 wild-type 
control and four potential ptr3Δ strains were tested and shown below.  A.  The 
NatMX4 cassette is 1.2 kb shorter than PTR3.  Using primers flanking the knocked-out 
region, PCR amplification yielded either a 2.9 kb fragment corresponding to PTR3, or a 
1.7 kb fragment corresponding to the inserted cassette.  Here, strain B was found to be 
a false positive:  it was incorrectly identified as a knock-out in the colony selection 
process.  B.  Genomic DNA of each potential knock-out strain and wild-type was cut 
with either FspI (F) or SacI (S), and separated by agarose gel electrophoresis; the lanes 
were loaded equally.  When the gel was probed with radiolabeled DNA corresponding 
to a large part of PTR3 (nucleotides 35-1969), strain B was again shown to be a false 
positive.  Probe DNA hybridized to a 7.9 kb band when genomic DNA was cut with FspI 
(F) and hybridized to 2.5 kb and 5.9 kb bands when DNA was cut with SacI (S), 
demonstrating the presence of PTR3 in the wild-type control (FY2) and in strain B.  The 
strains labeled A, C, and D did not contain genomic DNA that hybridized to the probe; 
strain A was used as the ptr3Δ strain in this study. 
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was labeled for the probes were as follows:  2 units of RedTaq™ (Sigma-Aldrich; St. 
Louis, MO), 1 pmol of each primer (Appendix 4), 200 µM dNTPs, 1x Sigma RedTaq 
buffer with MgCl2, and 8 ng genomic DNA obtained as described in Chapter 1.  The 
components were combined on ice and immediately placed at 95 C for five minutes to 
begin the reaction.  Forty cycles were carried out:  1 minute at 95 C, 1 minute at 55 C, 
and 3 minutes at 72 C.  An additional seven minutes were added at 72 C for extension, 
followed by a hold at 4 C. 
 
Plasmid constructions containing a reporter gene. 
In order to compare the relative amounts of transcript produced from a given 
promoter under a defined set of conditions, a reporter gene is commonly used.  The 
gene, for example lacZ, is placed directly under the control of the promoter of interest.  
This construct is most often introduced into a cell via a plasmid.  Enzyme activity of the 
reporter gene product is then measured in order to estimate transcript quantities.  The 
low-copy plasmid pYLZ6 (Appendix 3) contains lacZ and was constructed specifically for 
the study of promoters by measurement of β-galactosidase activity in S. cerevisiae; it was 
therefore chosen for this study. 
The promoters of OPT1, OPT2, and YGL114W were cloned into pYLZ6 (Appendix 3) 
by PCR amplification of 1 kb upstream of the ORF, including the start codon.  Primers 
(Appendix 4) were designed for homologous recombination into the plasmid, which had 
been linearized at the HindIII site.  PCR conditions to amplify the promoters were as 
follows:  2 units of Pfu DNA polymerase (Stratagene; La Jolla, CA), 1 pmol of each 
primer, 200 µM dNTPs, 1x buffer supplied with enzyme, 2.5 mM MgCl2, and 8 ng 
genomic DNA.  The components were combined on ice and immediately placed at 95 C 
for five minutes to begin the reaction.  Forty cycles were carried out:  45 seconds at 95 
C, 45 seconds at 53 C, and 5 minutes at 72 C.  An additional seven minutes were added 
at 72 C for extension, followed by a hold at 4 C.  The reaction was visualized by 
separation of DNA on a 1% agarose/TAE gel with subsequent staining with ethidium 
bromide.  PCR products were purified by SOPE column (Open Biosystems).  Each 
product and the linearized plasmid were co-transformed into FY2 (Appendix 2) as 
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described in Chapter 1.  Plasmid was isolated from transformants and sequenced 
(Appendix 4).  These new plasmids were named pYLZ6-OPT1, pYLZ6-OPT2, and 
pYLZ6-YGL114W after the gene whose promoter it contained. 
 
Media and growth assays. 
Synthetic complete (SC) medium was made using the original recipe for yeast 
nitrogen base (Wickerham 1946; Wickerham 1951, Appendix 1).  Modifications were 
made to Wickerham’s medium to create media with reduced nutrients.  Reduced 
carbon medium contained 25% the amount of glucose as SC; reduced nitrogen medium 
contained 10% the amount of ammonium sulfate, with the sulfate added back via sodium 
sulfate; and reduced sulfur medium contained no ammonium sulfate and 10% the 
amount of magnesium sulfate as SC, with the ammonium and magnesium added back via 
the corresponding chloride salts.  Reduced nitrogen and sulfur medium had no 
ammonium sulfate and 10% of the magnesium sulfate that of SC; 10% the ammonium; 
and 90% of magnesium added with their chloride salts.  The full recipes may be found in 
Appendix 1.  To determine growth curves or gene expression levels in these media, 
cells were first grown overnight in SC, harvested at top speed in a tabletop centrifuge, 
and washed twice with cold water.  These various media were then inoculated at 5 x 
105 cell/mL. 
 
β-galactosidase assays. 
Assays for β-galactosidase activity were conducted using a protocol modified from 
that of Hoffman et al. (2002).  Cells containing the empty vector pYLZ6 or the vector 
containing 1 kb upstream of the gene of interest (pYLZ6-OPT1, pYLZ6-OPT2, or 
pYLZ6-YGL114W) were scraped from a fresh plate and grown overnight in 25 mL SC.  
They were harvested in a tabletop centrifuge at high speed at 4 C, and washed three 
times with cold water.  Cells were inoculated into fresh media at 5 x 105 cells/mL and 
grown for two to 12 hours.  If amino acids were added, they were added simultaneously 
with the cells, at concentrations required to fulfill auxotrophic requirements (Appendix 
1).  If GSH was added, it was at 250 µM.  Aliquots were harvested as above for the 
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growth assay.  In a black 96-well plate, 100 µL of cells at 1 x 108 cells/mL were added to 
each well.  A fluorescein di-β-D-galactopyranoside (FDG; Molecular Probes/Invitrogen; 
Eugene, OR) stock solution was made with 100 µM FDG in 25 mM PIPES (pH 7.2).  The 
stock solution was combined 1:1 with a 5% Triton X-100, 250 mM PIPES (pH 7.2) 
solution; 20 µl of this final solution was added to each well.  The 96-well plate was 
incubated at 37 C in the dark for 4 hours.  It was then read with a Victor2 Wallac 
fluorescence multi-well plate reader (PerkinElmer; Gathersburg, MD) with an excitation 
of 485 nm and an emission of 530 nm. 
 
Leu-enkephalin uptake assays. 
Cells containing the empty plasmid pYLZ6 were grown in SC or no sulfur medium 
with or without amino acids or GSH as described for β-galactosidase assays.  Uptake 
assays were conducted over a 10-minute time period as described in Chapter 1. 
 
Results 
Determination of growth curves in media with limited and absent 
nutrients. 
Seven media variations were made:  synthetic complete (SC; Wickerham’s yeast 
nitrogen base with 2% glucose without amino acids), SC with reduced carbon, SC with 
no carbon, SC with reduced nitrogen, SC with no nitrogen, SC with reduced sulfur, and 
SC with no sulfur (Appendix 1).  Each of the eight strains constructed, including wild-
type, were grown in these seven media for up to 12 hours to determine log-phase 
growth, with the inoculum being 5 x 105 cells/mL.  Wild-type cells were in log-phase 
between four and ten hours when grown in SC medium (Figure 2-2).  After four hours, 
growth of cells in media without a nitrogen source slowed compared to the growth of 
cells in SC; the growth curves of cells without nitrogen and cells without nitrogen or 
sulfur overlap (Figure 2-2.A).  Growth of cells without sulfur slowed between eight and 
ten hours, while cells grown with no carbon did not divide at all. There was no apparent 
difference in growth curves between cells grown in SC and cells grown in any reduced 
nutrient media.  All deletion strains except for ygl114wΔ grew at the same rate as 
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Figure 2-2.  Growth curves in reduced nutrient media and media 
lacking nutrients.  A.  The strain FY2 was grown for up to 12 hours in SC, reduced 
nitrogen (r N), no nitrogen (no N), reduced sulfur (r S), no sulfur (no S), reduced 
nitrogen and reduced sulfur (r NS), no nitrogen or sulfur (no NS), reduced carbon (r C), 
or no carbon media (no C).  Cell density was measured every two hours.  B.  The 
strains FY2 and ygl114wΔ were grown for up to 12 hours in SC, no sulfur (no S), or no 
nitrogen (no N) media, and cell density was measured every two hours. 
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wild-type (data not shown).  When ygl114wΔ was grown in SC, its growth curve was 
comparable to wild-type grown without nitrogen (Figure 2-2.B).  Not only did ygl114wΔ 
have limited growth, but also its colony and culture color was white in comparison to 
wild-type S. cerevisiae, which was cream-colored.  There was no visible microscopic 
difference between ygl114wΔ and wild-type under growth conditions used in this study. 
 
OPTp-lacZ expression under starvation conditions. 
In order to create a reporter system, the lacZ ORF was placed under the control of 
the promoter of OPT1, OPT2, or YGL114W; three plasmids were constructed.  The 
segment of DNA 1 kb upstream of the ORFs of OPT1, OPT2, and YGL114W, including 
the start codon, was amplified and cloned into pYLZ6 (Appendix 3), immediately 
upstream of the lacZ gene present in the plasmid.  Cells of the wild-type strain FY2, 
harboring pYLZ6-OPT1, pYLZ6-OPT2, or pYLZ6-YGL114W, were grown for up to 12 
hours in each of the seven media.  Cells were harvested every two hours and tested for 
β-galactosidase activity.  Background was determined using FY2 transformed with the 
empty vector pYLZ6 grown in SC. 
Cells containing pYLZ6-OPT1 grown without sulfur showed increased β-
galactosidase activity by six hours (Figure 2-3).  Cells containing either pYLZ6-OPT2 or 
pYLZ6-YGL114W did not show any increased activity when grown in these media when 
compared to when grown in SC (data not shown). 
 
OPT1p-lacZ expression in the presence of amino acids. 
Since OPT1 expression increased when cells were grown without sulfur, the study of 
OPT1 expression was extended.  Because the cell growth slowed after eight hours when 
cells were grown with no sulfur, cells of the strain FY2 bearing pYLZ6-OPT1 were 
grown for up to eight hours in either SC or no sulfur media containing leucine, proline, 
or no added amino acids.  Cells were harvested every two hours and assessed for β-
galactosidase activity (Figure 2-4).  As seen in Figure 2-3, no sulfur medium induced 
OPT1 expression by the six-hour time point.  Proline and leucine both increased 
expression of OPT1; the highest induction of leucine was at the six-hour time point 
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Figure 2-3.  Sulfur-free medium induces OPT1 expression.  Wild-type cells 
(FY2) harboring pYLZ6-OPT1, pYLZ6-OPT2, or pYLZ6-YGL114W were grown in SC 
medium.  Additionally, cells containing pYLZ6-OPT1 were grown in medium lacking 
sulfur.  Aliquots were taken every two hours for 12 hours and assayed for β-
galactosidase activity.  β-galactosidase activity was reported as relative fluorescence. 
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Figure 2-4.  Time course of OPT1 induction by amino acids.  Wild-type 
cells (FY2) harboring pYLZ6-OPT1 were grown in SC (+ on abscissa) or no sulfur 
medium (- on abscissa) with leucine (grey bars) or proline (checkered bars), or without 
supplemented amino acid (open bars).  Aliquots were taken every two hours for eight 
hours, and β-galactosidase activity was measured.  β-galactosidase activity was reported 
as relative fluorescence. 
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while proline’s induction was more constant over the course of the experiment, 
inducing best between four and six hours.  From these results, the six-hour time point 
was chosen for all further experiments. 
The induction of OPT1p-lacZ was then assayed after growth in SC and no sulfur 
media with each of the twenty naturally occurring amino acids individually present 
(Figure 2-5).  While leucine and tryptophan were the best inducers of OPT1 when cells 
were grown in SC, they were not the best inducers when cells were grown without 
sulfur in the medium.  Unlike leucine, most amino acids seemed to have a synergistic 
effect on OPT1 expression when combined with no sulfur medium.  The acidic amino 
acids — aspartic acid and glutamic acid — followed by tyrosine, were the best inducers 
of OPT1 when added to medium lacking sulfur.  The sulfur-containing amino acids, 
cysteine and methionine, did not induce OPT1 even when all other sulfur was removed 
from the medium; methionine even down-regulated OPT1 in both SC and no sulfur 
media. 
 
OPT1p-lacZ expression in deletion strains. 
Because both Ptr3p and Ssy1p are known to induce gene expression of amino acid 
and di/tri-peptide transporters by sensing leucine and tryptophan, it was hypothesized 
that these proteins were also involved in the regulation of the gene encoding the 
oligopeptide transporter Opt1p.  Additionally, it was hypothesized that the presence or 
absence of the other gene encoding the other oligopeptide transporter in S. cerevisiae, 
OPT2, also affected OPT1 expression.  If Opt2p is not present, perhaps the yeast cell is 
able to recognize that fewer oligopeptide transporters are present and the transcription 
of available OPTs is stepped up to compensate for this deficiency.  Likewise, the cell may 
be capable of detecting the lack of Opt1p itself, and attempt to up-regulate OPT1 in its 
absence.  To test these hypotheses, gene knock-out strains that were constructed in the 
FY2 background (Appendix 2) containing pYLZ6-OPT1 (Appendix 3) were assayed for 
β-galactosidase activity.  Cells of the knock-out strains opt1Δ, opt2Δ, ptr3Δ, ssy1Δ, ptr3Δ 
ssy1Δ, and ptr3Δ opt1Δ and the wild-type strain FY2 were transformed with pYLZ6-
OPT1 and grown in the presence and the absence of several of the naturally occurring 
44 
Figure 2-5.  Amino acids modulate OPT1 expression.  Wild-type cells (FY2) 
bearing pYLZ6-OPT1 were grown for six hours in SC (grey bars) or no sulfur medium 
(black bars) without supplemented amino acids (none) or with each amino acid added, 
indicated by one-letter abbreviations.  β-galactosidase activity is represented as a ratio 
of fluorescence compared to FY2 grown in SC without amino acids:  the relative 
fluorescence was calculated by dividing the fluorescence of β-galactosidase activity in the 
experimental sample by the fluorescence of β-galactosidase activity produced in the 
strain FY2 grown in SC medium without amino acids. 
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amino acids or GSH (γ-Glu-Cys-Gly) for six hours.  These strains were then assayed for 
β-galactosidase activity (Figure 2-6). 
When knock-out strains were grown in either SC or no sulfur medium 
supplemented with leucine, OPT1 expression in the strains with the single gene 
knockouts of opt1Δ and opt2Δ responded to leucine comparably to wild-type (Figure 2-
6.A).  OPT1 expression in strains containing deletions of ptr3 and ssy1, however, was not 
up-regulated in the presence of leucine.  The effect of these gene knock-outs are similar 
when cells were grown in either SC or no sulfur media without any addition of amino 
acids. 
When the sulfur-containing amino acids, methionine and cysteine, were 
supplemented to SC or no sulfur medium, OPT1 was not up-regulated in any of the 
deletion mutants or in wild-type cells (Figure 2.6.B).  It is likely that these amino acids 
supply the cell with enough sulfur as to not require the up-regulation of OPT1.  Similarly, 
the effect of no sulfur medium is not seen when it is supplemented with GSH.  The only 
strain to retain the up-regulation of OPT1 in this instance is opt1Δ.  Since the gene 
encoding the GSH transporter is absent, the cell is not able to take up the sulfur 
supplied by the GSH, and thus OPT1p-lacZ is up-regulated since it is obtaining no sulfur 
from its environment (Figure 2-6.B). 
The effect of PTR3, SSY1, OPT1, and OPT2 on the expression of OPT1p-lacZ was also 
examined in the presence of the inducing amino acids aspartic acid, glutamic acid, and 
tyrosine (Figure 2-6.C).  Similar to results observed upon the addition of leucine (Figure 
2-6.A), the absence of PTR3 and SSY1 eliminated the induction of OPT1 in the presence 
of the acidic amino acids and tyrosine when cells were grown in sulfur-free medium.  
Unlike induction by leucine, the absence of OPT1 and OPT2 affected OPT1p-lacZ 
expression when cells grown without sulfur were supplemented with aspartic acid, 
glutamic acid or tyrosine (Figure 2-6.C).  Without OPT1 or OPT2, OPT1p-lacZ expression 
is reduced by almost half with the addition of aspartic acid, as is OPT1p-lacZ expression 
when opt1Δ cells are supplemented with glutamic acid.  OPT1 is not induced in opt2Δ 
cells, however, when glutamic acid is added.  When either OPT is knocked-out, 
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Figure 2-6.  OPT1 induction is dependent on PTR3, SSY1, and OPT2.  
Wild-type cells (FY2) and the deletion mutant strains opt1Δ, opt2Δ, ptr3Δ, ssy1Δ, ptr3Δ 
ssy1Δ, and ptr3Δ opt1Δ harboring pYLZ6-OPT1 were grown for six hours in SC or no 
sulfur medium with or without leucine (A); methionine, cysteine, or GSH (B); or 
aspartic acid, glutamic acid, or tyrosine (C).  β-galactosidase activity is represented as 
the ratio of fluorescence compared to the fluorescence of FY2 grown in SC without 
amino acids:  the relative fluorescence was calculated by dividing the fluorescence of β-
galactosidase activity in the experimental sample by the fluorescence of β-galactosidase 
activity produced in the strain FY2 grown in SC medium without additions.  For clarity, 
panels A, B, and C have different ordinate scales, and the values for no additions are 
repeated in each panel. 
47 
 
 
 
48 
OPT1p-lacZ expression is reduced by more than half when sulfur free medium is 
supplemented with tyrosine. 
The effect of the ORF YGL114W, although not likely an oligopeptide transporter, 
was also investigated as to its potential role in OPT1 expression.  Because ygl114wΔ cells 
grew poorly even in SC (Figure 2-2.B), the yield of cells from 2 L of primary culture was 
only enough to investigate YGL114W’s effect on OPT1p-lacZ expression in SC and 
medium lacking sulfur, each with or without leucine or cysteine.  Under all six medium 
conditions, these cells showed OPT1 expression that was barely above background 
levels.  Thus, the result of the influence of YGL114W on expression of OPT1 could not 
be calculated with this strain. 
 
Leu-enkephalin uptake under variant nutrient conditions. 
Since the β-galactosidase assay only measured expression levels of OPT1, a functional 
assay for Opt1p was used to complement the gene expression data.  Leu-enkephalin 
uptake was measured, thereby assessing the functionality of Opt1p.  Cells grown under 
the same conditions used in the lacZ study were assayed for their ability to accumulate 
[3H]-Leu-enkephalin over ten minutes (Figure 2-7).  FY2 cells harboring the empty 
vector pYLZ6 were grown in either SC or no sulfur medium with or without amino 
acids and GSH (Figure 2-7.A).  Consistent with the lacZ assay results, growth in sulfur-
free medium with the addition of aspartic acid, glutamic acid, or tyrosine increased the 
cells’ ability to transport Leu-enkephalin.  Growth with the addition of either cysteine or 
GSH did not increase Leu-enkephalin uptake, and the addition of methionine reduced 
transport of the pentapeptide to half of that observed in FY2 cells grown in SC.  Leucine 
increased the transport capability of FY2 when grown without sulfur, but did not 
increase transport when cells had been grown in SC supplemented with leucine, even 
though β-galactosidase activity suggested leucine increased OPT1 expression in this 
medium. 
When opt2Δ cells were tested for their ability to accumulate [3H]-Leu-enkephalin, 
results were consistent with those of the lacZ assay:  compared to FY2, uptake of 
substrate was reduced when aspartic acid was supplemented and similar to 
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Figure 2-7.  [3H]-Leu-enkephalin uptake.  Cells were grown for six hours 
with or without sulfur, the media supplemented with various amino acids, GSH, or 
nothing.  To be consistent with the media used in the lacZ assays, all cells harbored the 
vector pYLZ6.  Cells were incubated for ten minutes with 250 µM [3H]-Leu-enkephalin.  
Uptake is represented as the accumulation of nmol [3H]-Leu-enkephalin per milligram of 
cells (dry weight).  A.  Accumulation of Leu-enkephalin in the wild-type strain FY2 after 
growth in either SC or sulfur-free medium supplemented with methionine, cysteine, or 
GSH.  B.  Accumulation of Leu-enkephalin in FY2 after growth in either SC or sulfur-
free medium and in opt2Δ after growth in sulfur-free medium.  These media were 
supplemented with leucine, aspartic acid, glutamic acid, tyrosine, or nothing.  C.  
Accumulation of Leu-enkephalin in FY2, opt2Δ, ptr3Δ, ssy1Δ, and opt1Δ after growth in 
medium lacking sulfur supplemented with leucine.  Also included is the control of FY2 
grown in SC with leucine added. 
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unsupplemented SC when tyrosine was added (Figure 2-7.B).  The effect of the absence 
of PTR3, SSY1, and OPT1 on Leu-enkephalin uptake was tested after cells were grown 
without sulfur and supplemented with leucine (Figure 2-7.C).  As expected, leucine did 
not lead to increased uptake in ptr3Δ or ssy1Δ cells.  The opt1Δ strain showed no 
transport of Leu-enkephalin. 
Taken together with the results of the β-galactosidase assays, these data yield a set 
of environmental conditions that govern the expression profile of OPT1. 
 
Discussion 
Little is known about the transcriptional regulation of the OPT genes in S. cerevisiae, 
but some evidence is available regarding native conditions for transcription for members 
of the OPT family in other species (Hauser et al. 2001).  Isp4p from S. pombe was initially 
identified in a screen to find factors in mating, induced by poor nitrogen (Sato et al. 
1994), but later found to be up-regulated by use of proline as the sole source of 
nitrogen (Lubkowitz et al. 1998).  Although this regulation is most likely transcriptional, 
the up-regulation was demonstrated by the ability of cells to grow on peptide as the 
sole source of a required amino acid. 
Here we show that absence of sulfur in the medium up-regulates expression of 
OPT1.  Boer et al. (Boer et al. 2003) found similar results in microarray studies in 
chemostat cultures grown with limited sulfur.  Unlike Boer et al., however, we observed 
no change in OPT1 expression in the absence of carbon for up to ten hours — they 
observed the down-regulation of OPT1 under conditions limiting carbon.  Gasch et al. 
(2000) detected a great increase in OPT1 expression by microarray analysis when cells 
were depleted of nitrogen, yet our study as well as that of Boer et al. did not see this 
result.  PTR2, the gene encoding the di/tri-peptide transporter in S. cerevisiae, is also 
regulated by limited nutrient conditions.  The gene is up-regulated when cells are grown 
in a poor nitrogen source (Perry et al. 1994).  Ptr2p’s substrate is similar to Opt1p’s, but 
perhaps physiologically they are more different than initially thought.  Ptr2p is likely 
present to scavenge amino acids as a nitrogen source whereas Opt1p’s primary function 
may be to obtain sulfur for the cell, namely in the form of glutathione. 
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Our data indicate that OPT1 is differentially regulated by various amino acids when 
starved for sulfur.  Of the twenty naturally occurring amino acids, the acidic amino acids 
— aspartic acid and glutamic acid — up-regulate OPT1 to the greatest degree, followed 
by tyrosine.  The only amino acids not to up-regulate OPT1 expression in sulfur-free 
medium are the two containing sulfur, cysteine and methionine.  Additionally, 
glutathione does not up-regulate OPT1.  It is likely that when these compounds are 
transported into the cell, they supply it with enough sulfur to negate the effect of the 
sulfur-free medium.  When opt1Δ cells are grown in medium lacking sulfur that has been 
supplemented with glutathione, OPT1p-lacZ expression is up-regulated to the same 
extent as if it were grown in sulfur-free medium without any additions.  This suggests 
that with no Opt1p expression, no GSH was able to enter the cell, and the condition 
therefore simulated a no sulfur medium.  Unlike cysteine and glutathione, however, 
methionine down-regulates OPT1.  One untested hypothesis explaining this is that in the 
wild, the presence of certain amino acids indicates to the cell that certain peptides are 
available for scavenging.  Another is that no sulfur in the medium signals the cell that 
there is a lack of, or at least very few, amino acids, but the presence of methionine in 
the environment is a signal to the cell that there is enough sulfur and therefore there 
are enough amino acids being taken into the cell and so OPT1 is down-regulated. 
When cells were grown in SC and an amino acid, leucine and tryptophan up-
regulated OPT1 the most when compared to other amino acids.  This is similar to PTR2 
and BAP2 induction — leucine and tryptophan are the best inducers (Didion et al. 1998) 
— but OPT1 expression is not increased as much by these amino acids as PTR2 is.  PTR2 
is up-regulated 100-fold upon the addition of tryptophan or leucine (Narita 2002), 
whereas OPT1 is up-regulated about 10-fold.  Leucine and tryptophan induce OPT1 when 
cells are grown without sulfur, but only moderately when compared to the other amino 
acids. 
The amino acid sensor Ssy1p and its associated protein Ptr3p are responsible for the 
regulation of genes encoding amino acid transporters and the regulation of PTR2.  The 
SPS system responds to leucine and tryptophan (Didion et al. 1998) and is able to sense 
all other amino acids except proline and arginine in assays measuring AGP1p-lacZ 
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expression (Iraqui et al. 1999).  Here we show that both SSY1 and PTR3 are required for 
induction of OPT1.  A microarray study investigating the effects of the SPS sensor system 
responding to leucine found less than a two-fold change in OPT1 expression, but the 
medium in which the cells were grown was SC (Forsberg et al. 2001). 
No difference was seen in either OPT2 or YGL114W expression when cells were 
grown without various nutrients as compared to when grown in SC.  They are 
therefore induced by different conditions than those tested in this study.  There must be 
a different physiological state in which Opt2p is the preferred oligopeptide transporter.  
Perhaps its favored substrate is something other than a peptide.  It may be that Opt2p 
transports a variety of biological molecules in the same manner that Opt1p transports 
glutathione with better affinity than Leu-enkephalin (Chapter 1) and Ptr2p is able to 
transport β-lactams (Meredith and Boyd 2000). 
Few studies have been conducted on genes expressed under sulfur-starvation.  For 
the first time, direct evidence is shown that OPT1 and Opt1p expression is dependent 
on the sulfur content of the medium.  Additionally, we show for the first time, evidence 
that expression is induced by all but the sulfur-containing amino acids and that 
expression is dependent upon the presence of PTR3 and SSY1.  This extends the roles of 
Ptr3p and Ssy1p to regulation of all peptide and amino acid permeases in yeast. 
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Chapter 3 
Search for a gene encoding a mammalian enkephalin 
transporter. 
 
Background and Significance 
We have identified a permease family with members from a number of fungi and 
plants that transports tetra- and pentapeptides (Hauser et al. 2001; Koh et al. 2002) 
Chapter 1).  A Saccharomyces cerevisiae member, Opt1p, transports the pentapeptides 
Leu-enkephalin (YGGFL) and Met-enkephalin (YGGFM) (Hauser et al. 2000; Chapter 1).  
The enkephalins are in a class of compounds known as the endorphins (for endogenous 
morphine), which are potent analgesics found exclusively in mammals (Goldstein 1976).  
Although the physiological effects of the endorphins, including the enkephalins, have 
been well-studied, the molecular mechanisms of the molecules are less well understood. 
 
The role of enkephalins in mammalian brain. 
A group of G-protein coupled receptors, known as opioid receptors, is found in 
mammalian brain and cause analgesia.  The three types of opioid receptors are µ, κ, and 
δ (Pasternak 2004).  The enkephalins, both Leu- and Met-enkephalin, were first 
identified as agonists of the µ-opioid receptors, inhibitors of the exogenous antagonist 
naloxone (Hughes et al. 1975; Simantov and Snyder 1976).  They were soon after 
determined to be neurotransmitters, along with the other endorphins dynorphin and β-
endorphin (Nicoll et al. 1977).  Of the endorphins, the two enkephalins are by far the 
most effective at producing effects down-stream of receptor binding, specifically a 
decreased perception of pain and an increase in eating and drinking (Miller).  The binding 
of the enkephalins to µ-opioid receptors can be inhibited by the agonists tyrosine-D-
penicillamide-glycine-phenylalanine-D-penicillamide ([D-penicillamide2,5]enkephalin; 
DPDPE), D-Ala,D-Leu-enkephalin (Tyr-D-Ala-Gly-Phe-D-Leu; DADLE), and morphine; by 
the antagonists naloxone and naltrexone (Pasternak 2004); and by the endogenous 
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antiopiate tetrapeptide Tyrosine Melanocyte-stimulating Hormone Inhibitory Factor 1 
(Tyr-MIF-1; Tyr-Pro-Leu-Gly-NH2). 
The µ-opioid receptor agonist morphine was the first opioid identified and has long 
been used as an analgesic due to its long retention time in the brain (see Nestler 1992 
for review).  Morphine’s endogenous role in the opium poppy Papaver somniferum is that 
of an early mechanical defense mechanism (Morimoto et al. 2001; Morimoto et al. 2003), 
a entirely different function than what it accomplishes in the mammalian brain.  The µ-
opioid receptor antagonists naloxone and naltrexone have been used to not only inhibit 
the binding of opioids (Pasternak 2004) but also to reduce the cravings for those opioids 
in individuals who are addicted to them (Schulteis et al. 2003).  Additionally, these 
antagonists have a pharmacological role in treating alcoholism by reducing volition 
ethanol drinking (Pulvirenti and Kastin 1988; Volpicelli et al. 1992).  Agonists of µ-opioid 
receptors do not have this effect (Pulvirenti and Kastin 1988) 
 
Transport of the enkephalins across the blood-brain barrier. 
Because the enkephalins are synthesized in the adrenal medulla (Wilson et al. 1980), 
yet have their primary action at opioid receptors in the brain, there must be some 
relatively efficient mechanism of transporting enkephalins across the blood-brain barrier 
(BBB) in order to access their receptors.  This transport had been observed in mice and 
rats (Cornford et al. 1978; Rapoport et al. 1980), and finally a saturable uptake system 
was identified by physiological criteria (Banks et al. 1986) and named peptide transport 
system 1 (PTS-1) (Banks and Kastin 1990).  Observations of a similar nature were made 
for the uptake of Tyr-MIF-1 (Banks et al. 1986), and it was later determined that the 
enkephalins and Tyr-MIF-1 share PTS-1 for transport across the BBB (Banks et al. 1987; 
Banks and Kastin).  It has been observed that Leu-enkephalin, however, may use more 
than one transport system to cross the BBB (Banks and Kastin 1989; Zlokovic et al. 
1989). 
Enkephalin uptake into the brain is inhibited by the µ-opioid receptor ligands 
naloxone, naltrexone, morphine, and DADLE (Kastin et al. 1991; Williams et al. 1996).  
Straight chain peptides composed of four to eight residues inhibit substrate 
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translocation by PTS-1, as long as the N-terminal residue is an L-tyrosine (Banks et al. 
1986).  Neither di/tri-peptide N-terminal truncations of Tyr-MIF-1 or enkephalin nor 
the amino acid tyrosine can inhibit substrate transport by PTS-1 (Banks et al. 1986; 
Zlokovic et al. 1989). 
In addition to enkephalins, it has been found that reduced glutathione (GSH) is able 
to traverse the BBB.  An intensive study determined that GSH is not synthesized in the 
brain from free amino acids but is rather transported into the brain (Zlokovic et al. 
1994).  Additionally, there are two transport mechanisms present to transport GSH 
into the liver (Ballatori and Dutczak 1994).  Neither of these two transport systems are 
ATP-dependent but are electrogenic.  Evidence also exists for a hepatic enkephalin 
transporter; this uptake of Leu-enkephalin is inhibited by naloxone (MacKinnon et al. 
1994).  Even though GSH and enkephalin are both transported into the brain and into 
the liver, no literature exists directly comparing the uptake of the two substrates. 
Researchers have begun to search for the permease that is PTS-1.  The P-
glycoprotein efflux system (P-gp system) was investigated as such.  Although it was 
shown that the P-gp system is responsible for transport of some µ-opioid receptor 
inhibitors, it is not required for enkephalin or Tyr-MIF-1 efflux (King et al. 2001).  We 
have investigated Opt1p for the possibility that it shares the function and transport 
characteristics of PTS-1.  We also set out to discover an OPT family member, or 
possibly a functional analog, in rat.  At the time this study was begun, there had been 
neither any BBB peptide transporter cloned nor any mammalian genome fully 
sequenced. 
 
Materials and Methods 
Competitive uptake assays. 
The strain BY4730 (Appendix 2), transformed with either pDB20 or pADH212c 
(Appendix 3), was grown to mid-logarithmic phase in poor nitrogen medium with 
methionine and leucine added for auxotrophic requirements (Appendix 1).  Uptake 
assays were conducted as described in Chapter 1, with either 250 µM [3H]-Leu-
enkephalin for cells constitutively expressing OPT1 or 160 µM [3H]-leucyl-leucine (Leu-
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Leu; dileucine) for cells induced with tryptophan to express PTR2, over a 12-minute time 
period.  Potential competitors of peptide transport were added simultaneously with the 
radiolabeled peptide (all competitors were purchased from Sigma; St. Louis, MO).  In 
experiments measuring inhibition of [3H]-Leu-enkephalin transport, 2.5 mM Met-
enkephalin, MIF-1, Tyr-MIF-1, Leu-enkephalin amine, DPDPE, DADLE, or morphine 
sulfate was present in the uptake medium (Chapter 1).  The concentration of naloxone 
was 9 mM and naltrexone was 15 mM in 1.25% methanol.  Ethanol concentration was at 
3% w/v. 
 
Southern blot analysis of mouse genomic DNA. 
Mouse genomic DNA (a generous gift from Amy Inselman, Mary Ann Handel’s lab) 
was probed for the presence of a member of the OPT family.  Southern blot analysis 
was performed as described in Chapter 1, and the wild-type strain FY2 (Appendix 2) 
was used as a positive control.  DNA was cut with the restriction enzymes HindIII and 
BamHI.  The blot was probed with OPT1 and degenerate primers designed at 
CODEHOP (Appendix 4). 
 
Library amplification in E. coli. 
The rat whole-brain cDNA library (pVT102Ulib) in the yeast vector pVT102U 
(Appendix 3) was a kind gift from Pietro De Camilli’s lab (Yale University, CT).  The 
library contained 2 x 106 individual recombinants and was constructed with all inserts to 
be larger than 500 bp; over 90% of the library contained inserts, the average size being 
1.5 kb (Maggie Butler, personal communication). 
pVT102Ulib was electroporated into DH5αE electro-competent cells (Invitrogen; 
Carlsbad, CA) using a MicroPulser (Bio-Rad; Hercules, CA) set on Ec1 (0.1 cm cuvette, 
1.8 kV, 1 pulse).  Two independent electroporations were carried out, each with 45 µL 
of DH5αE cells and 100 ng/µL pVT102Ulib in a final volume of 46 µL.  Immediately after 
electroporation, 1 mL ice-cold LB (Appendix 1) was added, and the cells were allowed 
to recover for 1 hour at 37 C while shaking at 225 rpm.  Aliquots of 50 µL of recovered 
cells in a total volume of 1 mL were spread onto 600 cm2 plates (Corning; Acton, MA) 
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containing LB +Amp (Appendix 1).  Plating was chosen over liquid culture to enrich for 
lower copy number clones.  Colonies were grown overnight at 37 C.  The cells on each 
of the 40 plates were scraped three times into LB with a sterile glass spreader and the 
suspension was pipetted off.  Cells were pelleted, and plasmid DNA was isolated using a 
total of four Wizard Plus Megaprep columns (Promega; Madison, WI).  The 
transformation efficiency averaged 1.95 x 108 (2 replicates: 1.8 x 108 and 2.1 x 108) 
CFU/µg and the plasmid preparation yielded an average of139 (3 replicates: 175, 128, 
113) ng/µL DNA at an A260/280 of 1.7 (3 replicates: 1.82, 1.62, 1.59) with a total amount 
of 832 µg of amplified pVT102Ulib. 
 
Transformation of cDNA library into S. cerevisiae. 
Four large scale, high-efficiency yeast transformations were done for each screen 
using a lithium acetate method modified from the standard Geitz lab method (Agatep et 
al. 1998).  The transformations were carried out in 15 mL Falcon tubes (BD Biosciences; 
San Jose, CA) with 25 µg amplified pVT102Ulib per tube.  The optimum heat shock time 
for the strain used, BY4742 opt1Δ (Appendix 2), was determined to be 20 minutes at 42 
C.  A small aliquot of each reaction was used to calculate the transformation efficiency.  
Using sterile glass beads, the remainder was plated onto 600 cm2 bioassay dishes 
(Corning) containing casamino acid medium (Appendix 1); the transformation efficiency 
was 1.1 x 105 CFU/µg DNA. 
 
Functional augmentation growth screen and analysis. 
The screens for the ability of cells transformed with a plasmid from the cDNA 
library to grow on peptide as the sole source of a required amino acid immediately 
followed their transformation (Figure 3-1).  After 72 hours of growth, transformed cells 
were scraped off the plates with a sterile glass spreader and 30 mL sterile water.  Cells 
were then pelleted and pooled, and 2 x 107 cells were plated on poor nitrogen medium 
(Appendix 1) with histidine and either lysine (screen 1) or leucine (screen 2) to fulfill 
auxotrophic requirements.  Additionally, plates used in screen 1 were supplemented 
with no leucine, leucine, YGGFL, KLLG, or KLLLG to fulfill the strain’s leucine 
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Figure 3-1.  Diagram of functional augmentation strategy.  Two screens 
were conducted to find a mammalian oligopeptide transporter by functional 
augmentation.  The initial round of the first screen required cells to grow on peptide as 
the sole source of leucine, whereas the second screen required them to grown on 
peptide as the sole source of lysine. 
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requirement; plates used in screen 2 contained no lysine, lysine, KLLG, or KLLLG for 
the strains lysine requirement.  Peptide concentrations were 300 µM and calculated to 
provide the cell with a molarity of leucine or lysine similar to that of the free amino acid 
provided in the control plates. 
Colonies that grew on peptide as the sole source of either leucine or lysine were 
streaked for isolation on medium corresponding to the medium on which they grew in 
the screen.  Plasmids from three isolates from each colony were recovered and 
subjected to restriction digest by XhoI to check for an insert, and one plasmid copy 
from each colony was sequenced (Appendix 4; Sanger et al. 1977).  Meanwhile, each 
plasmid was retransformed into BY4742 opt1Δ as described in Chapter 1 and tested for 
growth on YGGFL, KLLG, and KLLLG as the sole source of leucine or lysine.  (The 
strain used, BY4742 opt1Δ, was first tested to make certain it could not grown on media 
containing YGGFL, KLLG, or KLLLG as sole sources of leucine or lysine.) 
 
Results 
Inhibitors of PTS-1 also inhibit Opt1p. 
Competition uptake assays with S. cerevisiae strain BY4730 (Appendix 2) containing 
pADH212C (Appendix 3) over-expressing OPT1 were performed measuring the 
translocation of [3H]Leu-enkephalin in the presence of various small peptides, peptide 
analogs, and ligands of the mammalian enkephalin receptor (Figure 3-2.A).  As with PTS-
1 (Banks et al. 1986), the tripeptide MIF-1 does not compete for uptake of enkephalin by 
Opt1p, but inhibition was seen with other tetra- and pentapeptides present in the 
uptake medium, such as Met-enkephalin, TMIF-1, DPDPE, and DADLE.  The opioid 
receptor agonist morphine and antagonists naloxone and naltrexone all inhibited Leu-
enkephalin uptake by Opt1p in S. cerevisiae. 
The transport capabilities of Ptr2p were employed to demonstrate that the non-
peptide-based analogs naloxone and naltrexone were specifically inhibitors of Leu-
enkephalin transport by Opt1p and not general permease inhibitors or disrupters of 
cellular stability (Figure 3-2.B).  [3H]-dileucine uptake was measured in the presence of 
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Figure 3-2.  Peptide uptake by yeast in the presence of inhibitors of 
PTS-1 transport.  Substrate and competitors were added simultaneously at time 
zero, and transport was measured in quadruplicate over a 12-minute period at 30 C.  
Each competitor is reported as percentage of substrate transported as compared to 
control.  A.  [3H]-Leu-enkephalin uptake was measured at a final concentration of 250 
µM.  Concentration of competitors were:  9 mM naloxone, 15 mM naltrexone, 3% 
ethanol, and 2.5 mM for all others.  B.  [3H]-dileucine uptake was measured at a final 
concentration of 160 µM.  Concentrations of competitors were: 9 mM naloxone, 15 
mM naltrexone, and 3% ethanol. 
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naloxone and naltrexone, and it was found that these compounds did not inhibit 
dileucine uptake as they did Leu-enkephalin. 
In mammalian model systems, addiction to alcohol inhibits uptake of the enkephalins 
into the brain by PTS-1 (Plotkin et al. 1997).  When ethanol was added to the uptake 
medium, inhibition of Leu-enkephalin transport was seen (Figure 3-2.A); when the effect 
of ethanol on the transport of dileucine by Ptr2p was measured, however, similar results 
were observed (Figure 3-2.B), suggesting that this effect is not specific to transport by 
Opt1p. 
 
Techniques employed to find homologous OPT sequences in mouse 
yielded no members. 
Seven primers were constructed with a mouse-codon bias from highly conserved 
regions submitted to the algorithm Consensus-degenerate Hybrid Oligonulecotide 
Primers (CODEHOP; bioinformatics.weizmann.ac.il/blocks/codehop.html).  All twelve 
primer combinations were used in attempt to amplify a sequence bearing some similarity 
to the OPT family — specifically with similarity to the highly conserved regions found by 
BLOCKS (bioinformatics.weizmann.ac.il/blocks/).  Unfortunately, no PCR products were 
observed (data not shown). 
Genomic Southern blot analysis was also attempted to visualize potential OPT family 
members in mouse.  Genomic DNA prepared from the wild-type S. cerevisiae strain FY2 
was used as a control; genomic DNA from mouse was probed with OPT1 from S. 
cerevisiae.  As with the PCR method discussed above, no positive results for a potential 
murine OPT were observed (Figure 3-3). 
 
Functional augmentation screen of a rat brain cDNA library expressed 
in yeast revealed no oligopeptide transporter. 
In order to validate the selection process, a background of leu- cells was mixed with 
107 times fewer leu+ cells and spread in a lawn on plates lacking leucine.  This was done 
in three concentrations:  107, 108, and 109 leu- cells with 1, 10, and 100 leu+ cells, 
respectively.  Two, 12, and 96 leu+ colonies were observed, therefore cell background 
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Figure 3-3.  No mouse homologues are found by Southern blot 
analysis.  S. cerevisiae (FY2, control) and mouse genomic DNA was digested with 
HindIII or BamHI and separated by gel electrophoresis.  The subsequent Southern blot 
hybridization with OPT1 yielded two expected bands in the FY2 lane, but no positives 
were seen in the lanes containing mouse genomic DNA. 
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up to 109 cells per plate neither interferes with growth of leu+ colonies nor does the 
large cell mass allow non-leu- cells to propagate. 
Two independent functional augmentation screens were attempted.  Both involved 
plating cells of strain BY4742 opt1Δ that had been transformed with the rat brain cDNA 
library in pVT102U onto media selective for growth on peptides as a sole source of the 
appropriate amino acid (Figure 3-1).  In the first functional augmentation screen, cells 
transformed with the library were plated on each of the following:  medium containing 
YGGFL, KLLG, or KLLLG as the sole source of leucine and the controls of no leucine 
and free leucine.  In order to ensure the integrity of the media, an aliquot of each 
medium was poured as a small plate on which cells transformed with OPT1 or CaOPT1 
expressed from the ADH promoter or empty vector were spotted (Appendix 3).  
Unfortunately, there appeared to be a gene in the library that complimented the leu2 
auxotrophy of the cells.  Perhaps this was caused by another plasmid contaminating the 
library or even accidentally partially used in library creation since there is a sibling 
plasmid that bears LEU2 instead of URA3 as a selectable marker.  Regardless of the 
reason, the screen for cells bearing plasmids encoding peptide transporters that can 
grow on leucine-containing peptides as the sole source of the amino acid was unreliable, 
so another method needed to be performed. 
A second screen was therefore set up that relied on the ability of transformed cells 
to survive on a lysine-containing peptide as the sole source of that amino acid; this 
meant that Leu-enkephalin could not be used.  In this second screen, transformed cells 
were plated on medium containing either KLLG or KLLLG as the sole source of lysine 
and on the control media with or without free lysine.  No cells were observed on 
medium with no added lysine, and a lawn of cells was seen on medium containing free 
lysine.  In addition, 40 colonies grew on medium containing KLLLG after a period of 
three days.  No colonies were seen on the medium containing KLLG.  All observed 
colonies were streaked for isolation on medium with KLLLG as the only source of 
lysine.  Plasmids from these isolates were purified and sequenced.  No plasmids that 
were isolated in this manner contained an ORF, and when tested again for growth on 
YGGFL, KLLF, or KLLLG as the sole source of either leucine or lysine, no colonies that 
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contained one of these plasmids grew, thus all 40 of the colonies isolated in this screen 
were false positives. 
 
Discussion 
Opt1p, a yeast member of the Oligopeptide Transporter family, was discovered to 
transport the pentapeptides Met- and Leu-enkephalin — two endogenous, mammalian 
opioids — and glutathione (Chapter 1; Bourbouloux et al. 2000; Hauser et al. 2000).  
We have also determined that the transport of Leu-enkephalin by Opt1p is inhibited by 
peptides and other compounds that also inhibit PTS-1 in murine brain (Banks et al. 
1986).  Furthermore, we found that free amino acids and degradation products of Leu-
enkephalin up to tripeptide fragments did not inhibit substrate transport by Opt1p, just 
as it had been observed that fragments of the substrates Tyr-MIF-1 (Banks et al. 1986) 
and the enkephalins (Zlokovic et al. 1989) did not inhibit enkephalin transport by murine 
PTS-1. 
We found that Tyr-MIF-1 only inhibited uptake of Leu-enkephalin 22% when present 
at ten-fold the molarity of Leu-enkephalin, yet it has been noted that for rat PTS-1, 
which transports Tyr-MIF-1 across the BBB, has a higher affinity for Met-enkephalin than 
for Tyr-MIF-1 (Banks et al. 1986).  Morphine, naloxone, naltrexone, DPDPE, and DADLE 
also inhibited the uptake of Leu-enkephalin into the yeast cell by Opt1p.  This, of course, 
has been demonstrated to be true of PTS-1 by many authors (Banks and Kastin 1990).  
We know the inhibition by naloxone and naltrexone is specific for transport by Opt1p 
since dileucine transport by Ptr2p in yeast in unaffected by these molecules.  Other 
observations from our lab indicate that Opt1p also transports [3H]naloxone (Hauser, 
Becker, unpublished data).  Ethanol inhibits Leu-enkephalin uptake at just 3% and 
eliminates uptake at 10% (data not shown) during a 12-minute assay.  This inhibition is 
not specific:  ethanol inhibits dileucine transport by Ptr2p equally well. 
Because S. cerevisiae Opt1p had shown remarkable functional similarities to the 
mammalian BBB transport system PTS-1, it was hypothesized that an OPT family 
member could be responsible for the effects of PTS-1.  No homologues were found, 
however, by searching various animal databases for sequence similarity (Chapter 1) nor 
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was a homologue found by probing mouse genomic DNA by Southern blot analysis or 
by PCR with degenerate primers in OPT regions of high homology (data not shown). 
Because no animal genomes had yet been fully sequenced when this endeavor was 
launched, we set out to screen a rat brain cDNA library, expressed in yeast, by 
functional augmentation, in order to find a mammalian protein that functioned as an 
OPT.  Although the library was screened with 10-fold redundancy, no such protein was 
found. 
There were several issues involved in the functional augmentation screen which, 
when taken together, may account for its lack of success.  First, the library had not been 
created unidirectionally (Burton et al. 1993), making it necessary to screen twice as 
many clones.  It also had not been constructed to enrich for low-copy transcripts, and it 
had been created from whole adult rat brain.  Since we were looking for a membrane 
transporter presumably found exclusively at the BBB, the construction of this cDNA 
library was not optimum for our needs.  Second, since it was necessary to screen so 
many clones, the cost of peptide required to plate only 105 cells per plate was 
prohibitive; instead, 2 x 107 cells were screened per plate.  Complications with the 
ability of leu- cells transformed with the library to grow on medium lacking leucine 
prevented screening on Leu-enkephalin as the sole source of leucine.  Although both 
OPT family members and the mammalian enkephalin transporter located at the BBB 
have a wide range of substrates, their total potential peptide substrates do not 
necessarily overlap.  Therefore, not being able to directly screen for enkephalin uptake 
was not optimal for selecting a gene encoding an enkephalin transporter. 
In addition, one of the benefits of conducting this screen in a non-native cell type is 
also a draw-back:  while there are no rat proteins in yeast that may interfere with the 
transporter, proteins and rat-specific co-factors it may require are also absent.  There 
may even be post-translational modifications that S. cerevisiae is unable to perform that 
are required for the rat transporter’s function, or differences in the membrane may be 
prohibitive.  A similar case is that of the human Ptr2p homologues.  Although the 
protein sequence of this peptide transporter family is conserved from bacteria to man, 
the human PTR members will not function when expressed in S. cerevisiae.  When 
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expressed in the heterologous system Pichia pastoris, however, they will transport 
peptide (Doring et al. 1997).  Furthermore, early observations of PTS-1 showed that it 
was sodium-dependent (Banks et al. 1986); there was sodium in the poor nitrogen 
medium used, although perhaps not enough.  Additionally, Banks et al. (1986) observed 
that a tyrosine is required at the N-terminus of substrates of PTS-1.  Regrettably, none 
of the peptides used in the lysine-based screen had a tyrosine in this position.  The 
sodium dependency and the required N-terminal tyrosine on utilizable substrates appear 
to be the only difference between the OPT family and PTS-1 in rats and mice. 
There was no elegant way to screen the cDNA library for proteins conferring the 
ability to grow on glutathione.  Although not a detriment to the functional augmentation 
screen, this perhaps would have added to potential findings,.  Not only was the 
oxidation state of the cell a problem, but also the gene knock-outs that would have 
been required to eliminate the cells’ ability to synthesize glutathione would have 
required supplements of sulfur-containing amino acids and other sulfur-metabolizing 
genes would have likely interfered.  What was unexpected was that nothing was found 
that permitted utilization of the peptides KLLG and KLLLG:  neither a peptide 
transporter and nor an extracellular peptidase that would have permitted utilization of 
the peptides. 
Members of the organic anion transporting polypeptide superfamily (Oatp/OATP; 
TCDB #2.A.60) mediate the translocation of such anions as bile salts, hormones, 
eicosanoids, drugs, toxins, peptides, and other organic anions and cations.  As of late 
2003, there were 11 rat, 8 mouse, and 9 human Oatps/OATPs known.  The superfamily 
is ATP-independent (Li et al. 2000) and is divided into five families, from OATP1 to 
OATP5 (Hagenbuch and Meier 2003).  New evidence shows that Oatps/OATPs in 
subfamily OATP1A that are found at the BBB — rOatp1 and rOatp2 from rat and 
hOATP-A from human — facilitate the transport of opiate peptides such as Leu-
enkephalin, DPDPE, and deltorphin II (Gao et al. 2000).  Unlike PTS-1, this uptake is 
sodium-independent (Gao et al. 2000), but no correlative study has been done directly 
comparing PTS-1 with an Oatp/OATP.  It has also been noted that rOatp2 transports 
GSH into both the liver and the brain (Gao and Meier 2001).  Oatps/OATPs are only 
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found in animal genomes (Hagenbuch and Meier 2003), whereas OPTs are only found in 
fungal and plant genomes (Chapter 1).  It appears that convergent evolution has 
occurred:  both the OPT and the Oatp/OATP families facilitate the uptake of 
oligopeptides and glutathione.  One might expect that our strategy to isolate a rat OPT 
functional homologue would have uncovered a member of the Oatp/OATP family, but 
as mentioned above, not all mammalian proteins complement yeast homologues. 
Although considerable effort, time, and resources were put into this screen, no 
positive results were obtained.  The lack of an OPT homologue was reinforced once the 
rat genome was published and no homologue was found. 
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Chapter 4 
Topology prediction of the Oligopeptide Transport family. 
 
Background and Significance 
Families of multiple transmembrane domain (TMD) proteins are often characterized 
by conserved motifs and overall functional similarity.  G-protein coupled receptors, for 
instance, are characterized by having seven TMDs, binding to G-proteins, and 
transducing a signal via extracellular ligand binding (Hamm 1998).  Channels and 
permeases are characterized by substrate specificity, energy source, and location of 
conserved domains in relation to TMDs (Payne and Smith 1994).  With a full quarter of 
the yeast proteome estimated to be membrane-spanning (Bill 2001), understanding how 
TMD proteins operate is imperative to understanding how the cell ultimately functions.  
To gain a clear idea of how individual TMD proteins operate, one needs to determine 
their tertiary structure — their orientation in the membrane — and the location of 
their vital amino acid residues. 
Current studies of most proteins at the biochemical level involve determining their 
tertiary structure before further characterization.  Unfortunately for those studying 
transmembrane proteins, techniques such as X-ray crystallography and NMR are limited 
in use due to the hydrophobicity, and often large size, of these proteins (von Heijne 
1999).  There have been a token few prokaryotic transporter and channel proteins, 
however, that have had their three-dimensional structures solved (Doyle et al. 1998; 
Luecke et al. 1999; Kolbe et al. 2000; Abramson et al. 2003), but as compared to the vast 
number of proteins in this class, these structures can hardly be expected to represent all 
proteins of this type. 
The presently accepted methods of determining location of TMDs and their 
orientation in the membrane are chimera construction, antibody binding, glycosylation 
determination, and random or directed protein cleavage.  Chimera construction is the 
most common.  Truncations of the gene are made at various points, and the new 3’ 
ends are fused with a sequence encoding a reporter protein, such as genes for 
galactokinase (Green et al. 1989), β-lactamase (Cartwright and Tipper 1991), or Suc2p 
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(Gilstring and Ljungdahl 2000).  The protein chimeras are then expressed and the 
glycosylation state determined (in the case of galactokinase) or enzymatic activities 
assayed (in the cases of β-lactamase and Suc2p) on both whole cells and membrane 
preparations.  Raising antibodies against a protein can be costly in time and money — 
Fur4p is one of the rare proteins whose topology has been determined in this way 
(Garnier et al. 1996).  Again, both whole cells and membranes are analyzed.  
Glycosylation state is an indicator of membrane protein topology:  membrane proteins 
are glycosylated exclusively on the extracellular face.  Glycosylation was one method by 
which the topologies of both Fur4p (Garnier et al. 1996) and Gap1p (Gilstring and 
Ljungdahl 2000) were determined.  The glycosylation state of Fur4p was not determined 
in S. cerevisiae but the protein was reconstituted in canine pancreatic microsomes 
instead. 
Problems arise, however, with these techniques:  protein truncations or chimeras 
may be mis-folded, mis-localized, down regulated, or mis-inserted into the membrane.  
Indeed, Cartwright and Tipper (1991) had to express Ste2p-βla fusion in a strain 
background that reduced the turnover rate of mis-folded proteins.  They chose Ste2p as 
their subject because its hydrophobicity was highly suggestive of a seven TMD protein, 
and therefore they assumed it would be a relatively simple test case for their method.  
Random or directed cleavage is problematic in larger, multiple-pass TMD proteins such 
as transporters and channels:  it is not known how much of these proteins are solvent 
accessible, and this approach is not practical.  Even under optimal circumstances, TMD 
boundaries are difficult to ascertain by empirical methods (Ott and Lingappa 2002). 
For the most part, once there is experimental evidence for one representative of a 
polytopic protein family as to where and how many TMDs there are, the findings are 
immediately applied to the rest of the family.  Here we predict by computer algorithms 
the location of TMDs of a relatively new family of transporters, Oligopeptide Transport 
Family (OPT), and investigate possible conserved structure.  As of yet, the family has no 
empirical evidence suggesting topology, and the number of TMDs of this family has 
previously only been guessed by various databases to range from nine to 16 — here we 
suggest 12. 
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Materials and Methods 
Protein sequences used. 
Protein sequences of six functionally characterized OPT family members, Opt1p and 
Opt2p from Saccharomyces cerevisiae; Opt1p from Candida albicans, referred to here as 
CaOpt1p; Isp4p from Schizosaccharomyces pombe; Mtd1p from Schizophyllum commune; 
and OPT4 from Arabidopsis thaliana, here referred to as AtOPT4 (Table 4-1), were 
downloaded from Entrez (www.ncbi.nlm.nih.gov/Entrez/index.html).  The ORF 
translation of YGL114W from S. cerevisiae was retrieved from the Saccharomyces 
Genome Database (SGD; www.yeastgenome.org/).  These OPTs were chosen from 
among the many family members determined by homology since they have direct 
experimental evidence that they are, in fact, oligopeptide transporters, or, the case of 
Mtd1p, strong indirect evidence.  Ygl114wp was examined because it had been 
suggested by others to be an OPT (Yen et al. 2001), although I have shown it has no 
transport phenotype (Chapter 1).  The sequences of each of the four proteins whose 
crystal structures had been solved were retrieved from the Protein Data Bank (PDB; 
www.rcsb.org/pdb/). 
 
Programs used. 
All 11 proteins were subjected to six separate transmembrane-finding algorithms:  
the Kyte-Doolittle hydropathy method (Kyte and Doolittle 1982) run on Protean in 
Lasergene® (DNAstar Inc; Madison, WI), TopPred2 (von Heijne 1992; www.sbc.su.se/ 
~erikw/toppred2/), TMpred ( Hofmann and Stoffel 1993; www.ch.embnet.org/software/ 
TMPRED_form.html), PHDhtm (Rost et al. 1996; PredictProtein Server at www.embl-
heidelberg.de/predictprotein/predictprotein.html), TMHMM 2.0 (Sonnhammer et al. 
1998; Krogh et al. 2001; www.cbs.dtu.dk/services/TMHMM/), and SVMtm (Yuan et al. 
2004; ccb.imb.uq.edu.au/svmtm/svmtm_predictor.shtml).  All default settings were used, 
and “eukaryotic protein” was chosen when prompted.  In PHDhtm, domains specified 
with a Best HTM score lower than 0.600 were designated as putative.  These algorithms 
were chosen as being those available for public use that were designed to predict TMDs 
in eukaryotic proteins. 
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Table 4-1.  Proteins used in this study.  Sequences of members of the OPT 
family were downloaded from Entrez at their given accession numbers.  Sequences and 
structures of proteins of known structure were downloaded from PDB at their given ID 
number. 
 
 
OPT (OligoPeptide Transport) Family 
Protein Species Accession number 
Opt1p Saccharomyces cerevisiae NP_012323 
Opt2p Saccharomyces cerevisiae NP_015520 
AtOPT4 Arabidopsis thaliana AAN15658 
CaOpt1p Candida albicans EAK99436 
Isp4p Schizosaccharomyces pombe NP_595653 
Mtd1p Schizophyllum commune AAF26618 
Bacterial Polytopic Proteins 
Protein Species ID number 
K+ channel Streptomyces lividans 1BL8 
Bacteriorhodopsin Halbacterium salinarum 1C3W 
Halorhodopsin Halbacterium salinarum 1E12 
LacY Escherichia coli 1PV6 
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Kyte-Doolittle calculates a hydropathy score for each amino acid and averages them 
in a sliding window, which was set as nine.  TopPred2 predicts topology based on 
hydrophobicity and includes the positive-inside rule (von Heijne 1986).  The output is 
set to only yield TMDs of exactly 21 residues.  TMpred not only uses hydrophobicity, 
but scores a combination of characteristics, including using residues predicted to be in 
all TMD proteins, residues in regions flanking TMDs, and species and homology specific 
residue weights.  PHDhtm is a trained neural network, TMHMM 2.0 a hidden Markov 
model, and SVMtm a support vector machine function.  Since the main fault of computer 
algorithm prediction methods is the assignment of signal sequences as false-positives, the 
signal sequence prediction algorithm SignalP 3.0 was used (Bendtsen et al. 2004; 
www.cbs.dtu.dk/services/SignalP/).  iMol (www.pirx.com/iMol/) was used to determine 
the boundaries of membrane-spanning segments of crystal structure proteins. 
The six OPT members were aligned using Clustal W in the program MegAlign in 
Lasergene®.  DrawTree in Phylip (evolution.genetics.washington.edu/phylip.html) was 
used to create an unrooted tree of the selected family members. 
 
Family transmembrane domain prediction. 
A consensus for each potential transmembrane segment in each protein was 
determined and, in the case of OPT family members, superimposed on the multiple 
sequence alignment.  The borders of each potential transmembrane region were fine-
tuned with attention paid to specific algorithmic outputs and conserved regions of each 
family; this was done in an attempt to keep TMD prediction consistent in relation to 
conserved residue location.  A more thorough explanation is given in the results section 
of this chapter. 
 
Results 
Transmembrane domain predictions of proteins with known 
structure. 
To test the authenticity of the consensus approach, four multiple-pass 
transmembrane proteins with solved crystal structures were chosen from PDB (Table 
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4-1).  The protein sequences that had been deposited were submitted to the six TMD 
prediction methods used in this study.  A consensus for each potential TMD was 
determined (Figure 4-1).  These were then compared to the helices as described in each 
of the PDB files. 
As can be seen in Figure 4-1A, our consensuses agree with the location of the α-
helices that cross the membrane as reported by Doyle et al. (1998) for the K+ channel 
(1BL8).  The crystal structure’s second α-helix does not appear to cross the membrane; 
both PHDhtm and TMHMM 2.0, algorithms that have a better probability of correctly 
identifying TMDs than Kyte-Dootlittle, TopPred2, or TMpred, incorrectly assigned that 
helix as a TMD.  In B (bacteriorhodopsin) and C (halorhodopsin) of Figure 4-1, the 
consensus approach correctly found the TMDs designated by Luecke et al. (1999) 
(1C3W) and Kolbe et al. (2000) (1E12) as α-helices, although for halorhodopsin, the 
consensus TMDs tend to be offset toward the C-terminus.  SVMtm did not predict any 
TMDs for halorhodopsin until the first two residues were removed from the submitted 
sequence.  It is clear that not all methods correctly predicted all 12 TMDs of LacY 
(1PV6) (Figure 4-1.D), but our consensus method found their locations.  The particular 
shortcoming of TMpred, PHDhtm, and TMHMM 2.0 was TM10, with its helical region 
between S311 and F341 (Abramson et al. 2003).  Since the assignments of the Kyte-
Doolittle method, TopPred2, and especially SVMtm, and also because of the sequence 
we designated as TM9, we specified TM10 to be between V315 and F334. 
 
Determination of signal sequences in the OPT family. 
The major problem with algorithmic TMD prediction methods is that they falsely 
assign signal sequences that do not span the membrane as TMDs (Moller et al. 2001).  
For this reason, all OPT members in this study were submitted to SignalP 3.0 (Bendtsen 
et al. 2004) to determine, albeit computationally, if any contained any signal peptides; 
they did not. 
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Figure 4-1.  Transmembrane domain predictions for integral 
membrane proteins with solved crystal structures.  The alignment was 
constructed with ClustalW in MegAlign from Lasergene®.  Each protein (A, B, C, and D) 
is first represented on six lines corresponding to each algorithm used to predicted its 
topology, from top to bottom:  Kyte-Doolittle hydropathy, TopPred2, TMpred, 
PHDhtm, TMHMM 2.0, and SVMtm.  Regions predicted to be TMDs are highlighted in 
black — those that have been labeled as putative in grey. TMHMM 2.0 and SVMtm do 
not list putative domains.  The protein is then represented on another two lines, the 
first of which contains highlighted areas of consensus predictions, the second containing 
helical regions found in its crystal structure.  The sequence ruler is located above each 
sequence segment.  A.  K+ channel (1BL8) (Doyle et al. 1998).  In the crystal structure, 
the second helix appears to be embedded in the membrane but does not cross it.  B.  
Bacteriorhodopsin (1C3W) (Luecke et al. 1999).  C. Halorhodopsin (1E12) (Kolbe et al. 
2000).  In the crystal structure, the eighth helix (NNERT) is not a transmembrane 
domain.  D.  LacY (1PV6) (Abramson et al. 2003).  According to the crystal structure, 
residues N165, G287, and G377 (shown by small arrows) are each assigned to two 
different, adjacent α-helices that cross the membrane in opposite directions.  The three 
helices that do not appear to be embedded in the membrane (M1-N6, S209-Q219, and 
S407-A417) have been omitted from this figure for clarity. 
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A.  K+ Channel 
  1 ---------+---------+---------+---------+---------+---------+---------+---------+---------+------- 
  1 ALHWRAAGAATVLLVIVLLAGSYLAVLAERGAPGAQLITYPRALWWSVETATTVGYGDLYPVTLWGRCVAVVVMVAGITSFGLVTAALATWFVGREQ  Kyte-Doolittle 
  1 ALHWRAAGAATVLLVIVLLAGSYLAVLAERGAPGAQLITYPRALWWSVETATTVGYGDLYPVTLWGRCVAVVVMVAGITSFGLVTAALATWFVGREQ  TopPred 2 
  1 ALHWRAAGAATVLLVIVLLAGSYLAVLAERGAPGAQLITYPRALWWSVETATTVGYGDLYPVTLWGRCVAVVVMVAGITSFGLVTAALATWFVGREQ  TMpred 
  1 ALHWRAAGAATVLLVIVLLAGSYLAVLAERGAPGAQLITYPRALWWSVETATTVGYGDLYPVTLWGRCVAVVVMVAGITSFGLVTAALATWFVGREQ  PHDhtm 
  1 ALHWRAAGAATVLLVIVLLAGSYLAVLAERGAPGAQLITYPRALWWSVETATTVGYGDLYPVTLWGRCVAVVVMVAGITSFGLVTAALATWFVGREQ  TMHMM 2.0 
  1 ALHWRAAGAATVLLVIVLLAGSYLAVLAERGAPGAQLITYPRALWWSVETATTVGYGDLYPVTLWGRCVAVVVMVAGITSFGLVTAALATWFVGREQ  SVMtm 
 
  1 ALHWRAAGAATVLLVIVLLAGSYLAVLAERGAPGAQLITYPRALWWSVETATTVGYGDLYPVTLWGRCVAVVVMVAGITSFGLVTAALATWFVGREQ  Our prediction based on consensus 
  1 ALHWRAAGAATVLLVIVLLAGSYLAVLAERGAPGAQLITYPRALWWSVETATTVGYGDLYPVTLWGRCVAVVVMVAGITSFGLVTAALATWFVGREQ  Helices found in crystal structure 
 
B.  Bacterorhodopsin 
  1 ---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+ 
  1 TGRPEWIWLALGTALMGLGTLYFLVKGMGVSDPDAKKFYAITTLVPAIAFTMYLSMLLGYGLTMVPFGGEQNPIYWARYADWLFTTPLLLLDLALLVDADQGTILALVGADGIMIGTGLVGALTKVYSYRFVWWAISTAAMLYILYVLFF 
  1 TGRPEWIWLALGTALMGLGTLYFLVKGMGVSDPDAKKFYAITTLVPAIAFTMYLSMLLGYGLTMVPFGGEQNPIYWARYADWLFTTPLLLLDLALLVDADQGTILALVGADGIMIGTGLVGALTKVYSYRFVWWAISTAAMLYILYVLFF 
  1 TGRPEWIWLALGTALMGLGTLYFLVKGMGVSDPDAKKFYAITTLVPAIAFTMYLSMLLGYGLTMVPFGGEQNPIYWARYADWLFTTPLLLLDLALLVDADQGTILALVGADGIMIGTGLVGALTKVYSYRFVWWAISTAAMLYILYVLFF 
  1 TGRPEWIWLALGTALMGLGTLYFLVKGMGVSDPDAKKFYAITTLVPAIAFTMYLSMLLGYGLTMVPFGGEQNPIYWARYADWLFTTPLLLLDLALLVDADQGTILALVGADGIMIGTGLVGALTKVYSYRFVWWAISTAAMLYILYVLFF 
  1 TGRPEWIWLALGTALMGLGTLYFLVKGMGVSDPDAKKFYAITTLVPAIAFTMYLSMLLGYGLTMVPFGGEQNPIYWARYADWLFTTPLLLLDLALLVDADQGTILALVGADGIMIGTGLVGALTKVYSYRFVWWAISTAAMLYILYVLFF 
  1 TGRPEWIWLALGTALMGLGTLYFLVKGMGVSDPDAKKFYAITTLVPAIAFTMYLSMLLGYGLTMVPFGGEQNPIYWARYADWLFTTPLLLLDLALLVDADQGTILALVGADGIMIGTGLVGALTKVYSYRFVWWAISTAAMLYILYVLFF 
 
  1 TGRPEWIWLALGTALMGLGTLYFLVKGMGVSDPDAKKFYAITTLVPAIAFTMYLSMLLGYGLTMVPFGGEQNPIYWARYADWLFTTPLLLLDLALLVDADQGTILALVGADGIMIGTGLVGALTKVYSYRFVWWAISTAAMLYILYVLFF 
  1 TGRPEWIWLALGTALMGLGTLYFLVKGMGVSDPDAKKFYAITTLVPAIAFTMYLSMLLGYGLTMVPFGGEQNPIYWARYADWLFTTPLLLLDLALLVDADQGTILALVGADGIMIGTGLVGALTKVYSYRFVWWAISTAAMLYILYVLFF 
 
151 ---------+---------+---------+---------+---------+---------+---------+-- 
151 GFSMRPEVASTFKVLRNVTVVLWSAYPVVWLIGSEGAGIVPLNIETLLFMVLDVSAKVGFGLILLRSRAIFG 
151 GFSMRPEVASTFKVLRNVTVVLWSAYPVVWLIGSEGAGIVPLNIETLLFMVLDVSAKVGFGLILLRSRAIFG 
151 GFSMRPEVASTFKVLRNVTVVLWSAYPVVWLIGSEGAGIVPLNIETLLFMVLDVSAKVGFGLILLRSRAIFG 
151 GFSMRPEVASTFKVLRNVTVVLWSAYPVVWLIGSEGAGIVPLNIETLLFMVLDVSAKVGFGLILLRSRAIFG 
151 GFSMRPEVASTFKVLRNVTVVLWSAYPVVWLIGSEGAGIVPLNIETLLFMVLDVSAKVGFGLILLRSRAIFG 
151 GFSMRPEVASTFKVLRNVTVVLWSAYPVVWLIGSEGAGIVPLNIETLLFMVLDVSAKVGFGLILLRSRAIFG 
 
151 GFSMRPEVASTFKVLRNVTVVLWSAYPVVWLIGSEGAGIVPLNIETLLFMVLDVSAKVGFGLILLRSRAIFG 
151 GFSMRPEVASTFKVLRNVTVVLWSAYPVVWLIGSEGAGIVPLNIETLLFMVLDVSAKVGFGLILLRSRAIFG 
 
C.  Halorhodopsin 
  1 ---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+ 
  1 AVRENALLSSSLWVNVALAGIAILVFVYMGRTIRPGRPRLIWGATLMIPLVSISSYLGLLSGLTVGMIEMPAGHALAGEMVRSQWGRYLTWALSTPMILLALGLLADVDLGSLFTVIAADIGMCVTGLAAAMTTSALLFRWAFYAISCAF 
  1 AVRENALLSSSLWVNVALAGIAILVFVYMGRTIRPGRPRLIWGATLMIPLVSISSYLGLLSGLTVGMIEMPAGHALAGEMVRSQWGRYLTWALSTPMILLALGLLADVDLGSLFTVIAADIGMCVTGLAAAMTTSALLFRWAFYAISCAF 
  1 AVRENALLSSSLWVNVALAGIAILVFVYMGRTIRPGRPRLIWGATLMIPLVSISSYLGLLSGLTVGMIEMPAGHALAGEMVRSQWGRYLTWALSTPMILLALGLLADVDLGSLFTVIAADIGMCVTGLAAAMTTSALLFRWAFYAISCAF 
  1 AVRENALLSSSLWVNVALAGIAILVFVYMGRTIRPGRPRLIWGATLMIPLVSISSYLGLLSGLTVGMIEMPAGHALAGEMVRSQWGRYLTWALSTPMILLALGLLADVDLGSLFTVIAADIGMCVTGLAAAMTTSALLFRWAFYAISCAF 
  1 AVRENALLSSSLWVNVALAGIAILVFVYMGRTIRPGRPRLIWGATLMIPLVSISSYLGLLSGLTVGMIEMPAGHALAGEMVRSQWGRYLTWALSTPMILLALGLLADVDLGSLFTVIAADIGMCVTGLAAAMTTSALLFRWAFYAISCAF 
  1 AVRENALLSSSLWVNVALAGIAILVFVYMGRTIRPGRPRLIWGATLMIPLVSISSYLGLLSGLTVGMIEMPAGHALAGEMVRSQWGRYLTWALSTPMILLALGLLADVDLGSLFTVIAADIGMCVTGLAAAMTTSALLFRWAFYAISCAF 
 
  1 AVRENALLSSSLWVNVALAGIAILVFVYMGRTIRPGRPRLIWGATLMIPLVSISSYLGLLSGLTVGMIEMPAGHALAGEMVRSQWGRYLTWALSTPMILLALGLLADVDLGSLFTVIAADIGMCVTGLAAAMTTSALLFRWAFYAISCAF 
  1 AVRENALLSSSLWVNVALAGIAILVFVYMGRTIRPGRPRLIWGATLMIPLVSISSYLGLLSGLTVGMIEMPAGHALAGEMVRSQWGRYLTWALSTPMILLALGLLADVDLGSLFTVIAADIGMCVTGLAAAMTTSALLFRWAFYAISCAF 
 
151 ---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+--- 
151 FVVVLSALVTDWAASASSAGTAEIFDTLRVLTVVLWLGYPIVWAVGVEGLALVQSVGATSWAYSVLDVFAKYVFAFILLRWVANNERTVAVAGQTLGTMSSDD 
151 FVVVLSALVTDWAASASSAGTAEIFDTLRVLTVVLWLGYPIVWAVGVEGLALVQSVGATSWAYSVLDVFAKYVFAFILLRWVANNERTVAVAGQTLGTMSSDD 
151 FVVVLSALVTDWAASASSAGTAEIFDTLRVLTVVLWLGYPIVWAVGVEGLALVQSVGATSWAYSVLDVFAKYVFAFILLRWVANNERTVAVAGQTLGTMSSDD 
151 FVVVLSALVTDWAASASSAGTAEIFDTLRVLTVVLWLGYPIVWAVGVEGLALVQSVGATSWAYSVLDVFAKYVFAFILLRWVANNERTVAVAGQTLGTMSSDD 
151 FVVVLSALVTDWAASASSAGTAEIFDTLRVLTVVLWLGYPIVWAVGVEGLALVQSVGATSWAYSVLDVFAKYVFAFILLRWVANNERTVAVAGQTLGTMSSDD 
151 FVVVLSALVTDWAASASSAGTAEIFDTLRVLTVVLWLGYPIVWAVGVEGLALVQSVGATSWAYSVLDVFAKYVFAFILLRWVANNERTVAVAGQTLGTMSSDD 
 
151 FVVVLSALVTDWAASASSAGTAEIFDTLRVLTVVLWLGYPIVWAVGVEGLALVQSVGATSWAYSVLDVFAKYVFAFILLRWVANNERTVAVAGQTLGTMSSDD 
151 FVVVLSALVTDWAASASSAGTAEIFDTLRVLTVVLWLGYPIVWAVGVEGLALVQSVGATSWAYSVLDVFAKYVFAFILLRWVANNERTVAVAGQTLGTMSSDD 
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D.  LacY, lactose permease 
  1 ---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+ 
  1 MYYLKNTNFWMFGLFFFFYFFIMGAYFPFFPIWLHDINHISKSDTGIIFAAISLFSLLFQPLFGLLSDKLGLRKYLLWIITGMLVMFAPFFIFIFGPLLQYNILVGSIVGGIYLGFCFNAGAPAVEAFIEKVSRRSNFEFGRARMFGCVG 
  1 MYYLKNTNFWMFGLFFFFYFFIMGAYFPFFPIWLHDINHISKSDTGIIFAAISLFSLLFQPLFGLLSDKLGLRKYLLWIITGMLVMFAPFFIFIFGPLLQYNILVGSIVGGIYLGFCFNAGAPAVEAFIEKVSRRSNFEFGRARMFGCVG 
  1 MYYLKNTNFWMFGLFFFFYFFIMGAYFPFFPIWLHDINHISKSDTGIIFAAISLFSLLFQPLFGLLSDKLGLRKYLLWIITGMLVMFAPFFIFIFGPLLQYNILVGSIVGGIYLGFCFNAGAPAVEAFIEKVSRRSNFEFGRARMFGCVG 
  1 MYYLKNTNFWMFGLFFFFYFFIMGAYFPFFPIWLHDINHISKSDTGIIFAAISLFSLLFQPLFGLLSDKLGLRKYLLWIITGMLVMFAPFFIFIFGPLLQYNILVGSIVGGIYLGFCFNAGAPAVEAFIEKVSRRSNFEFGRARMFGCVG 
  1 MYYLKNTNFWMFGLFFFFYFFIMGAYFPFFPIWLHDINHISKSDTGIIFAAISLFSLLFQPLFGLLSDKLGLRKYLLWIITGMLVMFAPFFIFIFGPLLQYNILVGSIVGGIYLGFCFNAGAPAVEAFIEKVSRRSNFEFGRARMFGCVG 
  1 MYYLKNTNFWMFGLFFFFYFFIMGAYFPFFPIWLHDINHISKSDTGIIFAAISLFSLLFQPLFGLLSDKLGLRKYLLWIITGMLVMFAPFFIFIFGPLLQYNILVGSIVGGIYLGFCFNAGAPAVEAFIEKVSRRSNFEFGRARMFGCVG 
 
  1 MYYLKNTNFWMFGLFFFFYFFIMGAYFPFFPIWLHDINHISKSDTGIIFAAISLFSLLFQPLFGLLSDKLGLRKYLLWIITGMLVMFAPFFIFIFGPLLQYNILVGSIVGGIYLGFCFNAGAPAVEAFIEKVSRRSNFEFGRARMFGCVG 
  1 MYYLKNTNFWMFGLFFFFYFFIMGAYFPFFPIWLHDINHISKSDTGIIFAAISLFSLLFQPLFGLLSDKLGLRKYLLWIITGMLVMFAPFFIFIFGPLLQYNILVGSIVGGIYLGFCFNAGAPAVEAFIEKVSRRSNFEFGRARMFGCVG 
 
151 ---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+ 
151 WALGASIVGIMFTINNQFVFWLGSGCALILAVLLFFAKTDAPSSATVANAVGANHSAFSLKLALELFRQPKLWFLSLYVIGVSCTYDVFDQQFANFFTSFFATGEQGTRVFGYVTTMGELLNASIMFFAPLIINRIGGKNALLLAGTIMS 
151 WALGASIVGIMFTINNQFVFWLGSGCALILAVLLFFAKTDAPSSATVANAVGANHSAFSLKLALELFRQPKLWFLSLYVIGVSCTYDVFDQQFANFFTSFFATGEQGTRVFGYVTTMGELLNASIMFFAPLIINRIGGKNALLLAGTIMS 
151 WALGASIVGIMFTINNQFVFWLGSGCALILAVLLFFAKTDAPSSATVANAVGANHSAFSLKLALELFRQPKLWFLSLYVIGVSCTYDVFDQQFANFFTSFFATGEQGTRVFGYVTTMGELLNASIMFFAPLIINRIGGKNALLLAGTIMS 
151 WALGASIVGIMFTINNQFVFWLGSGCALILAVLLFFAKTDAPSSATVANAVGANHSAFSLKLALELFRQPKLWFLSLYVIGVSCTYDVFDQQFANFFTSFFATGEQGTRVFGYVTTMGELLNASIMFFAPLIINRIGGKNALLLAGTIMS 
151 WALGASIVGIMFTINNQFVFWLGSGCALILAVLLFFAKTDAPSSATVANAVGANHSAFSLKLALELFRQPKLWFLSLYVIGVSCTYDVFDQQFANFFTSFFATGEQGTRVFGYVTTMGELLNASIMFFAPLIINRIGGKNALLLAGTIMS 
151 WALGASIVGIMFTINNQFVFWLGSGCALILAVLLFFAKTDAPSSATVANAVGANHSAFSLKLALELFRQPKLWFLSLYVIGVSCTYDVFDQQFANFFTSFFATGEQGTRVFGYVTTMGELLNASIMFFAPLIINRIGGKNALLLAGTIMS 
 
151 WALGASIVGIMFTINNQFVFWLGSGCALILAVLLFFAKTDAPSSATVANAVGANHSAFSLKLALELFRQPKLWFLSLYVIGVSCTYDVFDQQFANFFTSFFATGEQGTRVFGYVTTMGELLNASIMFFAPLIINRIGGKNALLLAGTIMS 
151 WALGASIVGIMFTINNQFVFWLGSGCALILAVLLFFAKTDAPSSATVANAVGANHSAFSLKLALELFRQPKLWFLSLYVIGVSCTYDVFDQQFANFFTSFFATGEQGTRVFGYVTTMGELLNASIMFFAPLIINRIGGKNALLLAGTIMS 
 
301 ---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+------- 
301 VRIIGSSFATSALEVVILKTLHMFEVPFLLVGCFKYITSQFEVRFSATIYLVCFCFFKQLAMIFMSVLAGNMYESIGFQGAYLVLGLVALGFTLISVFTLSGPGPLSLLRRQVNEVA 
301 VRIIGSSFATSALEVVILKTLHMFEVPFLLVGCFKYITSQFEVRFSATIYLVCFCFFKQLAMIFMSVLAGNMYESIGFQGAYLVLGLVALGFTLISVFTLSGPGPLSLLRRQVNEVA 
301 VRIIGSSFATSALEVVILKTLHMFEVPFLLVGCFKYITSQFEVRFSATIYLVCFCFFKQLAMIFMSVLAGNMYESIGFQGAYLVLGLVALGFTLISVFTLSGPGPLSLLRRQVNEVA 
301 VRIIGSSFATSALEVVILKTLHMFEVPFLLVGCFKYITSQFEVRFSATIYLVCFCFFKQLAMIFMSVLAGNMYESIGFQGAYLVLGLVALGFTLISVFTLSGPGPLSLLRRQVNEVA 
301 VRIIGSSFATSALEVVILKTLHMFEVPFLLVGCFKYITSQFEVRFSATIYLVCFCFFKQLAMIFMSVLAGNMYESIGFQGAYLVLGLVALGFTLISVFTLSGPGPLSLLRRQVNEVA 
301 VRIIGSSFATSALEVVILKTLHMFEVPFLLVGCFKYITSQFEVRFSATIYLVCFCFFKQLAMIFMSVLAGNMYESIGFQGAYLVLGLVALGFTLISVFTLSGPGPLSLLRRQVNEVA 
 
301 VRIIGSSFATSALEVVILKTLHMFEVPFLLVGCFKYITSQFEVRFSATIYLVCFCFFKQLAMIFMSVLAGNMYESIGFQGAYLVLGLVALGFTLISVFTLSGPGPLSLLRRQVNEVA 
301 VRIIGSSFATSALEVVILKTLHMFEVPFLLVGCFKYITSQFEVRFSATIYLVCFCFFKQLAMIFMSVLAGNMYESIGFQGAYLVLGLVALGFTLISVFTLSGPGPLSLLRRQVNEVA 
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Transmembrane domain predictions of the OPT family. 
Since our consensus approach of TMD prediction seemed valid with little ambiguity, 
we applied a variation of it to the OPT family — a protein family with no empirical 
evidence for its structure to date.  Each protein selected (Table 4-1) has had some 
functional study done indicating that it is an OPT.  Of the six representatives, Mtd1p is 
the most distant relative (Figure 4-2); its conserved regions are the most divergent. 
As was done for the four proteins with crystal structures, each OPT member was 
submitted to the six prediction algorithms, but before a consensus was achieved for 
each potential TMD, a global multiple-sequence alignment was performed (Figure 4-3).  
A consensus was reached for each TMD in individual proteins only after it was 
compared to the conserved regions specified by the global alignment and the algorithmic 
predictions made for the rest of the family.  For example, when determining the borders 
of TM-A (Figures 4-3), it was noted that position 169 on the consensus ruler was 
aromatic in all proteins except Mtd1p.  If this TMD was predicted by an algorithm, 
residue 169 was included.  More than half of the algorithms also predicted residue 168, 
but only 12 algorithm results extended this TMD more N-terminal.  These 12 results 
were distributed over all six proteins.  The N-terminal end of TM-A was therefore 
predicted to be at consensus residue 168 for all six proteins.  Similarly, the consensus 
residues 185 and 186 were phenylalanines in all proteins except Mtd1p, where 186 was 
a tyrosine.  More than half of the algorithm results contained these two residues in the 
first TMD, but only 14 results extended the TMD more C-terminal, thus the C-terminal 
end of TM-A was predicted to be at consensus residue 186 for these proteins.  The 
Kyte-Doolittle method is notorious for not predicting ends of TMDs well, because it 
was not created to carry out this function.  TopPred2 was also not designed to predict 
borders; it always returns a result of exactly 21 residues, so it cannot be relied upon to 
predict the ends of TMDs.  PHDtm, TMHMM 2.0, and SVMtm were written with “cap” 
functions, so these three were relied more heavily upon for predicting the ends of 
TMDs. 
Of the 12 TMDs we have assigned to the OPT family, lettered A-L (Figure 4-3), only 
six were predicted with certainty by all algorithms in all six proteins.  Although TMHMM 
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Figure 4-2.  Rooted tree of selected OPT family members.  ClustalW in 
MegAlign from the package Lasergene® and DrawGram from the phylogeny package 
Phylip were used to create this tree.  Mtd1p is from S. commune, Opt1p and Opt2p are 
from S. cerevisiae, CaOpt1p is from C. albicans, Isp4p is from S. pombe, and AtOPT4 is 
from A. thaliana. 
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Figure 4-3.  Alignment of selected OPT family members and the 
transmembrane domain predictions by individual algorithms.  The 
alignment was constructed with ClustalW in MegAlign from Lasergene®.  Each family 
member studied is represented on six lines corresponding to each algorithm used to 
predict its topology, from top to bottom:  Kyte-Doolittle hydropathy, TopPred2, 
TMpred, PHDhtm, TMHMM 2.0, and SVMtm.  Regions predicted to be TMDs are 
highlighted in black — those that have been labeled as putative in light grey.  In TMpred, 
represented on the third line, residues marked with a small arrow are those that 
overlap two designated domains (Isp4p A511, AtOPT4 N644 and Y645).  Neither 
TMHMM 2.0 nor SVMtm list putative domains.  The consensus ruler is located at the 
top line of each page.  Highlighted in black are the regions proposed to be conserved 
TMDs in the family; these are lettered A-L.  Also boxed in on the consensus ruler are 
the two proline motifs PG[R/K]P and PPX[N/T]p. 
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          1 ---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+-------A-+---------+---------+--B------+---------+---------+---------+---------+ 
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  Isp4p   1 ----------MIGSINES---------PIEEHMNDSPSTKEKADSVDISDYIVSHSDDS------LSKDIKKDTKSFLDVEHGEISTVDEFE----ED---------------------------------------------SPYPEVRAAVPPTDDPSMPCNTIRMWTIGLIYSTVGAAVNMFFSLRNPTVTLSVLISELLAYPALQIWDLIFPDREFRI---GRLKFN-----FKPG 
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  Mtd1p   1 -----MATEDALPKLPHR-----------PEPAR-EKTDGSLDEKIDEKLNNNKGEG---------FQDEPFELETQAQLDRQHVVTTG---------------------------------------------------------QDVSRYVVNLRDDEDPALTFRSLVLGTVIAGLGAALCQIYIFKPVLVSVSTVFLLLLIYCIGNAWAVFLPKRSLVKG-TRFERYGGIIEFINPG 
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  Mtd1p   1 -----MATEDALPKLPHR-----------PEPAR-EKTDGSLDEKIDEKLNNNKGEG---------FQDEPFELETQAQLDRQHVVTTG---------------------------------------------------------QDVSRYVVNLRDDEDPALTFRSLVLGTVIAGLGAALCQIYIFKPVLVSVSTVFLLLLIYCIGNAWAVFLPKRSLVKG-TRFERYGGIIEFINPG 
  Mtd1p   1 -----MATEDALPKLPHR-----------PEPAR-EKTDGSLDEKIDEKLNNNKGEG---------FQDEPFELETQAQLDRQHVVTTG---------------------------------------------------------QDVSRYVVNLRDDEDPALTFRSLVLGTVIAGLGAALCQIYIFKPVLVSVSTVFLLLLIYCIGNAWAVFLPKRSLVKG-TRFERYGGIIEFINPG 
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  Opt1p 172 -PFTKKEHAVVTIAVALT--SST--AYAMYILNAQGSFYNMKLNVGYQFLLVWTSQMIGYGAAGLTRRWVVNPASSIWPQTLISVSLFDSLHSRKVEKTVANGWTMPRYRFFLIVLIGSFIWYWVPGFLFTGLSYFNVILWGSKTRH---NFIANTIFGT---QSGLGALP--ITFDYTQVSQAMSGSVFATPFYVSANTYASVLIFFVIVLPCLYF-TNTWYAKYMPVISGSTYDNTQN 
  Opt1p 172 -PFTKKEHAVVTIAVALT--SST--AYAMYILNAQGSFYNMKLNVGYQFLLVWTSQMIGYGAAGLTRRWVVNPASSIWPQTLISVSLFDSLHSRKVEKTVANGWTMPRYRFFLIVLIGSFIWYWVPGFLFTGLSYFNVILWGSKTRH---NFIANTIFGT---QSGLGALP--ITFDYTQVSQAMSGSVFATPFYVSANTYASVLIFFVIVLPCLYF-TNTWYAKYMPVISGSTYDNTQN 
  Opt1p 172 -PFTKKEHAVVTIAVALT--SST--AYAMYILNAQGSFYNMKLNVGYQFLLVWTSQMIGYGAAGLTRRWVVNPASSIWPQTLISVSLFDSLHSRKVEKTVANGWTMPRYRFFLIVLIGSFIWYWVPGFLFTGLSYFNVILWGSKTRH---NFIANTIFGT---QSGLGALP--ITFDYTQVSQAMSGSVFATPFYVSANTYASVLIFFVIVLPCLYF-TNTWYAKYMPVISGSTYDNTQN 
  Opt1p 172 -PFTKKEHAVVTIAVALT--SST--AYAMYILNAQGSFYNMKLNVGYQFLLVWTSQMIGYGAAGLTRRWVVNPASSIWPQTLISVSLFDSLHSRKVEKTVANGWTMPRYRFFLIVLIGSFIWYWVPGFLFTGLSYFNVILWGSKTRH---NFIANTIFGT---QSGLGALP--ITFDYTQVSQAMSGSVFATPFYVSANTYASVLIFFVIVLPCLYF-TNTWYAKYMPVISGSTYDNTQN 
  Opt1p 172 -PFTKKEHAVVTIAVALT--SST--AYAMYILNAQGSFYNMKLNVGYQFLLVWTSQMIGYGAAGLTRRWVVNPASSIWPQTLISVSLFDSLHSRKVEKTVANGWTMPRYRFFLIVLIGSFIWYWVPGFLFTGLSYFNVILWGSKTRH---NFIANTIFGT---QSGLGALP--ITFDYTQVSQAMSGSVFATPFYVSANTYASVLIFFVIVLPCLYF-TNTWYAKYMPVISGSTYDNTQN 
  Opt1p 172 -PFTKKEHAVVTIAVALT--SST--AYAMYILNAQGSFYNMKLNVGYQFLLVWTSQMIGYGAAGLTRRWVVNPASSIWPQTLISVSLFDSLHSRKVEKTVANGWTMPRYRFFLIVLIGSFIWYWVPGFLFTGLSYFNVILWGSKTRH---NFIANTIFGT---QSGLGALP--ITFDYTQVSQAMSGSVFATPFYVSANTYASVLIFFVIVLPCLYF-TNTWYAKYMPVISGSTYDNTQN 
 
  Opt2p 233 KPWTQKEQMFSTLLYAIC----QGAFYTHYNILTQKLFYHSAFSFGYQFLLSLSVQFIGFGFAGILRKFVVYPARALWPTVMPTIAINKALLGK-----EKHESGMSRYKFFFLTFFIMFIYNWFPTYIINILNTFNWMTWIKPS-----NINLANITGG---VTGLGINP-ISSFDWNVIS--FN-SPLVYPFWSYLTQYLGCILAALIVI-AVYY-SNYMSCQYLPIFTNSLYTNTGH 
  Opt2p 233 KPWTQKEQMFSTLLYAIC----QGAFYTHYNILTQKLFYHSAFSFGYQFLLSLSVQFIGFGFAGILRKFVVYPARALWPTVMPTIAINKALLGK-----EKHESGMSRYKFFFLTFFIMFIYNWFPTYIINILNTFNWMTWIKPS-----NINLANITGG---VTGLGINP-ISSFDWNVIS--FN-SPLVYPFWSYLTQYLGCILAALIVI-AVYY-SNYMSCQYLPIFTNSLYTNTGH 
  Opt2p 233 KPWTQKEQMFSTLLYAIC----QGAFYTHYNILTQKLFYHSAFSFGYQFLLSLSVQFIGFGFAGILRKFVVYPARALWPTVMPTIAINKALLGK-----EKHESGMSRYKFFFLTFFIMFIYNWFPTYIINILNTFNWMTWIKPS-----NINLANITGG---VTGLGINP-ISSFDWNVIS--FN-SPLVYPFWSYLTQYLGCILAALIVI-AVYY-SNYMSCQYLPIFTNSLYTNTGH 
  Opt2p 233 KPWTQKEQMFSTLLYAIC----QGAFYTHYNILTQKLFYHSAFSFGYQFLLSLSVQFIGFGFAGILRKFVVYPARALWPTVMPTIAINKALLGK-----EKHESGMSRYKFFFLTFFIMFIYNWFPTYIINILNTFNWMTWIKPS-----NINLANITGG---VTGLGINP-ISSFDWNVIS--FN-SPLVYPFWSYLTQYLGCILAALIVI-AVYY-SNYMSCQYLPIFTNSLYTNTGH 
  Opt2p 233 KPWTQKEQMFSTLLYAIC----QGAFYTHYNILTQKLFYHSAFSFGYQFLLSLSVQFIGFGFAGILRKFVVYPARALWPTVMPTIAINKALLGK-----EKHESGMSRYKFFFLTFFIMFIYNWFPTYIINILNTFNWMTWIKPS-----NINLANITGG---VTGLGINP-ISSFDWNVIS--FN-SPLVYPFWSYLTQYLGCILAALIVI-AVYY-SNYMSCQYLPIFTNSLYTNTGH 
  Opt2p 233 KPWTQKEQMFSTLLYAIC----QGAFYTHYNILTQKLFYHSAFSFGYQFLLSLSVQFIGFGFAGILRKFVVYPARALWPTVMPTIAINKALLGK-----EKHESGMSRYKFFFLTFFIMFIYNWFPTYIINILNTFNWMTWIKPS-----NINLANITGG---VTGLGINP-ISSFDWNVIS--FN-SPLVYPFWSYLTQYLGCILAALIVI-AVYY-SNYMSCQYLPIFTNSLYTNTGH 
 
 AtOPT4 105 -PFNMKEHVLISIFANAGSAFGSGSAYAVGIITIIKAFYGRSISFIAGWLLIITTQVLGYGWAGLLRKYVVEPAHMWWPSTLVQVSLFRALHEK------DD-QRMTRAKFFVIALVCSFGWYIVPGYLFTTLTSISWVCWAFPR-----SVTAQQIGSG---MRGLGLGA--FTLDWTAVAS-FLFSPLISPFFAIANVFIGYVLLIYFVLPLAYWGFDSYNATRFPIFSSHLFTSVGN 
 AtOPT4 105 -PFNMKEHVLISIFANAGSAFGSGSAYAVGIITIIKAFYGRSISFIAGWLLIITTQVLGYGWAGLLRKYVVEPAHMWWPSTLVQVSLFRALHEK------DD-QRMTRAKFFVIALVCSFGWYIVPGYLFTTLTSISWVCWAFPR-----SVTAQQIGSG---MRGLGLGA--FTLDWTAVAS-FLFSPLISPFFAIANVFIGYVLLIYFVLPLAYWGFDSYNATRFPIFSSHLFTSVGN 
 AtOPT4 105 -PFNMKEHVLISIFANAGSAFGSGSAYAVGIITIIKAFYGRSISFIAGWLLIITTQVLGYGWAGLLRKYVVEPAHMWWPSTLVQVSLFRALHEK------DD-QRMTRAKFFVIALVCSFGWYIVPGYLFTTLTSISWVCWAFPR-----SVTAQQIGSG---MRGLGLGA--FTLDWTAVAS-FLFSPLISPFFAIANVFIGYVLLIYFVLPLAYWGFDSYNATRFPIFSSHLFTSVGN 
 AtOPT4 105 -PFNMKEHVLISIFANAGSAFGSGSAYAVGIITIIKAFYGRSISFIAGWLLIITTQVLGYGWAGLLRKYVVEPAHMWWPSTLVQVSLFRALHEK------DD-QRMTRAKFFVIALVCSFGWYIVPGYLFTTLTSISWVCWAFPR-----SVTAQQIGSG---MRGLGLGA--FTLDWTAVAS-FLFSPLISPFFAIANVFIGYVLLIYFVLPLAYWGFDSYNATRFPIFSSHLFTSVGN 
 AtOPT4 105 -PFNMKEHVLISIFANAGSAFGSGSAYAVGIITIIKAFYGRSISFIAGWLLIITTQVLGYGWAGLLRKYVVEPAHMWWPSTLVQVSLFRALHEK------DD-QRMTRAKFFVIALVCSFGWYIVPGYLFTTLTSISWVCWAFPR-----SVTAQQIGSG---MRGLGLGA--FTLDWTAVAS-FLFSPLISPFFAIANVFIGYVLLIYFVLPLAYWGFDSYNATRFPIFSSHLFTSVGN 
 AtOPT4 105 -PFNMKEHVLISIFANAGSAFGSGSAYAVGIITIIKAFYGRSISFIAGWLLIITTQVLGYGWAGLLRKYVVEPAHMWWPSTLVQVSLFRALHEK------DD-QRMTRAKFFVIALVCSFGWYIVPGYLFTTLTSISWVCWAFPR-----SVTAQQIGSG---MRGLGLGA--FTLDWTAVAS-FLFSPLISPFFAIANVFIGYVLLIYFVLPLAYWGFDSYNATRFPIFSSHLFTSVGN 
 
CaOpt1p 155 -PFNVKEHTIITIMANVS--FGTGAAYATDILLAQNMFYKSNFGWGYNLLLIWSTQCIGFAFGGVMRRFVVDSPGAIWPSNLVTATFLTNMHIN--ENHTANGWKISRLAFFVIVFVASFVWYWFPGYIFQALSYFSWITWIKPN-----NVIINQVFGS---SSGLGMIPNNIALDWNQIAGYIG-SPLIPPASVIATIFGSIVLIFWIVVPAIHY-SNTWYSQYLPISSTGSFDRFQQ 
CaOpt1p 155 -PFNVKEHTIITIMANVS--FGTGAAYATDILLAQNMFYKSNFGWGYNLLLIWSTQCIGFAFGGVMRRFVVDSPGAIWPSNLVTATFLTNMHIN--ENHTANGWKISRLAFFVIVFVASFVWYWFPGYIFQALSYFSWITWIKPN-----NVIINQVFGS---SSGLGMIPNNIALDWNQIAGYIG-SPLIPPASVIATIFGSIVLIFWIVVPAIHY-SNTWYSQYLPISSTGSFDRFQQ 
CaOpt1p 155 -PFNVKEHTIITIMANVS--FGTGAAYATDILLAQNMFYKSNFGWGYNLLLIWSTQCIGFAFGGVMRRFVVDSPGAIWPSNLVTATFLTNMHIN--ENHTANGWKISRLAFFVIVFVASFVWYWFPGYIFQALSYFSWITWIKPN-----NVIINQVFGS---SSGLGMIPNNIALDWNQIAGYIG-SPLIPPASVIATIFGSIVLIFWIVVPAIHY-SNTWYSQYLPISSTGSFDRFQQ 
CaOpt1p 155 -PFNVKEHTIITIMANVS--FGTGAAYATDILLAQNMFYKSNFGWGYNLLLIWSTQCIGFAFGGVMRRFVVDSPGAIWPSNLVTATFLTNMHIN--ENHTANGWKISRLAFFVIVFVASFVWYWFPGYIFQALSYFSWITWIKPN-----NVIINQVFGS---SSGLGMIPNNIALDWNQIAGYIG-SPLIPPASVIATIFGSIVLIFWIVVPAIHY-SNTWYSQYLPISSTGSFDRFQQ 
CaOpt1p 155 -PFNVKEHTIITIMANVS--FGTGAAYATDILLAQNMFYKSNFGWGYNLLLIWSTQCIGFAFGGVMRRFVVDSPGAIWPSNLVTATFLTNMHIN--ENHTANGWKISRLAFFVIVFVASFVWYWFPGYIFQALSYFSWITWIKPN-----NVIINQVFGS---SSGLGMIPNNIALDWNQIAGYIG-SPLIPPASVIATIFGSIVLIFWIVVPAIHY-SNTWYSQYLPISSTGSFDRFQQ 
CaOpt1p 155 -PFNVKEHTIITIMANVS--FGTGAAYATDILLAQNMFYKSNFGWGYNLLLIWSTQCIGFAFGGVMRRFVVDSPGAIWPSNLVTATFLTNMHIN--ENHTANGWKISRLAFFVIVFVASFVWYWFPGYIFQALSYFSWITWIKPN-----NVIINQVFGS---SSGLGMIPNNIALDWNQIAGYIG-SPLIPPASVIATIFGSIVLIFWIVVPAIHY-SNTWYSQYLPISSTGSFDRFQQ 
 
  Isp4p 159 -PFNVKEHALIVVMSSVS--FGN--AYSTDIILAQRVHYKQRFGFGYEICLTLATQLIGYGLAGLSRRLLVRPASMLWPVNLVQCTLIKTLHRKDLRNAVANGWRISPFRFFLYVFIASFIWNWFPSYIFQALSLFAWVTWIRPN-----SPTVNQIFGE---STGISILP--MTFDWNQISAYIL-SPLMAPADALMNILLGVILFFWIVTPALNF-TNTWYGDYLPISSSGIIDHFGN 
  Isp4p 159 -PFNVKEHALIVVMSSVS--FGN--AYSTDIILAQRVHYKQRFGFGYEICLTLATQLIGYGLAGLSRRLLVRPASMLWPVNLVQCTLIKTLHRKDLRNAVANGWRISPFRFFLYVFIASFIWNWFPSYIFQALSLFAWVTWIRPN-----SPTVNQIFGE---STGISILP--MTFDWNQISAYIL-SPLMAPADALMNILLGVILFFWIVTPALNF-TNTWYGDYLPISSSGIIDHFGN 
  Isp4p 159 -PFNVKEHALIVVMSSVS--FGN--AYSTDIILAQRVHYKQRFGFGYEICLTLATQLIGYGLAGLSRRLLVRPASMLWPVNLVQCTLIKTLHRKDLRNAVANGWRISPFRFFLYVFIASFIWNWFPSYIFQALSLFAWVTWIRPN-----SPTVNQIFGE---STGISILP--MTFDWNQISAYIL-SPLMAPADALMNILLGVILFFWIVTPALNF-TNTWYGDYLPISSSGIIDHFGN 
  Isp4p 159 -PFNVKEHALIVVMSSVS--FGN--AYSTDIILAQRVHYKQRFGFGYEICLTLATQLIGYGLAGLSRRLLVRPASMLWPVNLVQCTLIKTLHRKDLRNAVANGWRISPFRFFLYVFIASFIWNWFPSYIFQALSLFAWVTWIRPN-----SPTVNQIFGE---STGISILP--MTFDWNQISAYIL-SPLMAPADALMNILLGVILFFWIVTPALNF-TNTWYGDYLPISSSGIIDHFGN 
  Isp4p 159 -PFNVKEHALIVVMSSVS--FGN--AYSTDIILAQRVHYKQRFGFGYEICLTLATQLIGYGLAGLSRRLLVRPASMLWPVNLVQCTLIKTLHRKDLRNAVANGWRISPFRFFLYVFIASFIWNWFPSYIFQALSLFAWVTWIRPN-----SPTVNQIFGE---STGISILP--MTFDWNQISAYIL-SPLMAPADALMNILLGVILFFWIVTPALNF-TNTWYGDYLPISSSGIIDHFGN 
  Isp4p 159 -PFNVKEHALIVVMSSVS--FGN--AYSTDIILAQRVHYKQRFGFGYEICLTLATQLIGYGLAGLSRRLLVRPASMLWPVNLVQCTLIKTLHRKDLRNAVANGWRISPFRFFLYVFIASFIWNWFPSYIFQALSLFAWVTWIRPN-----SPTVNQIFGE---STGISILP--MTFDWNQISAYIL-SPLMAPADALMNILLGVILFFWIVTPALNF-TNTWYGDYLPISSSGIIDHFGN 
 
  Mtd1p 157 -PFMIKEHVVSTLVASTA---AYG-ATSVNNFAVQRLYYDTHVGPLTAVFATFSTLTFGMGLVGILRPLTVYPAEMVYWSNLPQVTVFQALHFN-------RHESTKRVRVFWWGFTIMFIYELFPAYIFPLLNSVSIFCLASQKAKPSTRDVFTNIFGGGNANEGLGLLN--FSFDWQYIGS----NYMSYPLLQQANSWIG-LGACYVIMAAIYY-SNAWDSKNYKMLSTSIFNHNGT 
  Mtd1p 157 -PFMIKEHVVSTLVASTA---AYG-ATSVNNFAVQRLYYDTHVGPLTAVFATFSTLTFGMGLVGILRPLTVYPAEMVYWSNLPQVTVFQALHFN-------RHESTKRVRVFWWGFTIMFIYELFPAYIFPLLNSVSIFCLASQKAKPSTRDVFTNIFGGGNANEGLGLLN--FSFDWQYIGS----NYMSYPLLQQANSWIG-LGACYVIMAAIYY-SNAWDSKNYKMLSTSIFNHNGT 
  Mtd1p 157 -PFMIKEHVVSTLVASTA---AYG-ATSVNNFAVQRLYYDTHVGPLTAVFATFSTLTFGMGLVGILRPLTVYPAEMVYWSNLPQVTVFQALHFN-------RHESTKRVRVFWWGFTIMFIYELFPAYIFPLLNSVSIFCLASQKAKPSTRDVFTNIFGGGNANEGLGLLN--FSFDWQYIGS----NYMSYPLLQQANSWIG-LGACYVIMAAIYY-SNAWDSKNYKMLSTSIFNHNGT 
  Mtd1p 157 -PFMIKEHVVSTLVASTA---AYG-ATSVNNFAVQRLYYDTHVGPLTAVFATFSTLTFGMGLVGILRPLTVYPAEMVYWSNLPQVTVFQALHFN-------RHESTKRVRVFWWGFTIMFIYELFPAYIFPLLNSVSIFCLASQKAKPSTRDVFTNIFGGGNANEGLGLLN--FSFDWQYIGS----NYMSYPLLQQANSWIG-LGACYVIMAAIYY-SNAWDSKNYKMLSTSIFNHNGT 
  Mtd1p 157 -PFMIKEHVVSTLVASTA---AYG-ATSVNNFAVQRLYYDTHVGPLTAVFATFSTLTFGMGLVGILRPLTVYPAEMVYWSNLPQVTVFQALHFN-------RHESTKRVRVFWWGFTIMFIYELFPAYIFPLLNSVSIFCLASQKAKPSTRDVFTNIFGGGNANEGLGLLN--FSFDWQYIGS----NYMSYPLLQQANSWIG-LGACYVIMAAIYY-SNAWDSKNYKMLSTSIFNHNGT 
  Mtd1p 157 -PFMIKEHVVSTLVASTA---AYG-ATSVNNFAVQRLYYDTHVGPLTAVFATFSTLTFGMGLVGILRPLTVYPAEMVYWSNLPQVTVFQALHFN-------RHESTKRVRVFWWGFTIMFIYELFPAYIFPLLNSVSIFCLASQKAKPSTRDVFTNIFGGGNANEGLGLLN--FSFDWQYIGS----NYMSYPLLQQANSWIG-LGACYVIMAAIYY-SNAWDSKNYKMLSTSIFNHNGT 
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        481 ---------+---------+---------+G--------+---------+---------+---------+---------+---------+---------+---------+--H------+---------+---------+I--------+---------+---------+---------+---------+---------+---------+---------+--J------+---------+ 
  Opt1p 398 KYNVTKILN-EDYSINLEKYKEYSPVFVPFSYLLSYALNFAAVIAVFVHCILYHG---KDIVAKFKDRKN-----------------------GGTDIHMRIYSKNYKDCPDWWYLLLQIVMIGLGFVAVCCF--DTKFPAWAFVIAILISLVNFIPQGILEAMTNQHVGLNIITELICGYMLPLRPMANLLFKLYGFIVMRQGLNLSRDLKLAMYMKVSPRLIFAVQIYATIISGMVNV 
  Opt1p 398 KYNVTKILN-EDYSINLEKYKEYSPVFVPFSYLLSYALNFAAVIAVFVHCILYHG---KDIVAKFKDRKN-----------------------GGTDIHMRIYSKNYKDCPDWWYLLLQIVMIGLGFVAVCCF--DTKFPAWAFVIAILISLVNFIPQGILEAMTNQHVGLNIITELICGYMLPLRPMANLLFKLYGFIVMRQGLNLSRDLKLAMYMKVSPRLIFAVQIYATIISGMVNV 
  Opt1p 398 KYNVTKILN-EDYSINLEKYKEYSPVFVPFSYLLSYALNFAAVIAVFVHCILYHG---KDIVAKFKDRKN-----------------------GGTDIHMRIYSKNYKDCPDWWYLLLQIVMIGLGFVAVCCF--DTKFPAWAFVIAILISLVNFIPQGILEAMTNQHVGLNIITELICGYMLPLRPMANLLFKLYGFIVMRQGLNLSRDLKLAMYMKVSPRLIFAVQIYATIISGMVNV 
  Opt1p 398 KYNVTKILN-EDYSINLEKYKEYSPVFVPFSYLLSYALNFAAVIAVFVHCILYHG---KDIVAKFKDRKN-----------------------GGTDIHMRIYSKNYKDCPDWWYLLLQIVMIGLGFVAVCCF--DTKFPAWAFVIAILISLVNFIPQGILEAMTNQHVGLNIITELICGYMLPLRPMANLLFKLYGFIVMRQGLNLSRDLKLAMYMKVSPRLIFAVQIYATIISGMVNV 
  Opt1p 398 KYNVTKILN-EDYSINLEKYKEYSPVFVPFSYLLSYALNFAAVIAVFVHCILYHG---KDIVAKFKDRKN-----------------------GGTDIHMRIYSKNYKDCPDWWYLLLQIVMIGLGFVAVCCF--DTKFPAWAFVIAILISLVNFIPQGILEAMTNQHVGLNIITELICGYMLPLRPMANLLFKLYGFIVMRQGLNLSRDLKLAMYMKVSPRLIFAVQIYATIISGMVNV 
  Opt1p 398 KYNVTKILN-EDYSINLEKYKEYSPVFVPFSYLLSYALNFAAVIAVFVHCILYHG---KDIVAKFKDRKN-----------------------GGTDIHMRIYSKNYKDCPDWWYLLLQIVMIGLGFVAVCCF--DTKFPAWAFVIAILISLVNFIPQGILEAMTNQHVGLNIITELICGYMLPLRPMANLLFKLYGFIVMRQGLNLSRDLKLAMYMKVSPRLIFAVQIYATIISGMVNV 
 
  Opt2p 450 SFKVTEVLD-SDNKLDVKKYQSYSPPYYSAGNLVSYGAFICAYPLMITWSFIVHS---KLLFNAFKDWALNLWAMRKLKSWVTMFKSDYRALDDYDDPHSNAM-KNYKEVPDWWYFAILIGSLVVGIAVVEHY--PTNTPVWGLFVCLGFNFVFLIPTTILQATTGYSFGLNLLIEMVMGYALPGNPIAIMILKAFGYNIDGQADNYVSNLKIAHYCKIPPMALFRGQCVIVFIQIFVNL 
  Opt2p 450 SFKVTEVLD-SDNKLDVKKYQSYSPPYYSAGNLVSYGAFICAYPLMITWSFIVHS---KLLFNAFKDWALNLWAMRKLKSWVTMFKSDYRALDDYDDPHSNAM-KNYKEVPDWWYFAILIGSLVVGIAVVEHY--PTNTPVWGLFVCLGFNFVFLIPTTILQATTGYSFGLNLLIEMVMGYALPGNPIAIMILKAFGYNIDGQADNYVSNLKIAHYCKIPPMALFRGQCVIVFIQIFVNL 
  Opt2p 450 SFKVTEVLD-SDNKLDVKKYQSYSPPYYSAGNLVSYGAFICAYPLMITWSFIVHS---KLLFNAFKDWALNLWAMRKLKSWVTMFKSDYRALDDYDDPHSNAM-KNYKEVPDWWYFAILIGSLVVGIAVVEHY--PTNTPVWGLFVCLGFNFVFLIPTTILQATTGYSFGLNLLIEMVMGYALPGNPIAIMILKAFGYNIDGQADNYVSNLKIAHYCKIPPMALFRGQCVIVFIQIFVNL 
  Opt2p 450 SFKVTEVLD-SDNKLDVKKYQSYSPPYYSAGNLVSYGAFICAYPLMITWSFIVHS---KLLFNAFKDWALNLWAMRKLKSWVTMFKSDYRALDDYDDPHSNAM-KNYKEVPDWWYFAILIGSLVVGIAVVEHY--PTNTPVWGLFVCLGFNFVFLIPTTILQATTGYSFGLNLLIEMVMGYALPGNPIAIMILKAFGYNIDGQADNYVSNLKIAHYCKIPPMALFRGQCVIVFIQIFVNL 
  Opt2p 450 SFKVTEVLD-SDNKLDVKKYQSYSPPYYSAGNLVSYGAFICAYPLMITWSFIVHS---KLLFNAFKDWALNLWAMRKLKSWVTMFKSDYRALDDYDDPHSNAM-KNYKEVPDWWYFAILIGSLVVGIAVVEHY--PTNTPVWGLFVCLGFNFVFLIPTTILQATTGYSFGLNLLIEMVMGYALPGNPIAIMILKAFGYNIDGQADNYVSNLKIAHYCKIPPMALFRGQCVIVFIQIFVNL 
  Opt2p 450 SFKVTEVLD-SDNKLDVKKYQSYSPPYYSAGNLVSYGAFICAYPLMITWSFIVHS---KLLFNAFKDWALNLWAMRKLKSWVTMFKSDYRALDDYDDPHSNAM-KNYKEVPDWWYFAILIGSLVVGIAVVEHY--PTNTPVWGLFVCLGFNFVFLIPTTILQATTGYSFGLNLLIEMVMGYALPGNPIAIMILKAFGYNIDGQADNYVSNLKIAHYCKIPPMALFRGQCVIVFIQIFVNL 
 
 AtOPT4 326 TYDIPAIVN-DNFELDLAKYEQQGRINLSMFFALTYGLGFATIASTLTHVALFYG---KEISERFRVSYK-----------------------GKEDIHTRLM-KRYKDIPSWWFYSMLAATLLISLALCVFLNDEVQMPWWGLVFASAMAFVFTLPISIITATTNQTPGLNIITEYAMGLIYPGRPIANVCFKVYGYMSMAQAVSFLNDFKLGHYMKIPPRSMFLVQFIGTILAGTINI 
 AtOPT4 326 TYDIPAIVN-DNFELDLAKYEQQGRINLSMFFALTYGLGFATIASTLTHVALFYG---KEISERFRVSYK-----------------------GKEDIHTRLM-KRYKDIPSWWFYSMLAATLLISLALCVFLNDEVQMPWWGLVFASAMAFVFTLPISIITATTNQTPGLNIITEYAMGLIYPGRPIANVCFKVYGYMSMAQAVSFLNDFKLGHYMKIPPRSMFLVQFIGTILAGTINI 
 AtOPT4 326 TYDIPAIVN-DNFELDLAKYEQQGRINLSMFFALTYGLGFATIASTLTHVALFYG---KEISERFRVSYK-----------------------GKEDIHTRLM-KRYKDIPSWWFYSMLAATLLISLALCVFLNDEVQMPWWGLVFASAMAFVFTLPISIITATTNQTPGLNIITEYAMGLIYPGRPIANVCFKVYGYMSMAQAVSFLNDFKLGHYMKIPPRSMFLVQFIGTILAGTINI 
 AtOPT4 326 TYDIPAIVN-DNFELDLAKYEQQGRINLSMFFALTYGLGFATIASTLTHVALFYG---KEISERFRVSYK-----------------------GKEDIHTRLM-KRYKDIPSWWFYSMLAATLLISLALCVFLNDEVQMPWWGLVFASAMAFVFTLPISIITATTNQTPGLNIITEYAMGLIYPGRPIANVCFKVYGYMSMAQAVSFLNDFKLGHYMKIPPRSMFLVQFIGTILAGTINI 
 AtOPT4 326 TYDIPAIVN-DNFELDLAKYEQQGRINLSMFFALTYGLGFATIASTLTHVALFYG---KEISERFRVSYK-----------------------GKEDIHTRLM-KRYKDIPSWWFYSMLAATLLISLALCVFLNDEVQMPWWGLVFASAMAFVFTLPISIITATTNQTPGLNIITEYAMGLIYPGRPIANVCFKVYGYMSMAQAVSFLNDFKLGHYMKIPPRSMFLVQFIGTILAGTINI 
 AtOPT4 326 TYDIPAIVN-DNFELDLAKYEQQGRINLSMFFALTYGLGFATIASTLTHVALFYG---KEISERFRVSYK-----------------------GKEDIHTRLM-KRYKDIPSWWFYSMLAATLLISLALCVFLNDEVQMPWWGLVFASAMAFVFTLPISIITATTNQTPGLNIITEYAMGLIYPGRPIANVCFKVYGYMSMAQAVSFLNDFKLGHYMKIPPRSMFLVQFIGTILAGTINI 
 
CaOpt1p 380 TYNVSKIIDHKTLSFNEAEYKKYSPLFLSTTFAISYGLSFASILATITHTICFHG---RDLIASLKAKEK-------------------------PDVHNRLM-KAYKPVPEWWYLVVFLVFFGMSIATVRAW--PTEMPVWGLVFALIIAIIFLLPVAIIYAKTNIAVGLNVVTEFIVGYVLGGRPLCMMLFKTFGYITNNQAVTFVQDMKLGHYMKIDPRTLFWAQFAATIWGSLVQI 
CaOpt1p 380 TYNVSKIIDHKTLSFNEAEYKKYSPLFLSTTFAISYGLSFASILATITHTICFHG---RDLIASLKAKEK-------------------------PDVHNRLM-KAYKPVPEWWYLVVFLVFFGMSIATVRAW--PTEMPVWGLVFALIIAIIFLLPVAIIYAKTNIAVGLNVVTEFIVGYVLGGRPLCMMLFKTFGYITNNQAVTFVQDMKLGHYMKIDPRTLFWAQFAATIWGSLVQI 
CaOpt1p 380 TYNVSKIIDHKTLSFNEAEYKKYSPLFLSTTFAISYGLSFASILATITHTICFHG---RDLIASLKAKEK-------------------------PDVHNRLM-KAYKPVPEWWYLVVFLVFFGMSIATVRAW--PTEMPVWGLVFALIIAIIFLLPVAIIYAKTNIAVGLNVVTEFIVGYVLGGRPLCMMLFKTFGYITNNQAVTFVQDMKLGHYMKIDPRTLFWAQFAATIWGSLVQI 
CaOpt1p 380 TYNVSKIIDHKTLSFNEAEYKKYSPLFLSTTFAISYGLSFASILATITHTICFHG---RDLIASLKAKEK-------------------------PDVHNRLM-KAYKPVPEWWYLVVFLVFFGMSIATVRAW--PTEMPVWGLVFALIIAIIFLLPVAIIYAKTNIAVGLNVVTEFIVGYVLGGRPLCMMLFKTFGYITNNQAVTFVQDMKLGHYMKIDPRTLFWAQFAATIWGSLVQI 
CaOpt1p 380 TYNVSKIIDHKTLSFNEAEYKKYSPLFLSTTFAISYGLSFASILATITHTICFHG---RDLIASLKAKEK-------------------------PDVHNRLM-KAYKPVPEWWYLVVFLVFFGMSIATVRAW--PTEMPVWGLVFALIIAIIFLLPVAIIYAKTNIAVGLNVVTEFIVGYVLGGRPLCMMLFKTFGYITNNQAVTFVQDMKLGHYMKIDPRTLFWAQFAATIWGSLVQI 
CaOpt1p 380 TYNVSKIIDHKTLSFNEAEYKKYSPLFLSTTFAISYGLSFASILATITHTICFHG---RDLIASLKAKEK-------------------------PDVHNRLM-KAYKPVPEWWYLVVFLVFFGMSIATVRAW--PTEMPVWGLVFALIIAIIFLLPVAIIYAKTNIAVGLNVVTEFIVGYVLGGRPLCMMLFKTFGYITNNQAVTFVQDMKLGHYMKIDPRTLFWAQFAATIWGSLVQI 
 
  Isp4p 382 SYNVTRILT-KDATFDLDAYQNYSPIFMSTTYALAFGLSFASITSVIFHVILYHG---KEIYDRLRDPPA-------------------------PDIHEKLM-KAYDEVPFYWYLSVFLAFFGMMMGTIYGW--KTETPWWVIIVGVIFSAVWFIPIGIVQAITNIQLGLNVFTEFIVGYMYPGRPLAMMIFKTVGYITMTQGLAFAADLKFGHYMKLPPRIMFYTQMIATIWSCFVQI 
  Isp4p 382 SYNVTRILT-KDATFDLDAYQNYSPIFMSTTYALAFGLSFASITSVIFHVILYHG---KEIYDRLRDPPA-------------------------PDIHEKLM-KAYDEVPFYWYLSVFLAFFGMMMGTIYGW--KTETPWWVIIVGVIFSAVWFIPIGIVQAITNIQLGLNVFTEFIVGYMYPGRPLAMMIFKTVGYITMTQGLAFAADLKFGHYMKLPPRIMFYTQMIATIWSCFVQI 
  Isp4p 382 SYNVTRILT-KDATFDLDAYQNYSPIFMSTTYALAFGLSFASITSVIFHVILYHG---KEIYDRLRDPPA-------------------------PDIHEKLM-KAYDEVPFYWYLSVFLAFFGMMMGTIYGW--KTETPWWVIIVGVIFSAVWFIPIGIVQAITNIQLGLNVFTEFIVGYMYPGRPLAMMIFKTVGYITMTQGLAFAADLKFGHYMKLPPRIMFYTQMIATIWSCFVQI 
  Isp4p 382 SYNVTRILT-KDATFDLDAYQNYSPIFMSTTYALAFGLSFASITSVIFHVILYHG---KEIYDRLRDPPA-------------------------PDIHEKLM-KAYDEVPFYWYLSVFLAFFGMMMGTIYGW--KTETPWWVIIVGVIFSAVWFIPIGIVQAITNIQLGLNVFTEFIVGYMYPGRPLAMMIFKTVGYITMTQGLAFAADLKFGHYMKLPPRIMFYTQMIATIWSCFVQI 
  Isp4p 382 SYNVTRILT-KDATFDLDAYQNYSPIFMSTTYALAFGLSFASITSVIFHVILYHG---KEIYDRLRDPPA-------------------------PDIHEKLM-KAYDEVPFYWYLSVFLAFFGMMMGTIYGW--KTETPWWVIIVGVIFSAVWFIPIGIVQAITNIQLGLNVFTEFIVGYMYPGRPLAMMIFKTVGYITMTQGLAFAADLKFGHYMKLPPRIMFYTQMIATIWSCFVQI 
  Isp4p 382 SYNVTRILT-KDATFDLDAYQNYSPIFMSTTYALAFGLSFASITSVIFHVILYHG---KEIYDRLRDPPA-------------------------PDIHEKLM-KAYDEVPFYWYLSVFLAFFGMMMGTIYGW--KTETPWWVIIVGVIFSAVWFIPIGIVQAITNIQLGLNVFTEFIVGYMYPGRPLAMMIFKTVGYITMTQGLAFAADLKFGHYMKLPPRIMFYTQMIATIWSCFVQI 
 
  Mtd1p 377 VYDQAAVFG-KNGILNETALEEYGLPAMTGSNAWANFAQNLAIGALIAHVTLFWSGDMRDAVLHFRNGKK-----------------------TNDDPHYLAM-QKYKEAPWWWYFILLFLAFIAGLIVCIKG--ETSLPWWSYIVSLAVGAFITPFSTILYGRMGNGIATNNLMKMIPGALNPGRPVANLYFSMWSHDVVSTSIGLAGDLKVGQYTKVPPRVMFLTQLWGCILGAIVNY 
  Mtd1p 377 VYDQAAVFG-KNGILNETALEEYGLPAMTGSNAWANFAQNLAIGALIAHVTLFWSGDMRDAVLHFRNGKK-----------------------TNDDPHYLAM-QKYKEAPWWWYFILLFLAFIAGLIVCIKG--ETSLPWWSYIVSLAVGAFITPFSTILYGRMGNGIATNNLMKMIPGALNPGRPVANLYFSMWSHDVVSTSIGLAGDLKVGQYTKVPPRVMFLTQLWGCILGAIVNY 
  Mtd1p 377 VYDQAAVFG-KNGILNETALEEYGLPAMTGSNAWANFAQNLAIGALIAHVTLFWSGDMRDAVLHFRNGKK-----------------------TNDDPHYLAM-QKYKEAPWWWYFILLFLAFIAGLIVCIKG--ETSLPWWSYIVSLAVGAFITPFSTILYGRMGNGIATNNLMKMIPGALNPGRPVANLYFSMWSHDVVSTSIGLAGDLKVGQYTKVPPRVMFLTQLWGCILGAIVNY 
  Mtd1p 377 VYDQAAVFG-KNGILNETALEEYGLPAMTGSNAWANFAQNLAIGALIAHVTLFWSGDMRDAVLHFRNGKK-----------------------TNDDPHYLAM-QKYKEAPWWWYFILLFLAFIAGLIVCIKG--ETSLPWWSYIVSLAVGAFITPFSTILYGRMGNGIATNNLMKMIPGALNPGRPVANLYFSMWSHDVVSTSIGLAGDLKVGQYTKVPPRVMFLTQLWGCILGAIVNY 
  Mtd1p 377 VYDQAAVFG-KNGILNETALEEYGLPAMTGSNAWANFAQNLAIGALIAHVTLFWSGDMRDAVLHFRNGKK-----------------------TNDDPHYLAM-QKYKEAPWWWYFILLFLAFIAGLIVCIKG--ETSLPWWSYIVSLAVGAFITPFSTILYGRMGNGIATNNLMKMIPGALNPGRPVANLYFSMWSHDVVSTSIGLAGDLKVGQYTKVPPRVMFLTQLWGCILGAIVNY 
  Mtd1p 377 VYDQAAVFG-KNGILNETALEEYGLPAMTGSNAWANFAQNLAIGALIAHVTLFWSGDMRDAVLHFRNGKK-----------------------TNDDPHYLAM-QKYKEAPWWWYFILLFLAFIAGLIVCIKG--ETSLPWWSYIVSLAVGAFITPFSTILYGRMGNGIATNNLMKMIPGALNPGRPVANLYFSMWSHDVVSTSIGLAGDLKVGQYTKVPPRVMFLTQLWGCILGAIVNY 
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  Opt1p 609 GVQEWMMHNIDGLCTTDQP---NGFTCANGRTVFNASIIWSL--PKYLFSSGRIYNPLMWFFLIGLLFPLAVYAVQWKFPKFK--FAKHIHTPVFFTGPGNIPPSTPYNYSLFFA---MSFCLN-LIRKRWRAWFNKYNFVMGAGVEAGVAISVVIIFLCVQYPG---GKLS-WWGNNVWKRTYDNDYKK--FYTLKKGETFGYDKWW 
  Opt1p 609 GVQEWMMHNIDGLCTTDQP---NGFTCANGRTVFNASIIWSL--PKYLFSSGRIYNPLMWFFLIGLLFPLAVYAVQWKFPKFK--FAKHIHTPVFFTGPGNIPPSTPYNYSLFFA---MSFCLN-LIRKRWRAWFNKYNFVMGAGVEAGVAISVVIIFLCVQYPG---GKLS-WWGNNVWKRTYDNDYKK--FYTLKKGETFGYDKWW 
  Opt1p 609 GVQEWMMHNIDGLCTTDQP---NGFTCANGRTVFNASIIWSL--PKYLFSSGRIYNPLMWFFLIGLLFPLAVYAVQWKFPKFK--FAKHIHTPVFFTGPGNIPPSTPYNYSLFFA---MSFCLN-LIRKRWRAWFNKYNFVMGAGVEAGVAISVVIIFLCVQYPG---GKLS-WWGNNVWKRTYDNDYKK--FYTLKKGETFGYDKWW 
  Opt1p 609 GVQEWMMHNIDGLCTTDQP---NGFTCANGRTVFNASIIWSL--PKYLFSSGRIYNPLMWFFLIGLLFPLAVYAVQWKFPKFK--FAKHIHTPVFFTGPGNIPPSTPYNYSLFFA---MSFCLN-LIRKRWRAWFNKYNFVMGAGVEAGVAISVVIIFLCVQYPG---GKLS-WWGNNVWKRTYDNDYKK--FYTLKKGETFGYDKWW 
  Opt1p 609 GVQEWMMHNIDGLCTTDQP---NGFTCANGRTVFNASIIWSL--PKYLFSSGRIYNPLMWFFLIGLLFPLAVYAVQWKFPKFK--FAKHIHTPVFFTGPGNIPPSTPYNYSLFFA---MSFCLN-LIRKRWRAWFNKYNFVMGAGVEAGVAISVVIIFLCVQYPG---GKLS-WWGNNVWKRTYDNDYKK--FYTLKKGETFGYDKWW 
  Opt1p 609 GVQEWMMHNIDGLCTTDQP---NGFTCANGRTVFNASIIWSL--PKYLFSSGRIYNPLMWFFLIGLLFPLAVYAVQWKFPKFK--FAKHIHTPVFFTGPGNIPPSTPYNYSLFFA---MSFCLN-LIRKRWRAWFNKYNFVMGAGVEAGVAISVVIIFLCVQYPG---GKLS-WWGNNVWKRTYDNDYKK--FYTLKKGETFGYDKWW 
 
  Opt2p 683 GVLNWQISNIKDFCTPHQN---AKFTCPDAVTYYNASVVWGAIGPKRIFN--YIYPIFKWCWLIGACIG-IFFGVWKRWGK----FYPRYFDPMLFVG-GMLNMSPPYNLMYYTSGMIVSYISQYYMKRHHLNLWEKYNYVLSAGFSTGLVLSAIIIFFAVQYKD---TAFN-WWGNTVPYAGADGVGYPLKNITDTANGYFGYAPGHYP 
  Opt2p 683 GVLNWQISNIKDFCTPHQN---AKFTCPDAVTYYNASVVWGAIGPKRIFN--YIYPIFKWCWLIGACIG-IFFGVWKRWGK----FYPRYFDPMLFVG-GMLNMSPPYNLMYYTSGMIVSYISQYYMKRHHLNLWEKYNYVLSAGFSTGLVLSAIIIFFAVQYKD---TAFN-WWGNTVPYAGADGVGYPLKNITDTANGYFGYAPGHYP 
  Opt2p 683 GVLNWQISNIKDFCTPHQN---AKFTCPDAVTYYNASVVWGAIGPKRIFN--YIYPIFKWCWLIGACIG-IFFGVWKRWGK----FYPRYFDPMLFVG-GMLNMSPPYNLMYYTSGMIVSYISQYYMKRHHLNLWEKYNYVLSAGFSTGLVLSAIIIFFAVQYKD---TAFN-WWGNTVPYAGADGVGYPLKNITDTANGYFGYAPGHYP 
  Opt2p 683 GVLNWQISNIKDFCTPHQN---AKFTCPDAVTYYNASVVWGAIGPKRIFN--YIYPIFKWCWLIGACIG-IFFGVWKRWGK----FYPRYFDPMLFVG-GMLNMSPPYNLMYYTSGMIVSYISQYYMKRHHLNLWEKYNYVLSAGFSTGLVLSAIIIFFAVQYKD---TAFN-WWGNTVPYAGADGVGYPLKNITDTANGYFGYAPGHYP 
  Opt2p 683 GVLNWQISNIKDFCTPHQN---AKFTCPDAVTYYNASVVWGAIGPKRIFN--YIYPIFKWCWLIGACIG-IFFGVWKRWGK----FYPRYFDPMLFVG-GMLNMSPPYNLMYYTSGMIVSYISQYYMKRHHLNLWEKYNYVLSAGFSTGLVLSAIIIFFAVQYKD---TAFN-WWGNTVPYAGADGVGYPLKNITDTANGYFGYAPGHYP 
  Opt2p 683 GVLNWQISNIKDFCTPHQN---AKFTCPDAVTYYNASVVWGAIGPKRIFN--YIYPIFKWCWLIGACIG-IFFGVWKRWGK----FYPRYFDPMLFVG-GMLNMSPPYNLMYYTSGMIVSYISQYYMKRHHLNLWEKYNYVLSAGFSTGLVLSAIIIFFAVQYKD---TAFN-WWGNTVPYAGADGVGYPLKNITDTANGYFGYAPGHYP 
 
 AtOPT4 528 TVAWWQLNSIKNICQEELLPPNSPWTCPGDRVFFDASVIWGLVGPKRIFGSQGNYAAMNWFFLGGALGPVIVWSLHKAFPKRS--WIPLVNLPVLLGATAMMPPATAVNYNSWIL---VGTIFNLFVFRYRKSWWQRYNYVLSAAMDAGVAFMAVLLYFSVGMEE---KSLD-WWGTRGEHCDLAKCPTA--RGVIVDGCP 
 AtOPT4 528 TVAWWQLNSIKNICQEELLPPNSPWTCPGDRVFFDASVIWGLVGPKRIFGSQGNYAAMNWFFLGGALGPVIVWSLHKAFPKRS--WIPLVNLPVLLGATAMMPPATAVNYNSWIL---VGTIFNLFVFRYRKSWWQRYNYVLSAAMDAGVAFMAVLLYFSVGMEE---KSLD-WWGTRGEHCDLAKCPTA--RGVIVDGCP 
 AtOPT4 528 TVAWWQLNSIKNICQEELLPPNSPWTCPGDRVFFDASVIWGLVGPKRIFGSQGNYAAMNWFFLGGALGPVIVWSLHKAFPKRS--WIPLVNLPVLLGATAMMPPATAVNYNSWIL---VGTIFNLFVFRYRKSWWQRYNYVLSAAMDAGVAFMAVLLYFSVGMEE---KSLD-WWGTRGEHCDLAKCPTA--RGVIVDGCP 
 AtOPT4 528 TVAWWQLNSIKNICQEELLPPNSPWTCPGDRVFFDASVIWGLVGPKRIFGSQGNYAAMNWFFLGGALGPVIVWSLHKAFPKRS--WIPLVNLPVLLGATAMMPPATAVNYNSWIL---VGTIFNLFVFRYRKSWWQRYNYVLSAAMDAGVAFMAVLLYFSVGMEE---KSLD-WWGTRGEHCDLAKCPTA--RGVIVDGCP 
 AtOPT4 528 TVAWWQLNSIKNICQEELLPPNSPWTCPGDRVFFDASVIWGLVGPKRIFGSQGNYAAMNWFFLGGALGPVIVWSLHKAFPKRS--WIPLVNLPVLLGATAMMPPATAVNYNSWIL---VGTIFNLFVFRYRKSWWQRYNYVLSAAMDAGVAFMAVLLYFSVGMEE---KSLD-WWGTRGEHCDLAKCPTA--RGVIVDGCP 
 AtOPT4 528 TVAWWQLNSIKNICQEELLPPNSPWTCPGDRVFFDASVIWGLVGPKRIFGSQGNYAAMNWFFLGGALGPVIVWSLHKAFPKRS--WIPLVNLPVLLGATAMMPPATAVNYNSWIL---VGTIFNLFVFRYRKSWWQRYNYVLSAAMDAGVAFMAVLLYFSVGMEE---KSLD-WWGTRGEHCDLAKCPTA--RGVIVDGCP 
 
CaOpt1p 589 AVLEWAYGAIDNLCAADQK---NHYTCPNGKVFFNASIIWGVIGPQRQFSHGQIYYGLLFFFIIGAVTPVINWLILKKWPN-S--PVKYLHWPVFFSGTGYIPPATPYNYTSYCA---VGLFFGWWIKKKWFHWWSKYNYSLSAGLDIGLAWCSLIIFLCLSLTN---TDFPSWWGNDVINTTLDTQVVTNIRHILKEGEAFGPSSW 
CaOpt1p 589 AVLEWAYGAIDNLCAADQK---NHYTCPNGKVFFNASIIWGVIGPQRQFSHGQIYYGLLFFFIIGAVTPVINWLILKKWPN-S--PVKYLHWPVFFSGTGYIPPATPYNYTSYCA---VGLFFGWWIKKKWFHWWSKYNYSLSAGLDIGLAWCSLIIFLCLSLTN---TDFPSWWGNDVINTTLDTQVVTNIRHILKEGEAFGPSSW 
CaOpt1p 589 AVLEWAYGAIDNLCAADQK---NHYTCPNGKVFFNASIIWGVIGPQRQFSHGQIYYGLLFFFIIGAVTPVINWLILKKWPN-S--PVKYLHWPVFFSGTGYIPPATPYNYTSYCA---VGLFFGWWIKKKWFHWWSKYNYSLSAGLDIGLAWCSLIIFLCLSLTN---TDFPSWWGNDVINTTLDTQVVTNIRHILKEGEAFGPSSW 
CaOpt1p 589 AVLEWAYGAIDNLCAADQK---NHYTCPNGKVFFNASIIWGVIGPQRQFSHGQIYYGLLFFFIIGAVTPVINWLILKKWPN-S--PVKYLHWPVFFSGTGYIPPATPYNYTSYCA---VGLFFGWWIKKKWFHWWSKYNYSLSAGLDIGLAWCSLIIFLCLSLTN---TDFPSWWGNDVINTTLDTQVVTNIRHILKEGEAFGPSSW 
CaOpt1p 589 AVLEWAYGAIDNLCAADQK---NHYTCPNGKVFFNASIIWGVIGPQRQFSHGQIYYGLLFFFIIGAVTPVINWLILKKWPN-S--PVKYLHWPVFFSGTGYIPPATPYNYTSYCA---VGLFFGWWIKKKWFHWWSKYNYSLSAGLDIGLAWCSLIIFLCLSLTN---TDFPSWWGNDVINTTLDTQVVTNIRHILKEGEAFGPSSW 
CaOpt1p 589 AVLEWAYGAIDNLCAADQK---NHYTCPNGKVFFNASIIWGVIGPQRQFSHGQIYYGLLFFFIIGAVTPVINWLILKKWPN-S--PVKYLHWPVFFSGTGYIPPATPYNYTSYCA---VGLFFGWWIKKKWFHWWSKYNYSLSAGLDIGLAWCSLIIFLCLSLTN---TDFPSWWGNDVINTTLDTQVVTNIRHILKEGEAFGPSSW 
 
  Isp4p 590 GVLDWALGNIDNVCQADQP---DNYTCPNATVFFNSSVIWGVIGPKRMFSGKNTYTGLQYFWLAGVLGTILFWALWKKWPQ-K--WWGQLNGPLIFGGTGYIPPATPVNYLAWSG---IGLFFNYYLKKIFADWWQKYNFTLSA-LDTGTQLSVIILFFCLQLPM---VNFPDWWGNDGAFNTLDATGAA-VRKLVNESAR 
  Isp4p 590 GVLDWALGNIDNVCQADQP---DNYTCPNATVFFNSSVIWGVIGPKRMFSGKNTYTGLQYFWLAGVLGTILFWALWKKWPQ-K--WWGQLNGPLIFGGTGYIPPATPVNYLAWSG---IGLFFNYYLKKIFADWWQKYNFTLSA-LDTGTQLSVIILFFCLQLPM---VNFPDWWGNDGAFNTLDATGAA-VRKLVNESAR 
  Isp4p 590 GVLDWALGNIDNVCQADQP---DNYTCPNATVFFNSSVIWGVIGPKRMFSGKNTYTGLQYFWLAGVLGTILFWALWKKWPQ-K--WWGQLNGPLIFGGTGYIPPATPVNYLAWSG---IGLFFNYYLKKIFADWWQKYNFTLSA-LDTGTQLSVIILFFCLQLPM---VNFPDWWGNDGAFNTLDATGAA-VRKLVNESAR 
  Isp4p 590 GVLDWALGNIDNVCQADQP---DNYTCPNATVFFNSSVIWGVIGPKRMFSGKNTYTGLQYFWLAGVLGTILFWALWKKWPQ-K--WWGQLNGPLIFGGTGYIPPATPVNYLAWSG---IGLFFNYYLKKIFADWWQKYNFTLSA-LDTGTQLSVIILFFCLQLPM---VNFPDWWGNDGAFNTLDATGAA-VRKLVNESAR 
  Isp4p 590 GVLDWALGNIDNVCQADQP---DNYTCPNATVFFNSSVIWGVIGPKRMFSGKNTYTGLQYFWLAGVLGTILFWALWKKWPQ-K--WWGQLNGPLIFGGTGYIPPATPVNYLAWSG---IGLFFNYYLKKIFADWWQKYNFTLSA-LDTGTQLSVIILFFCLQLPM---VNFPDWWGNDGAFNTLDATGAA-VRKLVNESAR 
  Isp4p 590 GVLDWALGNIDNVCQADQP---DNYTCPNATVFFNSSVIWGVIGPKRMFSGKNTYTGLQYFWLAGVLGTILFWALWKKWPQ-K--WWGQLNGPLIFGGTGYIPPATPVNYLAWSG---IGLFFNYYLKKIFADWWQKYNFTLSA-LDTGTQLSVIILFFCLQLPM---VNFPDWWGNDGAFNTLDATGAA-VRKLVNESAR 
 
  Mtd1p 590 VVMISIVDAQREVLLDASG--TNVWSGQTIQSLNSQAVTWSLA--KELYSASGPYVIVPIGLAIGLVPPFIQWLISKRWPTIKGIKVESIILPIIFNYAQTMSKGITSYVSTSIV---IGLVSQLWLRQHHPVWYRKYNYILGGAFDGGAQVMVFILSFAVFGASGVERPFPSWAGN-PAKGNIDYCNGN---GALDAS 
  Mtd1p 590 VVMISIVDAQREVLLDASG--TNVWSGQTIQSLNSQAVTWSLA--KELYSASGPYVIVPIGLAIGLVPPFIQWLISKRWPTIKGIKVESIILPIIFNYAQTMSKGITSYVSTSIV---IGLVSQLWLRQHHPVWYRKYNYILGGAFDGGAQVMVFILSFAVFGASGVERPFPSWAGN-PAKGNIDYCNGN---GALDAS 
  Mtd1p 590 VVMISIVDAQREVLLDASG--TNVWSGQTIQSLNSQAVTWSLA--KELYSASGPYVIVPIGLAIGLVPPFIQWLISKRWPTIKGIKVESIILPIIFNYAQTMSKGITSYVSTSIV---IGLVSQLWLRQHHPVWYRKYNYILGGAFDGGAQVMVFILSFAVFGASGVERPFPSWAGN-PAKGNIDYCNGN---GALDAS 
  Mtd1p 590 VVMISIVDAQREVLLDASG--TNVWSGQTIQSLNSQAVTWSLA--KELYSASGPYVIVPIGLAIGLVPPFIQWLISKRWPTIKGIKVESIILPIIFNYAQTMSKGITSYVSTSIV---IGLVSQLWLRQHHPVWYRKYNYILGGAFDGGAQVMVFILSFAVFGASGVERPFPSWAGN-PAKGNIDYCNGN---GALDAS 
  Mtd1p 590 VVMISIVDAQREVLLDASG--TNVWSGQTIQSLNSQAVTWSLA--KELYSASGPYVIVPIGLAIGLVPPFIQWLISKRWPTIKGIKVESIILPIIFNYAQTMSKGITSYVSTSIV---IGLVSQLWLRQHHPVWYRKYNYILGGAFDGGAQVMVFILSFAVFGASGVERPFPSWAGN-PAKGNIDYCNGN---GALDAS 
  Mtd1p 590 VVMISIVDAQREVLLDASG--TNVWSGQTIQSLNSQAVTWSLA--KELYSASGPYVIVPIGLAIGLVPPFIQWLISKRWPTIKGIKVESIILPIIFNYAQTMSKGITSYVSTSIV---IGLVSQLWLRQHHPVWYRKYNYILGGAFDGGAQVMVFILSFAVFGASGVERPFPSWAGN-PAKGNIDYCNGN---GALDAS 
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2.0 does not report putative TMDs, occasionally it is clear from the output graph that 
there are areas that have scored only slightly below threshold.  One such area was 
found in Isp4p where TM-B has been assigned.  TM-C was weakly predicted in both 
Opt2p and Isp4p, although designated as a membrane-spanning domain in the rest of the 
family.  TMHMM 2.0 also yielded a weakly predicted area in this region.  An area 
between TM-E and -F was very weakly predicted by the algorithms as a whole.  This 
area in Opt1p and Opt2p contains scores below the threshold of TMHMM 2.0.  Neither 
PHDhtm nor SVMtm predicted any TMDs in this region. 
The areas marked in grey on the consensus ruler in Figure 4-3 are two proline 
motifs, which we did not assign to be TMDs.  The consensus of the first marked proline 
motif is PG[R/K]P.  In Opt1p, the Kyte-Doolittle method and PHDhtm designated 
residues to be part of a TMD, while TMHMM 2.0 showed a score to be slightly below 
threshold for this region.  In Opt2p, only PHDhtm suggested a putative domain, and 
TopPred2 and PHDhtm suggested a putative domain in Mtd1p.  The area around the 
PGNP in Opt2p is predicted by all methods, but spread over 32 residues.  The area 
around the GGRP in CaOpt1p and the PGRP in Isp4p is predicted, at least putatively, by 
every method.  These predictions, however, are spread over 38 residues in CaOpt1p 
and 47 in Isp4p. 
The consensus of the second marked motif is PPX[N/T]p, which is not found in 
Mtd1p (Figure 4-3).  The lowercase “p” in the motif is not found in the motif as 
described in Chapter 1, but is conserved among the proteins in this study.  Overall, this 
region (residues 806 to 850, consensus ruler) was more consistently predicted as a 
transmembrane region than the region including the PG[R/K]P motif, but neither region 
containing PPX[N/T]p or PG[R/K]P was considered to be a TMD in our consensus 
because of the proximity of the prolines. 
Conservation of charged and hydrophobic residue location may easily be viewed in 
Figure 4-4.  In our model, most, but not all, of the eighteen conserved motifs discussed 
in Chapter 1 fall outside of the membrane-spanning areas.  Something, which in 
retrospect should not be surprising due to the work of Sipos and von Heijne (1993), 
was revealed after all TMD assignments had been made: on either side of the boundaries 
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Figure 4-4.  Alignment of selected OPT family members and the 
locations of their transmembrane domains as predicted by familial 
alignment.  The alignment was constructed with ClustalW in MegAlign from 
Lasergene®.  The color code for amino acid residue groups (for non-transmembrane and 
consensus transmembrane domains respectively) is as follows:  hydrophobic, dark green 
and light green; basic, dark blue and light blue; acidic, red and pink; proline, yellow and 
cream; other, dark grey and light grey.  The consensus ruler is found at the top, and the 
regions highlighted black are the consensus transmembrane domains for these select 
family members, while regions boxed are the proline motifs PG[R/K]P and PPX[N/T]p. 
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          1 ---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+---------+ 
  Opt1p   1 -----MSTIYRESDSLESEPSPTPTTIPIQINMEEEKKDAFVKNIDEDVNNLTATTDE---------EDRDPESQKFDRHSIQEEGLVWKGDPTYLPN---------------------------------------------SPYPEVR 
  Opt2p   1 MSETVKDKVIIDEKVSTKGTVDYAEGAEYSERLSNHSSDFSQWYTDEQILHFMKKLGYENRTLYDIPEDVAYILKKMPELTLEDSFKILKDSIIYFKDDENIPHDQYEEWKRLVDLEDLDSKEGIDEYDSFDIRAFASAIKFHSPYQEVR 
 AtOPT4   1 -------------------------------------------------------------------------MATADEFSDED-----------T-----------------------------------------------SPIEEVR 
CaOpt1p   1 -----MDKIRAVISGGEK---------PPVDTDNDHNTDFEADRKMPDLDIVVSKS-----------QEFDPVTSHLVNDIMEDEYAAVHVE----DD---------------------------------------------SPYPEVR 
  Isp4p   1 ----------MIGSINES---------PIEEHMNDSPSTKEKADSVDISDYIVSHSDDS------LSKDIKKDTKSFLDVEHGEISTVDEFE----ED---------------------------------------------SPYPEVR 
  Mtd1p   1 -----MATEDALPKLPHR-----------PEPAR-EKTDGSLDEKIDEKLNNNKGEG---------FQDEPFELETQAQLDRQHVVTTG---------------------------------------------------------QDVS 
 
        151 ---------+-------A-+---------+---------+--B------+---------+---------+---------+---------+--------C+---------+---------+---------+-----D---+---------+ 
  Opt1p  92 SAVSIEDDPTIRLNHWRTWFLTTVFVVVFAGVNQFFSLRYPSLEINFLVAQVVCYPIGRILA-LLPDWKCS----KVPFFD-----LNPG-PFTKKEHAVVTIAVALT--SST--AYAMYILNAQGSFYNMKLNVGYQFLLVWTSQMIGY 
  Opt2p 151 AVVDPEDDPTIPVETFRAYFLAIIWSVIGSGFNEFFSHRVVSISLNTPIIQMFLYICGKAWAKTIPCWTITI---RGRKYG-----INIDKPWTQKEQMFSTLLYAIC----QGAFYTHYNILTQKLFYHSAFSFGYQFLLSLSVQFIGF 
 AtOPT4  20 LTVTNTDDPTLPVWTFRMWFLGLISCSLLSFLNQFFSYRTEPLVITQITVQVATLPIGHFLAKVLPKTRFGLPGCGSARFS-----LNPG-PFNMKEHVLISIFANAGSAFGSGSAYAVGIITIIKAFYGRSISFIAGWLLIITTQVLGY 
CaOpt1p  77 AAVPSTDDPTLPQNTIRAWVIGLILTTVGCGMNMLFSFHSPSFAITTFVTSILAWPIGNFWAWIVPDWKI-------FGAS-----LNPG-PFNVKEHTIITIMANVS--FGTGAAYATDILLAQNMFYKSNFGWGYNLLLIWSTQCIGF 
  Isp4p  77 AAVPPTDDPSMPCNTIRMWTIGLIYSTVGAAVNMFFSLRNPTVTLSVLISELLAYPALQIWDLIFPDREFRI---GRLKFN-----FKPG-PFNVKEHALIVVMSSVS--FGN--AYSTDIILAQRVHYKQRFGFGYEICLTLATQLIGY 
  Mtd1p  68 RYVVNLRDDEDPALTFRSLVLGTVIAGLGAALCQIYIFKPVLVSVSTVFLLLLIYCIGNAWAVFLPKRSLVKG-TRFERYGGIIEFINPG-PFMIKEHVVSTLVASTA---AYG-ATSVNNFAVQRLYYDTHVGPLTAVFATFSTLTFGM 
 
        301 ---------+---------+---------+---------+---------+E--------+---------+---------+---------+---------+---------+---------+---------+-----F---+---------+ 
  Opt1p 227 GAAGLTRRWVVNPASSIWPQTLISVSLFDSLHSRKVEKTVANGWTMPRYRFFLIVLIGSFIWYWVPGFLFTGLSYFNVILWGSKTRH---NFIANTIFGT---QSGLGALP--ITFDYTQVSQAMSGSVFATPFYVSANTYASVLIFFVI 
  Opt2p 289 GFAGILRKFVVYPARALWPTVMPTIAINKALLGK-----EKHESGMSRYKFFFLTFFIMFIYNWFPTYIINILNTFNWMTWIKPS-----NINLANITGG---VTGLGINP-ISSFDWNVIS--FN-SPLVYPFWSYLTQYLGCILAALI 
 AtOPT4 164 GWAGLLRKYVVEPAHMWWPSTLVQVSLFRALHEK------DD-QRMTRAKFFVIALVCSFGWYIVPGYLFTTLTSISWVCWAFPR-----SVTAQQIGSG---MRGLGLGA--FTLDWTAVAS-FLFSPLISPFFAIANVFIGYVLLIYF 
CaOpt1p 212 AFGGVMRRFVVDSPGAIWPSNLVTATFLTNMHIN--ENHTANGWKISRLAFFVIVFVASFVWYWFPGYIFQALSYFSWITWIKPN-----NVIINQVFGS---SSGLGMIPNNIALDWNQIAGYIG-SPLIPPASVIATIFGSIVLIFWI 
  Isp4p 214 GLAGLSRRLLVRPASMLWPVNLVQCTLIKTLHRKDLRNAVANGWRISPFRFFLYVFIASFIWNWFPSYIFQALSLFAWVTWIRPN-----SPTVNQIFGE---STGISILP--MTFDWNQISAYIL-SPLMAPADALMNILLGVILFFWI 
  Mtd1p 212 GLVGILRPLTVYPAEMVYWSNLPQVTVFQALHFN-------RHESTKRVRVFWWGFTIMFIYELFPAYIFPLLNSVSIFCLASQKAKPSTRDVFTNIFGGGNANEGLGLLN--FSFDWQYIGS----NYMSYPLLQQANSWIG-LGACYV 
 
        451 ---------+---------+---------+---------+---------+---------+G--------+---------+---------+---------+---------+---------+---------+---------+--H------+ 
  Opt1p 369 VLPCLYF-TNTWYAKYMPVISGSTYDNTQNKYNVTKILN-EDYSINLEKYKEYSPVFVPFSYLLSYALNFAAVIAVFVHCILYHG---KDIVAKFKDRKN-----------------------GGTDIHMRIYSKNYKDCPDWWYLLLQI 
  Opt2p 422 VI-AVYY-SNYMSCQYLPIFTNSLYTNTGHSFKVTEVLD-SDNKLDVKKYQSYSPPYYSAGNLVSYGAFICAYPLMITWSFIVHS---KLLFNAFKDWALNLWAMRKLKSWVTMFKSDYRALDDYDDPHSNAM-KNYKEVPDWWYFAILI 
 AtOPT4 296 VLPLAYWGFDSYNATRFPIFSSHLFTSVGNTYDIPAIVN-DNFELDLAKYEQQGRINLSMFFALTYGLGFATIASTLTHVALFYG---KEISERFRVSYK-----------------------GKEDIHTRLM-KRYKDIPSWWFYSMLA 
CaOpt1p 351 VVPAIHY-SNTWYSQYLPISSTGSFDRFQQTYNVSKIIDHKTLSFNEAEYKKYSPLFLSTTFAISYGLSFASILATITHTICFHG---RDLIASLKAKEK-------------------------PDVHNRLM-KAYKPVPEWWYLVVFL 
  Isp4p 353 VTPALNF-TNTWYGDYLPISSSGIIDHFGNSYNVTRILT-KDATFDLDAYQNYSPIFMSTTYALAFGLSFASITSVIFHVILYHG---KEIYDRLRDPPA-------------------------PDIHEKLM-KAYDEVPFYWYLSVFL 
  Mtd1p 348 IMAAIYY-SNAWDSKNYKMLSTSIFNHNGTVYDQAAVFG-KNGILNETALEEYGLPAMTGSNAWANFAQNLAIGALIAHVTLFWSGDMRDAVLHFRNGKK-----------------------TNDDPHYLAM-QKYKEAPWWWYFILLF 
 
        601 ---------+---------+I--------+---------+---------+---------+---------+---------+---------+---------+--J------+---------+---------+---------+---------+ 
  Opt1p 491 VMIGLGFVAVCCF--DTKFPAWAFVIAILISLVNFIPQGILEAMTNQHVGLNIITELICGYMLPLRPMANLLFKLYGFIVMRQGLNLSRDLKLAMYMKVSPRLIFAVQIYATIISGMVNVGVQEWMMHNIDGLCTTDQP---NGFTCANG 
  Opt2p 565 GSLVVGIAVVEHY--PTNTPVWGLFVCLGFNFVFLIPTTILQATTGYSFGLNLLIEMVMGYALPGNPIAIMILKAFGYNIDGQADNYVSNLKIAHYCKIPPMALFRGQCVIVFIQIFVNLGVLNWQISNIKDFCTPHQN---AKFTCPDA 
 AtOPT4 418 ATLLISLALCVFLNDEVQMPWWGLVFASAMAFVFTLPISIITATTNQTPGLNIITEYAMGLIYPGRPIANVCFKVYGYMSMAQAVSFLNDFKLGHYMKIPPRSMFLVQFIGTILAGTINITVAWWQLNSIKNICQEELLPPNSPWTCPGD 
CaOpt1p 471 VFFGMSIATVRAW--PTEMPVWGLVFALIIAIIFLLPVAIIYAKTNIAVGLNVVTEFIVGYVLGGRPLCMMLFKTFGYITNNQAVTFVQDMKLGHYMKIDPRTLFWAQFAATIWGSLVQIAVLEWAYGAIDNLCAADQK---NHYTCPNG 
  Isp4p 472 AFFGMMMGTIYGW--KTETPWWVIIVGVIFSAVWFIPIGIVQAITNIQLGLNVFTEFIVGYMYPGRPLAMMIFKTVGYITMTQGLAFAADLKFGHYMKLPPRIMFYTQMIATIWSCFVQIGVLDWALGNIDNVCQADQP---DNYTCPNA 
  Mtd1p 472 LAFIAGLIVCIKG--ETSLPWWSYIVSLAVGAFITPFSTILYGRMGNGIATNNLMKMIPGALNPGRPVANLYFSMWSHDVVSTSIGLAGDLKVGQYTKVPPRVMFLTQLWGCILGAIVNYVVMISIVDAQREVLLDASG--TNVWSGQTI 
 
        751 ---------+---------+------K--+---------+---------+---------+---------+---------+---------+---------+---------+-L-------+---------+---------+---------+ 
  Opt1p 636 RTVFNASIIWSL--PKYLFSSGRIYNPLMWFFLIGLLFPLAVYAVQWKFPKFK--FAKHIHTPVFFTGPGNIPPSTPYNYSLFFA---MSFCLN-LIRKRWRAWFNKYNFVMGAGVEAGVAISVVIIFLCVQYPG---GKLS-WWGNNVW 
  Opt2p 710 VTYYNASVVWGAIGPKRIFN--YIYPIFKWCWLIGACIG-IFFGVWKRWGK----FYPRYFDPMLFVG-GMLNMSPPYNLMYYTSGMIVSYISQYYMKRHHLNLWEKYNYVLSAGFSTGLVLSAIIIFFAVQYKD---TAFN-WWGNTVP 
 AtOPT4 568 RVFFDASVIWGLVGPKRIFGSQGNYAAMNWFFLGGALGPVIVWSLHKAFPKRS--WIPLVNLPVLLGATAMMPPATAVNYNSWIL---VGTIFNLFVFRYRKSWWQRYNYVLSAAMDAGVAFMAVLLYFSVGMEE---KSLD-WWGTRGE 
CaOpt1p 616 KVFFNASIIWGVIGPQRQFSHGQIYYGLLFFFIIGAVTPVINWLILKKWPN-S--PVKYLHWPVFFSGTGYIPPATPYNYTSYCA---VGLFFGWWIKKKWFHWWSKYNYSLSAGLDIGLAWCSLIIFLCLSLTN---TDFPSWWGNDVI 
  Isp4p 617 TVFFNSSVIWGVIGPKRMFSGKNTYTGLQYFWLAGVLGTILFWALWKKWPQ-K--WWGQLNGPLIFGGTGYIPPATPVNYLAWSG---IGLFFNYYLKKIFADWWQKYNFTLSA-LDTGTQLSVIILFFCLQLPM---VNFPDWWGNDGA 
  Mtd1p 618 QSLNSQAVTWSLA--KELYSASGPYVIVPIGLAIGLVPPFIQWLISKRWPTIKGIKVESIILPIIFNYAQTMSKGITSYVSTSIV---IGLVSQLWLRQHHPVWYRKYNYILGGAFDGGAQVMVFILSFAVFGASGVERPFPSWAGN-PA 
 
        901 ---------+---------+---------+ 
  Opt1p 774 KRTYDNDYKK--FYTLKKGETFGYDKWW  
  Opt2p 848 YAGADGVGYPLKNITDTANGYFGYAPGHYP 
 AtOPT4 709 HCDLAKCPTA--RGVIVDGCP 
CaOpt1p 757 NTTLDTQVVTNIRHILKEGEAFGPSSW 
  Isp4p 757 FNTLDATGAA-VRKLVNESAR 
  Mtd1p 762 KGNIDYCNGN---GALDAS 
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of the TMDs were frequently tryptophans, phenylalanines, and tyrosines.  von Heijne has 
noted that there are frequently aromatics, specifically tryptophans and phenylalanines, at 
the ends of membrane-spanning segments — at the interface between the membrane 
and the aqueous environment.  TMs B, C, D, F, G, and L do not have conserved 
aromatic residues flanking them (Figure 4-4), but often non-conserved aromatic residues 
are located at the border.  In every member studied, TM-E is full of aromatic residues. 
 
Prediction of topological orientation of the OPT family. 
The distribution of the positively charged amino acids arginine and lysine were 
examined in our OPT family TMD model (Table 4-2).  The “positive-inside rule” (von 
Heijne 1986) states that the location of most arginines and lysines found in non-
transmembrane segments is preferentially the cytoplasmic side, although this is less 
pronounced in eukaryotes (Sipos and von Heijne 1993).  In the OPT family, we see 
strong evidence of this after TM-G (in loop 7), which is approximately the middle of the 
proteins.  In each of the OPTs in this study, more than half of the positively charged 
residues are in the C-terminal half of the protein. 
In eukaryotes, the “charge-difference rule” is a good predictor of the orientation of 
membrane-spanning proteins (Sipos and von Heijne 1993).  It states that of the 15 
residues on either side of the first TMD, the extra-cytoplasmic residues will have a 
greater net negative charge than those in the cytoplasm.  In the OPT family, the end of 
the first conserved motif, SPYXEVRXV[V/T]X3DDP, falls within 15 residues of the first 
predicted TMD.  The DD is 92/83% conserved, and often more aspartic acid, or even 
glutamic acid, residues are also present nearby.  Following this rule, the N-termini of the 
family would be extra-cellular. 
 
Discussion 
We have determined, via a combination of computational algorithms and multiple-
sequence alignment, the location of 12 TMDs in the OPT family.  Although a similar 
study has been conducted by Bertaccini and Trudell (2002) on human ligand-gated ion 
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Table 4-2.  Charged residues involved in determination of topological 
orientation of the OPT family.  A.  The number of negatively charged residues 
and total number of residues in the N-terminus is given for each protein in this study.  
The percentage of negatively charged residues is tightly conserved between 23.1 and 25.  
B.  The number of positively charged residues in the termini and loops shorter than 70.  
Loops are numbered starting with those most N-terminal:  loop 1 is between TM-A and 
-B, loop 2 is between TM-B and -C, etc. 
 
 
A. 
Negative charges in N-terminus 
 Opt1p Opt2p AtOPT4 CaOpt1p Isp4p Mtd1p 
negative 25 40 9 22 23 20 
total 109 168 36 94 94 85 
 
 
B. 
Positive charges 
loop Opt1p Opt2p AtOPT4 CaOpt1p Isp4p Mtd1p 
N-terminus * * 2 * * * 
1 1 1 1 1 0 1 
2 4 6 5 2 6 6 
3 1 1 2 1 3 1 
4 7 8 7 4 9 5 
5 2 1 2 1 1 3 
6 5 4 3 5 2 3 
7 8 9 9 7 5 6 
8 1 0 0 0 1 1 
9 7 4 5 6 5 6 
10 3 4 4 3 3 2 
11 9 7 7 7 6 8 
C-terminus 8 2 4 2 3 2 
*  Not relevant with respect to positive-inside rule since this segment is greater than 70 
residues long. 
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channels, never before has such been done over such a diverse family or over multiple 
species. 
The TMDs of four multiple-pass TMD proteins with solved crystal structures were 
correctly predicted by the consensus approach.  The use of multiple algorithms allowed 
results for each potential membrane-spanning region to be confirmed or rejected by the 
other algorithms.  Indeed, it has been suggested that compiling several algorithms 
improves the prediction outcome (Nilsson et al. 2002). 
Our model (Figure 4-5) shows that the conserved residues of the family (Chapter 1) 
fall outside of the TMDs.  One would expect highly conserved residues to reside in 
conserved locations with respect to the membrane.  If a region of a protein has had 
selective pressure placed on it so that it had been retained throughout evolution, the 
region likely has functional or structural significance.  One would not anticipate an area 
such as this to be located in the middle of the membrane in one family member while 
being more exposed in the loop of another member that carries out a similar function.  
Indeed, one would even go so far as to say one would expect a family to retain a similar 
topology. 
The conserved proline motifs EXIXGYX2PG[R/K]PXAX4KX2G and PPX[N/T]p have 
been assigned to loop regions found on the same side of the membrane.  Four of the 
OPTs in this study have yet another proline at the end of the PPX[N/T]p motif.  These 
regions are perhaps SH3 binding domains, which are characterized by the motif PXXP 
(Mayer 2001).  When PDB was searched for the sequence PGRP, 29 structures were 
found which contain the sequence; 18 of these were unique.  In each of these 
structures, a bend in the backbone occurred at the glycine, and about half of the time, 
the flanking sequences folded in a hairpin configuration.  We propose a similar structure 
in the OPT family.  Since the conserved region is E(X)7PG[R/K]P(X)6K, where X is 
almost always hydrophobic and never charged, the charged glutamyl and lysyl residues 
would bee brought together to form a potential ionic interaction, stabilizing the loop. 
Our predicted topology places both the N- and C-termini outside of the cell (Figure 
4-5).  Although this positions a similar number of positive charges inside versus outside 
of the cell, the concentration of negative charge immediately prior to the first TMD 
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Figure 4-5.  Diagram of Opt1p topology.  Our model places the termini in the 
extracellular space.  TMDs are labeled A through L, while loops connecting the TMDs 
are numbered 1-11.  Positively and negatively charged residues are shaded blue and red, 
respectively; aromatic residues are shaded green.  Conserved motifs (Chapter 1, Figure 
1-2) are circled with orange. 
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strongly suggests that the N-terminus is extracellular.  Not only is the N-terminal region 
immediately adjacent to TM-A highly negatively charged, but also the whole N-terminus 
is greatly negatively charged.  In the six OPT family members studied, aspartyl and 
glutamyl make up from 23.1% to 25% of the N-terminal segment — even the percentage 
of acidic residues is conserved!  Five of these six family members have over 80 residues 
in the N-terminus (AtOPT4 is the exception, with 36).  Perhaps this large negative 
charge serves to balance the positively charged residues found in the outer loops (Figure 
4-5).  Since these are transporters of charged peptides, we can imagine that both the 
excess positive charges in the loops and the abundance of negatively charged residues in 
the N-terminus are involved in recognition and binding of oligopeptides. 
Frequently, the boundaries of the TMDs are composed of aromatic residues.  Sipos 
and von Heijne (1993) have suggested this serves to stabilize the TMD at the 
hydrophilic-hydrophobic interface.  More than half of the tryptophan, phenylalanine, and 
tyrosine residues present in Opt1p are located within five residues from the edge of the 
transmembrane segment (Figure 4-5).  Only TMs D, E, and F contain three or more of 
these residues in their core.  Perhaps the juxtaposition of these more aromatic TMDs 
provides interaction with the substrate, or perhaps it allows them to simply stabilize 
each other. 
Our predicted topology of the OPT family (Figure 4-5) is not necessarily the only 
possible model.  Although Sipos and von Heijne (1993) state that the charge-difference 
rule is likely a better predictor of topology in eukaryotes than the positive-inside rule is, 
we show almost an equal number of positive charges on both faces of the proteins 
(Table 4-2).  There are two ways to fix this problem:  either omit TM-E or bend it so it 
does not pass through the membrane but exits the same side from which it entered.  
Since TM-E is very strongly predicted (Figure 4-4), perhaps the later conformation is 
more likely.  TM-E does contain a conserved proline, often followed by a glycine, which 
may induce a bend in the helix.  It also contains more aromatic residues in the core of 
the TMD than any other TMD in the protein; this suggests that it may not go through 
the middle of the membrane but remain at the membrane interface. 
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When comparing results of the S. cerevisiae protein Ygl114wp, which Milton Saier 
has classified as an OPT (Yen et al. 2001; tcdb.ucsd.edu/index.php), to the rest of the 
family’s topology prediction, they are not at all consistent with Ygl114wp being a family 
member (data not shown).  First of all, since most of the conserved domains of the OPT 
family are absent from Ygl114wp, an alignment is weak at best.  The overall topology of 
Ygl114wp is strikingly different in the size and location of the extra- and intracellular 
loops. 
It is obvious that individual algorithms are insufficient for the determination of even a 
initial secondary structure prediction of transporters residing in the membrane.  For the 
first time, the employment of multiple algorithms combined with a multiple sequence 
alignment can yield a prediction in which confidence can be placed and may be used as a 
basis for hypothesis-driven experiments that can lead to a more accurate structure.  But 
for now, from the data gathered from proteins with known structure, we likely have a 
good model for the OPT family.  Now what awaits is empirical evidence to support our 
consensus approach. 
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Chapter 5 
Summary and conclusions. 
 
Members of the Oligopeptide Transport (OPT) family are integral membrane 
proteins that transport tetra- and pentapeptides — and some of them glutathione or its 
derivatives — across the plasma membrane.  Our laboratory first identified the OPT 
family in Candida albicans by phenotype (Lubkowitz et al. 1997), and later homologues 
were identified by sequence similarity and their subsequent cloning (Lubkowitz et al. 
1998; Hauser et al. 2000; Koh et al. 2002).  Specifically, one of the family members found 
in Saccharomyces cerevisiae, Opt1p, transports the pentapeptide Leu-enkephalin (Tyr-Gly-
Gly-Phe-Leu) and reduced glutathione (γ-Glu-Cys-Gly).  This uptake can be inhibited by 
other tetra- and pentapeptides and ligands of opioid receptors, such as morphine and 
naloxone, but not inhibited by di- or tripeptides or by free amino acids. 
Currently, there are 103 OPT members identified by sequence homology:  81 in 
fungal species and 22 in plant.  If an OPT is found in a completed genome, there is a 
multiplicity of OPT members in that genome.  OPTs have been found only in fungal and 
plant species — our screen for a functional homologue of Opt1p from S. cerevisiae in rat 
yielded no peptide transporters.  Members of the family are identified by 18 conserved 
motifs stretching across almost the entire primary sequence, from before the first 
predicted transmembrane domain (TMD) until after the last; these conserved motifs are 
at least four residues long.  By a combination of familial, global alignment and numerous 
computational algorithms, we predict 12 TMDs in the OPT family, with the termini 
placed outside of the cell because of the charge-difference rule. 
The gene encoding Opt1p in S. cerevisiae, OPT1, is regulated by sulfur source and 
amino acids.  When grown without sulfate, cells up-regulate OPT1.  When this sulfur is 
added back in the form of cysteine, OPT1 is no longer up-regulated, and when media is 
supplemented with methionine, OPT1 is down-regulated.  All other amino acids up-
regulate OPT1, presumably through Ssy1p and Ptr3p, since no up-regulation is observed 
when the proteins are not present. 
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Future Directions 
The next step in the further study of the OPT family is to test our TMD predictions.  
Antibodies could be designed to the N- and C-termini to check their intra- versus 
extracellular locations, or a reporter protein could be used to tag the end to determine 
the location of the C-terminus.  Chimeric and mutational analyses could be performed, 
but it would be wise to consider using several methods and to position the truncations 
and mutations at various points along the predicted loops.  Additionally, the possibility 
of the two proline motifs being SH3 binding domains needs to be investigated. 
The roles of the other conserved motifs may also be examined.  These may confer 
specificity for substrate, couple transport with the symport of protons as an energy 
source, or be involved in the protein’s regulation and post-translational modification.    
A thorough alanine-scanning of these residues by site-directed mutagenesis is bound to 
reveal the function of at least some of these motifs. 
In addition, further studies of OPT regulation need to be carried out with regards to 
OPT2.  Gasch et al. (Gasch et al. 2000) made the observation that OPT2 was up-regulated 
during stationary phase, although we did not observe this when cells were grown up to 
48 hours.  Boer et al. (Boer et al. 2003) made no observations on OPT2 since it 
apparently was not included on their microarray — a common problem with genes on 
the second arm of the sixteenth chromosome.  A wider variety of nitrogen, sulfur, and 
carbon sources should be tried, as well as samples from close time-points over several 
days. 
Although it appears that the protein encoded by YGL114W is not an oligopeptide 
transporter, it is obviously plays an important role in cell growth:  ygl114wΔ cells have a 
doubling time of six hours, instead of two, and do not divide as many times as wild-type 
cells.  It is likely either involved in cell division or nutrient utilization, or perhaps even 
cell aging.  The first experiment to begin investigation of this protein’s function is 
microarray analysis comparing a ygl114wΔ strain to a wild-type strain. 
Perhaps the most interesting line of inquiry involves the role of the seven OPTs in C. 
albicans.  CaOpt1p is known to transport KLGL; it is not known what the substrates of 
the other six might be:  tetra- and pentapeptides, glutathione, or perhaps both.  Isp4p 
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from Schizosaccharomyces pombe and Mtd1p from Schizophyllum commune were both 
identified by their expression under conditions in which cells mate.  Three OPTs in C. 
albicans are up-regulated in the opaque phase of this organism, the only phase in which 
C. albicans has been observed to mate.  Perhaps these OPTs are required for mating, or 
even required to switch to the opaque phase.  These three OPTs are also up-regulated 
in C. albicans when the cell has been engulfed by a macrophage, which has an implication 
that they are involved with virulence.  While knocking-out genes in C. albicans is more 
difficult than in S. cerevisiae, Reuß et al. (Reuß et al. 2004) have begun knocking these 
genes out, and our lab is well equipped to carry out experiments involving white-opaque 
switching, mating, and even virulence. 
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Appendix 1 
Media 
All percentages are weight/volume (g/100 mL) unless otherwise noted.  If media was 
to be used for plates 2% agar was added before autoclaving.  Media were tempered at 
55 C before the addition any drug, peptide, or pre-made YNB.  Filtrations were done 
using 0.45 µM, HV Durapore membranes (Stericup, Millipore; Billerica, MA) attached to 
a syringe.  Unless otherwise noted, compounds were obtained from Difco/BD; Franklin 
Lakes, NJ. 
 
E. coli media. 
LB 
Tryptone (1%), yeast extract (0.5%), sodium chloride (1%).  Autoclaved to sterilize. 
With ampicillin (LB +Amp):  Final concentration 100 µg/mL (stock at 100 mg/mL in 50% 
ethanol) (Sigma; St. Louis, MO).  Filtered to sterilize. 
 
Yeast media. 
YEPD 
Yeast extract (1%), peptone (2%), glucose (2%).  Autoclaved to sterilize. 
With G418/geneticin (for KanMX3 cassette selection):  Final concentration 200 µg/mL 
(Invitrogen; Carlsbad, CA). Filtered to sterilize. 
With hygromycinB (for HphMX4 cassette selection):  Final concentration 300 µg/mL 
(Sigma; St. Louis, MO). Filtered to sterilize. 
With clonNAT (for NatMX4 cassette selection):  Final concentration 100 µg/mL 
(Werner BioAgents; Jena-Cospeda, Germany).  Filtered to sterilize. 
 
Casamino acid medium 
Glucose (2%), casamino acids (0.2%).  Autoclaved to sterilize. Filter sterilized YNB 
without amino acids added to the final concentration 6.7%. 
116 
Poor nitrogen medium 
Glucose (2%).  Autoclaved to sterilize.  Filter sterilized proline added at the final 
concentration of 0.1%.  Filter sterilized YNB without ammonium sulfate, without 
amino acids added to the final concentration 0.17%. 
With uracil:  when uracil was required for auxotrophic requirements, it was added at 
the final concentration of 20 µg/mL.  Filtered to sterilize. 
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Table A-1.  Synthetic complete medium formula and modifications.  
Synthetic complete medium (SC), with modifications made for media containing reduced 
carbon (r C) or no carbon (no C), reduced nitrogen (r N) or nitrogen (no N), reduced 
sulfur (r S) or no sulfur (no S), and reduced nitrogen and sulfur (r NS) or no nitrogen 
and sulfur (no NS).  The SC formula was first referred to as “nitrogen base for carbon 
assimilation tests” but without the listed amino acids, and it assembled as described 
(Wickerham 1946; Wickerham 1951).  Compounds are listed as mg/L. 
 
 
Compounds SC r C no C r N no N r S no S r NS no NS 
H3BO3 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
CuSO4⋅5H2O 0.04 0.04 0.04 0.04 0.04 — — — — 
CuCl2 — — — — — 0.022 0.022 0.022 0.022 
KI 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 
FeCl3⋅6H2O 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 
MnSO4⋅1H2O 0.4 0.4 0.4 0.4 0.4 — — — — 
MnCl2 — — — — — 0.298 0.298 0.298 0.298 
Na2MoO4⋅2H2O 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 
ZnSO4⋅7H2O 0.4 0.4 0.4 0.4 0.4 — — — — 
Zn(CH3CO2)2 — — — — — 0.305 0.305 0.305 0.305 
biotin 0.002 0.002 0.002 0.002 0.002 0.002 0.002 0.002 0.002 
calcium pantothenate 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 
folic acid 0.002 0.002 0.002 0.002 0.002 0.002 0.002 0.002 0.002 
inositol 2 2 2 2 2 2 2 2 2 
niacin 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 
p-aminobenzoic acid 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 
pyridoxine HCl 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 
riboflavin 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 
thiamine HCl 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 
KH2PO4 1000 1000 1000 1000 1000 1000 1000 1000 1000 
MgSO4⋅7H2O 500 500 500 500 500 50 — 50 — 
MgCl2 — — — — — 174.15 193.5 174.15 193.5 
NaCl 100 100 100 100 100 100 100 100 100 
CaCl2⋅2H2O 100 100 100 100 100 100 100 100 100 
glucose 20000 2500 — 20000 20000 20000 20000 20000 20000 
(NH4)2SO4 5000 5000 5000 500 — — — — — 
NH4Cl — — — — — 4046 4046 404.6 — 
Na2SO4 — — — 4830 5367 — — — — 
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Table A-2.  Amino acids added to satisfy auxotrophic requirements or 
to test induction of OPT1.  Final concentrations of amino acids supplemented to 
medium, given in µL/mL. 
 
 
Amino acid Final concentration 
A 40 
C 40 
D 100 
E 100 
F 50 
G 40 
H 20 
I 30 
K 30 
L 30 
M 20 
N 40 
P 40 
Q 40 
R 20 
S 400 
T 200 
V 150 
W 20 
Y 30 
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Appendix 2 
Strains 
 
Name Genotype Parent Reference 
FY2 MATa ura3-52 S288C (Winston et al. 1995) 
AW1001 MATa ura3-52 opt1Δ::KAN FY2 This study 
AW1002 MATa ura3-52 opt2Δ::HPH FY2 This study 
AW1003 MATa ura3-52 ygl114wΔ::NAT FY2 This study 
AW1004 MATa ura3-52 ptr3Δ::NAT FY2 This study 
AW1005 MATa ura3-52 ssy1Δ::KAN FY2 This study 
AW1009 MATa ura3-52 ptr3Δ::NAT ssy1Δ::HPH FY2 This study 
BY4730 MATa leu2Δ met15Δ ura3Δ FY2 (Brachmann et al. 1998) 
BY4730 
opt1Δ opt2Δ 
MATa leu2Δ met15Δ ura3Δ 
opt1Δ::KAN opt2Δ::HPH 
BY4730 This study 
BY4742 
opt1Δ 
MATα his3Δ leu2Δ lys2Δ ura3Δ 
opt1Δ 
FY2 (Brachmann et al. 1998) 
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Appendix 3 
Plasmids 
 
Name Genotype Parent Reference 
pDB20 URA3 AmpR ADHp — (Becker et al. 
1991) 
pADH212c URA3 AmpR ADHp-OPT1 pDB20 (Lubkowitz et al. 
1998) 
pADH194c URA3 AmpR ADHp-OPT2 pDB20 (Lubkowitz et al. 
1998) 
pADHCaOPT URA3 AmpR ADHp-CaOPT1 pDB20 (Lubkowitz et al. 
1997) 
pADH114w URA3 AmpR ADHp-YGL114W pDB20 This study 
pUG6 Contains the KAN cassette kanMX3, 
which is loxP-flanked, conferring 
resistance to G418 
— (Gueldener et al. 
1996) 
pAG25 Contains the NAT cassette natMX4, 
conferring resistance to (clonNAT) 
pUG6 (Goldstein and 
McCusker 1999) 
pAG32 Contains the HPH cassette hphMX4, 
conferring resistance to hygromycin B 
pUG6 (Goldstein and 
McCusker 1999) 
pYLZ6 URA3 AmpR lacZ (no promoter) — (Hermann et al. 
1992) 
pYLZ6-OPT1 URA3 AmpR OPT1p-lacZ pYLZ6 This study 
pYLZ6-OPT2 URA3 AmpR OPT2p-lacZ pYLZ6 This study 
pYLZ6-
YGL114W 
URA3 AmpR YLG114Wp-lacZ pYLZ6 This study 
pVT102U URA3 AmpR ADHp — (Vernet et al. 
1987) 
pVT102Ulib URA3 AmpR ADHp::rat brain cDNA 
library 
pVT102U (Burton et al. 
1993) 
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Appendix 4 
Primers 
 
Primer Sequence 5’ to 3’ Comments 
clone114F GCATACAACTCCAAGCTTCGAGATGCCTCAATCTAC 
  TCCAAGTCAAGAAG 
construction of 
pADH114W 
clone114R GGCGAAGAAGTCCAAAGCTTCGAGCGGCCGCTAATG 
  TGAGGGACATTTAAGCAGATGAAGAGC 
construction of 
pADH114W 
F_pDB20_insert_
check 
AATATTTCAAGCTATACCAAGC sequence check 
pADH114W 
R_pDB20_insert_
check 
GCCGACAACCTTGATTGG sequence check 
pADH114W 
F_114_checkA GCTGGGGTGTGTTAGCAC sequence check 
pADH114W 
R_114_checkB CATCCAGTGATAACGGTGG sequence check 
pADH114W 
KO_029_F GGTACGAAATACACAACTGATAGGCGTTCATGCACT 
  CTCACAGCTGAAGCTTCGTACGC 
YFR029W (PTR3) knockout 
KO_029_R GTGGAATATTTGCTTACATTTGGTGATTTCGCGAGA 
  TTGGGCATAGGCCACTAGTGGATCTG 
YFR029W (PTR3) knockout 
KO_114_F CCGTTAAAGATTCTAAATCGGTACTGTAAATACTTT 
  GAAACAGCTGAAGCTTCGTACGC 
YGL114W knockout 
KO_114_R CCTAATAGTGAGGGACATTTAAGCAGATGAAGAGCA 
  TGTTGCATAGGCCACTAGTGGATCTG 
YGL114W knockout 
KO_160_F GGGAAGTTCCTTGAGGAATATGAGTTCTGTCAACCA 
  AATACAGCTGAAGCTTCGTACGC 
YDR160W (SSY1) knockout 
KO_160_R CCCTAAATCAGCCAGGTAACCAACTTCTTCGCTCTT 
  TCCCGCATAGGCCACTAGTGGATCTG 
YDR160W (SSY1) knockout 
KO_194_F GGGTTTGTTATACGCAATATTGCTGTTGAATTATTA 
  GAAACAGCTGAAGCTTCGTACGC 
YPR194C (OPT2) knockout 
KO_194_R GCGTTCTAAGAAAAGTTCTAGTCATGGATAGTGTCC 
  TGGAGCATAGGCCACTAGTGGATCTG 
YPR194C (OPT2) knockout 
KO_212_F GGCAGAAAATAACCGCAACAATTATATAACGTCACA 
  GAACCAGCTGAAGCTTCGTACGC 
YJL212C (OPT1) knockout 
KO_212_R CCACCATTTATCATAACCAAATGTCTCACCTTTCTT 
  TAAGGCATAGGCCACTAGTGGATCTG 
YJL212C (OPT1) knockout 
check_029_F CCTTTATCATTATTTCATGAGGCGCAC YFR029W PCR check 
knockout 
check_029_R GCCACACCTGTGGGGTGAATTGTGG YFR029W PCR check 
knockout 
check_114_F CGCCGTAGAAGGTATTTTTCGTGAG YGL114W PCR check 
knockout 
check_114_R GATAGCCGATATTTCAAGGTCGCG YGL114W PCR check 
knockout 
check_160_F GGAAACAGGCGTGTGATAAGAGGCC YDR160W PCR check 
knockout 
check_160_R CAGTTACCCGCACAATCTAGTGCG YDR160W PCR check 
knockout 
cont. on next page 
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cont. from previous page 
Primer Sequence 5’ to 3’ Comments 
check_194_F CATTGAACGTCTAAACAACGGCGGC YPR194C PCR check 
knockout 
check_194_R CTATAGTACAGAGTTACTTTGATATG YPR194C PCR check 
knockout 
check_212_F GGGCTATTCAATGAATTGTTTCGAC YJL212C PCR check 
knockout 
check_212_R GGGGTCGCTTTGAATGTTTCGACC YJL212C PCR check 
knockout 
probe_029_F CGGATATAGCGAGGGTGCTCG YFR029W probe 
probe_029_R CCACAAAGAAAGTCCCCTTTCTG YFR029W probe 
probe_114_F CAGATAACACTCCGAGCAACC YGL114W probe 
probe_114_R CACCTAAGACCAACCCCGAACTG YGL114W probe 
probe_160_F CATGATACTTCGTCCAGCCTTGC YDR160W probe 
probe_160_R GTTCGGTCCAGTCAGTTCTGTCC YDR160W probe 
probe_194_F GGTACTGTTGATTACGCCGAGGG YPR194C probe 
probe_194_R GTATCAGTTATGTTCTTTAGAGG YPR194C probe 
probe_212_F CGACTCGTTGGAGTCGGAGCCC YJL212C probe 
probe_212_R CGTTGTTTCCCCACCAGCTGAGC YJL212C probe 
212prom_pYLZ_F GCAGCTGAATTCAAAGCTTAGGATCCCTAAATTAAC 
  CCATTTGTACAGC 
creation of pYLZ6-OPT1 
212prom_pYLZ_
R 
CCCAGTCACGACGTTGTAAAACGACCATAATTTCTA 
  ATAATTCAACAGC 
creation of pYLZ6-OPT1 
194prom_pYLZ_F GCAGCTGAATTCAAAGCTTAGGATCCCGTGTCAACT 
  TTGCATTAACGCG 
creation of pYLZ6-OPT2 
194prom_pYLZ_
R 
CCCAGTCACGACGTTGTAAAACGACCATAATTTCTA 
  ATAATTCAACAGC 
creation of pYLZ6-OPT2 
114prom_pYLZ_F GCAGCTGAATTCAAAGCTTAGGATCCCCTAGACCCT 
  TATTTGAGGCGTG 
creation of pYLZ6-
YGL114W 
114prom_pYLZ_
R 
CCCAGTCACGACGTTGTAAAACGACCATTTCAAAGT 
  ATTTACAGTACCG 
creation of pYLZ6-
YGL114W 
seqcheck_pYLZF GGAAGAGCGCCCAATACGCAAACCG sequence check a promoter 
in pYLZ6 
seqcheck_pYLZR CCAGTCACGACGTTGTAAAACGACC sequence check a promoter 
in pYLZ6 
212-lacZ-F CAAGGGCAGTCGATGGGTCTG sequence check pYLZ6-
OPT1 
212-lacZ-R CAGACCCATCGACTGCCCTTG sequence check pYLZ6-
OPT1 
194-lacZ-F GGAATGGAACACTATCCTGTG sequence check pYLZ6-
OPT2 
194-lacZ-R CACAGGATAGTGTTCCATTCC sequence check pYLZ6-
OPT2 
114-lacZ-F GAAGGAAGATAATGCAAAGCC sequence check pYLZ6-
YGL114W 
114-lacZ-R GGCTTTGCATTATCTTCCTTC sequence check pYLZ6-
YGL114W 
ADHP_F CTGCACAATATTTCAAGCTATACC sequence pVT102U inserts 
ADHT_R GGCAAGGTAGACAAGCCGACAACC sequence pVT102U inserts 
cont. on next page 
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cont. from previous page 
Primer Sequence 5’ to 3’ Comments 
AD1 CATCGCCATGTTCATGTCCWAYTGGKTNCCa Forward CODEHOP
b 
AD2 TTCATCGCCATGTTCATCTGBWAYTGGKTNCa Forward CODEHOP
b 
AD3 TGTTCATCGCCATGTTCATCTDBWAYRGGKTa Forward CODEHOP
b 
AD4 TGAAGATGTAGCCGGGGAMCCARTWVHAa Forward CODEHOP
b 
AD5 GCAGGTGGTGTACCACACGTYNKTNCCCCACCa Reverse CODEHOP
b 
AD6 GCAGGTGGTGTACCACACGKYNKTNCCCCACa Reverse CODEHOPb 
AD7 CAGGTGGTGTACCACACGTTGKTNCCCCACCAa Reverse CODEHOPb 
a The standard single-letter designations for degenerate nucleotides was used:  R (A or 
G), Y (C or T), M (A or C), K (G or T), W (A or T), S (C or G), B (C, G, or T), D (A, 
G, or T), H (A, C, or T), V (A, C, or G), and N (A, C, G, or T). 
b CODEHOPs (COnsensus-DEgenerate Hybrid Oligonucleotide Primers; (CODEHOP:  
bioinformatics.weizmann.ac.il/blocks/codehop.html; Rose et al. 1998) were designed 
from BLOCKS (bioinformatics.weizmann.ac.il/blocks/).  BLOCKS is an algorithm to 
which a multiple sequence alignment is submitted, and the output is small regions of high 
similarity between sequences entered.  These regions are then submitted to the 
CODEHOP algorithm, the output being degenerate primers.  The OPT family members 
used were too divergent to obtain CODEHOPs few degenerate nucleotides.  The 
mouse codon-bias was selected in designing the primers, since they were to be used in 
screening the mouse genome for an OPT homologue. 
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